| ABALOPARATIDE_OSTEO_AUTO_FULL | OR | 2 | 0.931 | 0.212 to 4.080 | — | 53.0% | 0.145 | 0.0000 | — |
| ABALOPARATIDE_OSTEO_AUTO_FULL_REVIEW | MD | 2 | 5.518 | -199.684 to 210.720 | — | 90.3% | 0.001 | 521.0046 | Yes |
| ABATACEPT_PSA_AUTO_FULL | OR | 2 | 1.965 | 0.000 to 15274997330990084821616689152.000 | — | 83.2% | 0.015 | 50.9618 | Yes |
| ABATACEPT_RA_AUTO_FULL | OR | 3 | 5.425 | 0.000 to 10307094463136011386880.000 | 0.000 to 18890404436397217304651602921445711704752128.000 | 86.1% | 7.67e-04 | 388.6391 | Yes |
| ABEMACICLIB_BREAST_AUTO_FULL | OR | 2 | 1.669 | 0.044 to 63.656 | — | 0.0% | 0.809 | 0.0000 | Yes |
| ABLATION_AF | OR | 4 | 0.722 | 0.536 to 0.973 | 0.504 to 1.036 | 13.5% | 0.224 | 0.0041 | — |
| ACALABRUTINIB_CLL | OR | 2 | 0.119 | 0.027 to 0.525 | 0.027 to 0.525 | 0.0% | 0.542 | 0.0000 | Yes |
| ACALABRUTINIB_CLL_REVIEW | HR | 2 | 0.251 | 0.043 to 1.476 | — | 13.9% | 0.281 | 0.0000 | — |
| ACLIDINIUM_COPD_AUTO_FULL_REVIEW | MD | 3 | 0.025 | -1.603 to 1.652 | -3.229 to 3.279 | 91.1% | 1.27e-05 | 0.4288 | Yes |
| ACS_ANTIPLATELET | OR | 4 | 0.840 | 0.466 to 1.512 | 0.237 to 2.978 | 95.9% | 2.59e-07 | 0.1241 | — |
| ACS_ANTIPLATELET_REVIEW | RR | 4 | 0.848 | 0.001 to 754.117 | 0.000 to 3321543.900 | 91.0% | 2.91e-07 | 18.2009 | Yes |
| ACUTE_HF_DIURESIS_NEW | OR | 10 | 1.600 | 0.965 to 2.653 | 0.340 to 7.522 | 90.7% | 7.76e-12 | 0.4183 | — |
| ACUTE_HF_DIURESIS_NEW_REVIEW | RR | 6 | 1.092 | 0.034 to 35.419 | 0.000 to 10805.800 | 79.9% | 1.51e-04 | 10.9762 | Yes |
| ADALIMUMAB_PSA_AUTO_FULL | OR | 2 | 0.153 | 0.004 to 5.398 | — | 42.0% | 0.189 | 0.0000 | — |
| ADALIMUMAB_PSO_AUTO_FULL | OR | 2 | 2.891 | 0.136 to 61.519 | — | 0.0% | 0.575 | 0.0000 | Yes |
| ADALIMUMAB_RA_AUTO_FULL | OR | 2 | 0.570 | 0.000 to 209258051575.364 | — | 76.3% | 0.040 | 8.7444 | Yes |
| ADC_HER2_LOW | OR | 2 | 0.550 | 0.038 to 7.884 | 0.009 to 33.636 | 68.7% | 0.074 | 0.0609 | — |
| ADC_HER2_NMA | OR | 3 | 0.405 | 0.094 to 1.754 | 0.024 to 6.947 | 91.5% | 2.67e-06 | 0.3203 | — |
| ADJUVANT_IO_MELANOMA | OR | 3 | 0.511 | 0.338 to 0.772 | 0.287 to 0.909 | 31.9% | 0.229 | 0.0088 | — |
| ADJUVANT_IO_MELANOMA_REVIEW | HR | 3 | 0.558 | 0.073 to 4.276 | 0.010 to 31.664 | 53.0% | 0.119 | 0.6569 | Yes |
| ADJUVANT_IO_PAN_TUMOR | OR | 11 | 0.644 | 0.578 to 0.718 | 0.510 to 0.815 | 30.9% | 0.182 | 0.0087 | — |
| ADJUVANT_IO_PAN_TUMOR_REVIEW | HR | 11 | 0.699 | 0.646 to 0.755 | 0.646 to 0.755 | 0.0% | 0.644 | 0.0000 | Yes |
| ADUCANUMAB_AD_AUTO_FULL_REVIEW | MD | 2 | 0.222 | -1.196 to 1.640 | — | 0.0% | 0.687 | 0.0000 | Yes |
| AD_PEDIATRIC_BIOLOGIC_NMA_REVIEW | RR | 4 | 5.263 | 0.033 to 837.340 | 0.000 to 429648.319 | 55.1% | 0.083 | 10.0924 | Yes |
| AFLIBERCEPT_DME_AUTO_FULL | OR | 3 | 0.967 | 0.455 to 2.053 | 0.455 to 2.053 | 43.3% | 0.172 | 0.0000 | — |
| AFLIBERCEPT_DME_AUTO_FULL_REVIEW | MD | 2 | 0.724 | -10.036 to 11.483 | — | 46.3% | 0.172 | 0.0000 | — |
| AFLIBERCEPT_HD | OR | 2 | — | — | — | 0.0% | 0.620 | 0.0000 | Yes |
| AFLIBERCEPT_HD_REVIEW | MD | 2 | 0.750 | -2.427 to 3.927 | — | 0.0% | 0.621 | 0.0000 | — |
| AFLIBERCEPT_RVO_AUTO_FULL_REVIEW | MD | 2 | -0.304 | -5.350 to 4.742 | — | 93.4% | 9.94e-05 | 0.0000 | — |
| AGALSIDASE_BETA_FABRY_AUTO_FULL | OR | 2 | 1.347 | 0.001 to 3165.124 | — | 53.3% | 0.143 | 0.0000 | — |
| AGRYLIN_ET_AUTO_FULL | OR | 2 | 0.690 | 0.008 to 56.223 | — | 0.0% | 0.798 | 0.0000 | Yes |
| AGYW_HIV_PREP | OR | 2 | 1.338 | 0.021 to 83.599 | 0.002 to 1062.669 | 80.2% | 0.024 | 0.1703 | — |
| ALDO_SYNTHASE | OR | 2 | — | — | — | 49.4% | 0.160 | 3.1980 | — |
| ALDO_SYNTHASE_REVIEW | MD | 2 | -8.956 | -31.615 to 13.704 | — | 49.4% | 0.160 | 3.1979 | — |
| ALECTINIB_ALK_NSCLC_AUTO_FULL | OR | 2 | 3.409 | 0.000 to 160227505007023505612092797743565649928691112612521434167658223186504313915997886574842745978880.000 | — | 91.4% | 6.38e-04 | 588.0600 | Yes |
| ALEMTUZUMAB_TX_AUTO_FULL | OR | 2 | 1.126 | 0.007 to 178.161 | — | 0.0% | 0.771 | 0.0000 | Yes |
| ALIROCUMAB_LIPID_AUTO_FULL | OR | 3 | 0.125 | 0.000 to 52125070538259591374646059991040.000 | 0.000 to 19668586982865578720149804473547685789649154539597751520229064704.000 | 93.6% | 1.53e-07 | 912.6020 | Yes |
| ALK_NSCLC | OR | 4 | 0.340 | 0.193 to 0.600 | 0.127 to 0.913 | 51.7% | 0.102 | 0.0646 | — |
| ALK_NSCLC_REVIEW | HR | 4 | 0.426 | 0.011 to 17.079 | 0.000 to 1605.134 | 53.9% | 0.090 | 5.3496 | Yes |
| ALOGLIPTIN_T2D_AUTO_FULL | OR | 2 | 1.400 | 0.000 to 328230461309622080.000 | — | 86.2% | 0.007 | 19.7785 | Yes |
| ALOGLIPTIN_T2D_AUTO_FULL_REVIEW | MD | 2 | -0.771 | -28.508 to 26.966 | — | 94.7% | 1.51e-05 | 9.5251 | Yes |
| ALOPECIA_JAKI | OR | 5 | 22.172 | 7.862 to 62.532 | 3.701 to 132.822 | 39.7% | 0.193 | 0.2763 | — |
| ALOPECIA_JAKI_REVIEW | OR | 4 | 17.436 | 5.437 to 55.911 | 5.437 to 55.911 | 5.8% | 0.364 | 0.0000 | — |
| ALPELISIB_BREAST_AUTO_FULL | OR | 2 | 2.313 | 0.147 to 36.483 | — | 0.0% | 0.693 | 0.0000 | Yes |
| ALS_NEW_AGENTS_NMA_REVIEW | MD | 5 | 1.978 | 0.702 to 3.253 | 0.702 to 3.253 | 0.0% | 0.881 | 0.0000 | Yes |
| AMIVANTAMAB_LUNG_AUTO_FULL_REVIEW | HR | 2 | 0.526 | 0.000 to 82071804222551.438 | — | 90.4% | 0.001 | 13.2155 | Yes |
| AML_TARGETED_NEW | OR | 9 | 0.691 | 0.388 to 1.231 | 0.142 to 3.372 | 88.1% | 5.42e-06 | 0.4098 | — |
| AML_TARGETED_NEW_REVIEW | HR | 7 | 0.683 | 0.114 to 4.095 | 0.004 to 106.663 | 40.4% | 0.122 | 3.7251 | Yes |
| AML_VEN_FLT3_NMA | OR | 10 | 0.616 | 0.422 to 0.901 | 0.195 to 1.949 | 80.8% | 2.76e-09 | 0.2309 | — |
| AML_VEN_FLT3_NMA_REVIEW | HR | 5 | 0.694 | 0.577 to 0.835 | 0.577 to 0.835 | 12.4% | 0.335 | 0.0000 | — |
| AMOXICILLIN_AOM_AUTO_FULL | OR | 2 | 0.468 | 0.000 to 4806753302636392358467378961981430844956044113523423576238022411157504.000 | — | 93.2% | 1.32e-04 | 321.6802 | Yes |
| ANAMORELIN_CACHEXIA_AUTO_FULL_REVIEW | MD | 2 | 1.559 | -1.419 to 4.538 | — | 0.0% | 0.721 | 0.0000 | Yes |
| ANCA_VASCULITIS_NMA | OR | 10 | 1.085 | 0.512 to 2.298 | 0.107 to 11.041 | 90.6% | 7.60e-12 | 0.9419 | — |
| ANCA_VASCULITIS_NMA_REVIEW | HR | 4 | 0.462 | 0.000 to 1562.904 | 0.000 to 34870239.630 | 80.6% | 0.001 | 25.9682 | Yes |
| ANDEXANET_BLEEDING_AUTO_FULL | OR | 3 | 0.005 | 0.000 to 0.312 | 0.000 to 0.312 | 0.0% | 0.431 | 0.0000 | Yes |
| ANDEXANET_BLEEDING_AUTO_FULL_REVIEW | MD | 3 | 49.259 | -1147.399 to 1245.917 | -2344.021 to 2442.539 | 99.8% | 1.14e-182 | 232044.8167 | Yes |
| ANIDULAFUNGIN_CANDIDA_AUTO_FULL | OR | 3 | 0.532 | 0.000 to 835.911 | 0.000 to 390410.790 | 37.2% | 0.203 | 6.9276 | Yes |
| ANIDULAFUNGIN_FUNGAL_AUTO_FULL | OR | 3 | 0.688 | 0.064 to 7.340 | 0.064 to 7.340 | 20.9% | 0.282 | 0.0000 | — |
| ANIFROLUMAB_LUPUS_2_AUTO_FULL | OR | 2 | 0.185 | 0.000 to 295.628 | — | 34.3% | 0.217 | 0.0000 | — |
| ANIFROLUMAB_LUPUS_AUTO_FULL | OR | 2 | 0.185 | 0.000 to 295.628 | — | 34.3% | 0.217 | 0.0000 | — |
| ANIFROLUMAB_SLE | OR | 2 | 2.055 | 1.522 to 2.774 | 1.522 to 2.774 | 0.0% | 0.878 | 0.0000 | Yes |
| ANIFROLUMAB_SLE_AUTO_FULL | OR | 2 | 0.185 | 0.000 to 295.628 | — | 34.3% | 0.217 | 0.0000 | — |
| ANIFROLUMAB_SLE_REVIEW | OR | 2 | 1.750 | 0.263 to 11.656 | — | 0.0% | 0.403 | 0.0000 | Yes |
| ANTIAMYLOID_AD | OR | 3 | — | — | — | 26.9% | 0.263 | 0.0068 | — |
| ANTIAMYLOID_AD_NMA | OR | 7 | 1.005 | 0.993 to 1.016 | 0.993 to 1.016 | 0.0% | 1.000 | 0.0000 | Yes |
| ANTIAMYLOID_AD_NMA_REVIEW | MD | 4 | -0.384 | -0.863 to 0.095 | -1.359 to 0.590 | 79.9% | 0.003 | 0.0711 | — |
| ANTIAMYLOID_AD_REVIEW | MD | 3 | -0.513 | -0.885 to -0.142 | -1.026 to -0.001 | 26.9% | 0.263 | 0.0068 | — |
| ANTIFUNGAL_NEWER_RESISTANT | OR | 7 | 2.802 | 1.887 to 4.161 | 1.144 to 6.866 | 56.5% | 0.031 | 0.1080 | — |
| ANTIFUNGAL_NEWER_RESISTANT_REVIEW | RR | 5 | 1.307 | 0.335 to 5.103 | 0.047 to 36.385 | 51.5% | 0.083 | 1.1949 | Yes |
| ANTIVEGF_NAMD_NMA | OR | 10 | 0.997 | 0.983 to 1.010 | 0.983 to 1.010 | 0.0% | 1.000 | 0.0000 | Yes |
| ANTIVEGF_NAMD_NMA_REVIEW | MD | 7 | 0.525 | 0.164 to 0.885 | 0.164 to 0.885 | 0.0% | 0.941 | 0.0000 | — |
| ANTI_CD20_MS | OR | 6 | 0.422 | 0.349 to 0.510 | 0.349 to 0.510 | 0.0% | 0.333 | 0.0000 | — |
| ANTI_CD20_MS_REVIEW | RR | 6 | 0.481 | 0.409 to 0.565 | 0.409 to 0.565 | 0.0% | 0.653 | 0.0000 | Yes |
| ANTI_PD1_GASTRIC | OR | 10 | 0.699 | 0.636 to 0.769 | 0.636 to 0.769 | 0.0% | 0.608 | 0.0000 | Yes |
| ANTI_PD1_GASTRIC_REVIEW | HR | 10 | 0.771 | 0.722 to 0.822 | 0.722 to 0.822 | 0.0% | 0.529 | 0.0000 | Yes |
| ANTI_PDL1_BLADDER | OR | 9 | 0.666 | 0.538 to 0.825 | 0.368 to 1.208 | 71.2% | 1.92e-04 | 0.0579 | — |
| ANTI_PDL1_BLADDER_REVIEW | HR | 9 | 0.731 | 0.157 to 3.393 | 0.006 to 93.258 | 69.7% | 9.07e-04 | 3.9786 | Yes |
| ANTI_TIGIT_TUMORS | OR | 11 | 0.679 | 0.599 to 0.770 | 0.599 to 0.770 | 0.0% | 0.653 | 0.0000 | Yes |
| ANTI_TIGIT_TUMORS_REVIEW | HR | 7 | 0.864 | 0.766 to 0.974 | 0.766 to 0.974 | 4.2% | 0.395 | 0.0000 | — |
| APIXABAN_ACS_AUTO_FULL | OR | 4 | 0.702 | 0.040 to 12.450 | 0.001 to 410.227 | 90.0% | 1.29e-06 | 3.1902 | Yes |
| APIXABAN_ACS_AUTO_FULL_REVIEW | HR | 2 | 0.810 | 0.000 to 22613324.507 | — | 85.5% | 0.009 | 3.6341 | Yes |
| APIXABAN_AF_AUTO_FULL | OR | 2 | 1.678 | 0.014 to 199.024 | — | 0.0% | 0.578 | 0.0000 | Yes |
| APIXABAN_VTE_AUTO_FULL | OR | 2 | 2.639 | 0.000 to 456831.870 | — | 0.0% | 0.337 | 0.0000 | Yes |
| APREMILAST_BEHCET_AUTO_FULL | OR | 2 | 0.556 | 0.000 to 72642.034 | — | 88.3% | 0.003 | 0.0000 | — |
| APREMILAST_BEHCET_AUTO_FULL_REVIEW | MD | 2 | -1.573 | -21.917 to 18.771 | — | 94.3% | 2.85e-05 | 0.0000 | — |
| APREMILAST_PSA_AUTO_FULL | OR | 2 | 0.354 | 0.019 to 6.549 | — | 0.0% | 0.429 | 0.0000 | Yes |
| APREPITANT_CINV_AUTO_FULL | OR | 2 | 1.138 | 0.011 to 115.689 | — | 0.0% | 0.605 | 0.0000 | Yes |
| APREPITANT_PONV_AUTO_FULL | OR | 2 | 0.479 | 0.000 to 273603582724230479872.000 | — | 64.1% | 0.095 | 27.9466 | Yes |
| ARDS_PRONE_POSITIONING | OR | 9 | 0.641 | 0.549 to 0.748 | 0.516 to 0.796 | 8.9% | 0.486 | 0.0044 | Yes |
| ARDS_PRONE_POSITIONING_REVIEW | HR | 3 | 0.617 | 0.000 to 8555.684 | 0.000 to 117033583.653 | 73.0% | 0.025 | 14.7127 | Yes |
| ARGATROBAN_HIT_AUTO_FULL | OR | 2 | 0.098 | 0.000 to 110335.635 | — | 0.0% | 0.844 | 0.0000 | Yes |
| ARIPIPRAZOLE_SCHIZO_AUTO_FULL | OR | 3 | 0.615 | 0.043 to 8.876 | 0.007 to 56.720 | 33.6% | 0.222 | 0.7206 | Yes |
| ARIPIPRAZOLE_SCHIZO_AUTO_FULL_REVIEW | MD | 2 | -2.050 | -427.782 to 423.682 | — | 85.9% | 0.008 | 2240.8812 | Yes |
| ARNI_HF | OR | 3 | 0.851 | 0.669 to 1.083 | 0.565 to 1.283 | 57.8% | 0.087 | 0.0060 | — |
| ARPI_NMCRPC | OR | 3 | 0.365 | 0.208 to 0.640 | 0.134 to 0.993 | 71.3% | 0.029 | 0.0370 | — |
| ARPI_NMCRPC_REVIEW | HR | 3 | 0.322 | 0.002 to 43.705 | 0.000 to 5880.972 | 77.5% | 0.012 | 3.8991 | Yes |
| ARPI_mHSPC | OR | 5 | 0.616 | 0.558 to 0.679 | 0.558 to 0.679 | 0.0% | 0.807 | 0.0000 | Yes |
| ARPI_mHSPC_REVIEW | HR | 5 | 0.664 | 0.588 to 0.751 | 0.588 to 0.751 | 0.0% | 0.998 | 0.0000 | Yes |
| ASCORBIC_ACID_SEPSIS_AUTO_FULL | OR | 2 | 0.510 | 0.009 to 30.070 | — | 0.0% | 0.741 | 0.0000 | Yes |
| ATALUREN_DMD_AUTO_FULL | OR | 2 | 1.047 | 0.002 to 446.503 | — | 0.0% | 0.604 | 0.0000 | Yes |
| ATEZOLIZUMAB_BLADDER_AUTO_FULL | OR | 2 | 0.693 | 0.005 to 89.400 | — | 83.3% | 0.014 | 0.0000 | — |
| ATEZOLIZUMAB_BLADDER_AUTO_FULL_REVIEW | HR | 2 | 0.794 | 0.219 to 2.876 | — | 42.8% | 0.186 | 0.0000 | — |
| ATOGEPANT_MIGRAINE_AUTO_FULL | OR | 2 | 3.907 | 0.005 to 3239.742 | — | 55.3% | 0.135 | 0.0000 | — |
| ATOGEPANT_PREVENT_AUTO_FULL | OR | 2 | 3.907 | 0.005 to 3239.742 | — | 55.3% | 0.135 | 0.0000 | — |
| ATOPIC_DERM_NMA | OR | 7 | 5.387 | 2.972 to 9.762 | 1.164 to 24.925 | 83.5% | 6.83e-06 | 0.3329 | — |
| ATOPIC_DERM_NMA_REVIEW | OR | 3 | 9.779 | 4.389 to 21.788 | 4.389 to 21.788 | 17.6% | 0.297 | 0.0000 | — |
| ATTR_CM | OR | 4 | 0.636 | 0.492 to 0.822 | 0.492 to 0.822 | 0.0% | 0.674 | 0.0000 | Yes |
| ATTR_PN | OR | 3 | — | — | — | 94.1% | 5.46e-07 | 101.3410 | — |
| ATTR_PN_REVIEW | MD | 3 | -21.802 | -47.742 to 4.137 | -72.289 to 28.685 | 94.1% | 5.46e-07 | 101.3410 | — |
| AVACINCAPTAD_GA | OR | 2 | — | — | — | 0.0% | 0.519 | 0.0000 | Yes |
| AVACINCAPTAD_GA_REVIEW | MD | 2 | -0.155 | -0.462 to 0.151 | — | 0.0% | 0.519 | 0.0000 | — |
| AVALGLUCOSIDASE_AUTO_FULL | OR | 3 | 1.784 | 0.001 to 2756.865 | 0.000 to 502625.580 | 36.2% | 0.208 | 5.5936 | Yes |
| AVALGLUCOSIDASE_POMPE_AUTO_FULL | OR | 3 | 1.784 | 0.001 to 2756.865 | 0.000 to 502625.580 | 36.2% | 0.208 | 5.5936 | Yes |
| AVAPRITINIB_GIST_AUTO_FULL | OR | 2 | 2.600 | 0.056 to 119.739 | — | 0.0% | 0.642 | 0.0000 | Yes |
| AVATROMBOPAG_CIT_AUTO_FULL | OR | 2 | 0.980 | 0.007 to 147.268 | — | 0.0% | 0.449 | 0.0000 | Yes |
| AVATROMBOPAG_CTCP_AUTO_FULL | OR | 2 | 0.980 | 0.007 to 147.268 | — | 0.0% | 0.449 | 0.0000 | Yes |
| AVATROMBOPAG_ITP_AUTO_FULL | OR | 2 | 0.980 | 0.007 to 147.268 | — | 0.0% | 0.449 | 0.0000 | Yes |
| AVELUMAB_OVARIAN_CANCER_AUTO_FULL | OR | 2 | 1.248 | 0.051 to 30.702 | — | 0.0% | 0.364 | 0.0000 | Yes |
| AXICABTAGENE_LYMPHOMA_AUTO_FULL | OR | 2 | 7.748 | 0.232 to 258.852 | — | 0.0% | 0.415 | 0.0000 | Yes |
| AXSPA_BIOLOGICS | OR | 10 | 3.381 | 2.485 to 4.601 | 2.031 to 5.629 | 25.7% | 0.065 | 0.0322 | — |
| AXSPA_BIOLOGICS_REVIEW | RR | 10 | 1.969 | 1.737 to 2.231 | 1.737 to 2.231 | 0.0% | 0.742 | 0.0000 | Yes |
| AZACITIDINE_MDS_AUTO_FULL | OR | 2 | 0.193 | 0.012 to 3.161 | — | 0.0% | 0.338 | 0.0000 | Yes |
| AZILSARTAN_HTN_AUTO_FULL | OR | 4 | 0.966 | 0.735 to 1.270 | 0.735 to 1.270 | 0.0% | 0.540 | 0.0000 | Yes |
| AZILSARTAN_HTN_AUTO_FULL_REVIEW | MD | 4 | -4.990 | -6.822 to -3.158 | -6.822 to -3.158 | 0.2% | 0.391 | 0.0000 | — |
| AZITHROMYCIN_CHILD_MORTALITY | OR | 3 | 0.857 | 0.839 to 0.876 | 0.839 to 0.876 | 0.0% | 0.940 | 0.0000 | Yes |
| AZITHROMYCIN_CHILD_MORTALITY_REVIEW | HR | 3 | 0.864 | 0.779 to 0.959 | 0.779 to 0.959 | 0.0% | 0.973 | 0.0000 | Yes |
| BAMLANIVIMAB_COVID_AUTO_FULL | OR | 4 | 1.182 | 0.415 to 3.364 | 0.415 to 3.364 | 44.8% | 0.143 | 0.0000 | — |
| BAMLANIVIMAB_COVID_AUTO_FULL_REVIEW | OR | 2 | 0.392 | 0.034 to 4.568 | — | 0.0% | 0.858 | 0.0000 | Yes |
| BAMLANIVIMAB_OUTP_AUTO_FULL | OR | 4 | 1.182 | 0.415 to 3.364 | 0.415 to 3.364 | 44.8% | 0.143 | 0.0000 | — |
| BAMLANIVIMAB_OUTP_AUTO_FULL_REVIEW | OR | 2 | 0.392 | 0.034 to 4.568 | — | 0.0% | 0.858 | 0.0000 | Yes |
| BARIATRIC_RYGB_VS_SG | OR | 10 | 2.360 | 1.170 to 4.762 | 0.324 to 17.178 | 82.9% | 2.10e-05 | 0.6737 | — |
| BARIATRIC_RYGB_VS_SG_REVIEW | RR | 3 | 1.228 | 0.081 to 18.623 | 0.006 to 269.008 | 46.1% | 0.156 | 1.1696 | Yes |
| BARICITINIB_AA_AUTO_FULL | OR | 2 | 0.198 | 0.000 to 120.786 | — | 0.0% | 0.913 | 0.0000 | Yes |
| BARICITINIB_AA_AUTO_FULL_REVIEW | OR | 2 | 6.387 | 0.130 to 314.087 | — | 0.0% | 0.630 | 0.0000 | Yes |
| BARICITINIB_AD_AUTO_FULL | OR | 4 | 0.572 | 0.169 to 1.934 | 0.169 to 1.934 | 53.3% | 0.093 | 0.0000 | — |
| BARICITINIB_AD_AUTO_FULL_REVIEW | OR | 3 | 2.385 | 0.000 to 15234404.666 | 0.000 to 93484213643373.516 | 76.0% | 0.016 | 39.6549 | Yes |
| BARICITINIB_ALOPECIA_AUTO_FULL | OR | 2 | 0.198 | 0.000 to 120.786 | — | 0.0% | 0.913 | 0.0000 | Yes |
| BARICITINIB_ALOPECIA_AUTO_FULL_REVIEW | OR | 2 | 6.387 | 0.130 to 314.087 | — | 0.0% | 0.630 | 0.0000 | Yes |
| BARICITINIB_SLE_AUTO_FULL | OR | 3 | 0.831 | 0.121 to 5.719 | 0.020 to 35.023 | 50.5% | 0.133 | 0.5550 | Yes |
| BARICITINIB_SLE_AUTO_FULL_REVIEW | OR | 3 | 1.288 | 0.757 to 2.191 | 0.757 to 2.191 | 7.4% | 0.340 | 0.0000 | — |
| BELIMUMAB_LN_AUTO_FULL | OR | 2 | 1.981 | 0.000 to 20781.226 | — | 0.0% | 0.624 | 0.0000 | Yes |
| BELIMUMAB_LUPUS_AUTO_FULL | OR | 3 | 0.666 | 0.088 to 5.059 | 0.088 to 5.059 | 89.7% | 6.05e-05 | 0.0000 | — |
| BELIMUMAB_LUPUS_AUTO_FULL_REVIEW | OR | 2 | 1.718 | 0.225 to 13.108 | — | 0.0% | 0.388 | 0.0000 | Yes |
| BELIMUMAB_LUPUS_NEPH_AUTO_FULL | OR | 2 | 1.981 | 0.000 to 20781.226 | — | 0.0% | 0.624 | 0.0000 | Yes |
| BELIMUMAB_SLE | OR | 4 | 1.634 | 1.471 to 1.815 | 1.471 to 1.815 | 0.0% | 0.942 | 0.0000 | Yes |
| BELIMUMAB_SLE_REVIEW | RR | 4 | 1.293 | 1.120 to 1.493 | 1.120 to 1.493 | 0.0% | 0.976 | 0.0000 | Yes |
| BEMPEDOIC_ACID | OR | 4 | 1.141 | 0.720 to 1.807 | 0.432 to 3.011 | 64.7% | 0.028 | 0.0721 | — |
| BEMPEDOIC_ACID_REVIEW | MD | 4 | -19.504 | -22.706 to -16.302 | -26.010 to -12.998 | 82.6% | 3.00e-04 | 3.1677 | — |
| BENDAMUSTINE_LYMPHOMA_AUTO_FULL | OR | 2 | 0.445 | 0.004 to 56.358 | — | 0.0% | 0.700 | 0.0000 | Yes |
| BENRALIZUMAB_ASTHMA_AUTO_FULL | OR | 2 | 1.805 | 0.020 to 166.433 | — | 0.0% | 0.570 | 0.0000 | Yes |
| BENRALIZUMAB_CRSWNP_AUTO_FULL | OR | 3 | 0.843 | 0.362 to 1.962 | 0.362 to 1.962 | 0.0% | 0.995 | 0.0000 | Yes |
| BENRALIZUMAB_CRSWNP_AUTO_FULL_REVIEW | MD | 2 | -0.385 | -12.627 to 11.856 | — | 63.3% | 0.099 | 1.8312 | Yes |
| BEVACIZUMAB_LUNG_AUTO_FULL | OR | 2 | 0.806 | 0.088 to 7.411 | — | 0.0% | 0.913 | 0.0000 | Yes |
| BEVACIZUMAB_RENAL_AUTO_FULL | OR | 4 | 4.303 | 0.000 to 2153809547026313.750 | 0.000 to 3133056295372761000705282489188352.000 | 93.4% | 7.04e-10 | 452.2164 | Yes |
| BEZLOTOXUMAB_CDIFF_AUTO_FULL | OR | 2 | 0.264 | 0.000 to 165.918 | — | 0.0% | 0.336 | 0.0000 | Yes |
| BEZLOTOXUMAB_CDI_AUTO_FULL | OR | 2 | 0.264 | 0.000 to 165.918 | — | 0.0% | 0.336 | 0.0000 | Yes |
| BIMEKIZUMAB_AS_AUTO_FULL | OR | 4 | 0.361 | 0.131 to 0.997 | 0.131 to 0.997 | 40.2% | 0.171 | 0.0000 | — |
| BIMEKIZUMAB_AS_AUTO_FULL_REVIEW | OR | 3 | 3.067 | 1.412 to 6.662 | 1.412 to 6.662 | 0.0% | 0.818 | 0.0000 | Yes |
| BIMEKIZUMAB_AXIAL_AUTO_FULL | OR | 4 | 0.361 | 0.131 to 0.997 | 0.131 to 0.997 | 40.2% | 0.171 | 0.0000 | — |
| BIMEKIZUMAB_AXIAL_AUTO_FULL_REVIEW | OR | 3 | 3.067 | 1.412 to 6.662 | 1.412 to 6.662 | 0.0% | 0.818 | 0.0000 | Yes |
| BIMEKIZUMAB_HS_AUTO_FULL | OR | 3 | 0.991 | 0.023 to 43.168 | 0.001 to 1085.815 | 60.1% | 0.082 | 1.8769 | Yes |
| BIMEKIZUMAB_HS_AUTO_FULL_REVIEW | OR | 2 | 2.210 | 0.090 to 54.534 | — | 0.0% | 0.705 | 0.0000 | Yes |
| BIMEKIZUMAB_PSORIASIS | OR | 3 | 11.010 | 0.121 to 1001.093 | 0.002 to 63869.329 | 93.7% | 5.93e-08 | 2.9577 | — |
| BIMEKIZUMAB_PSORIASIS_2_AUTO_FULL | OR | 3 | 1.594 | 0.353 to 7.196 | 0.353 to 7.196 | 82.2% | 0.004 | 0.0000 | — |
| BIMEKIZUMAB_PSORIASIS_AUTO_FULL | OR | 3 | 1.594 | 0.353 to 7.196 | 0.353 to 7.196 | 82.2% | 0.004 | 0.0000 | — |
| BIMEKIZUMAB_PSORIASIS_REVIEW | OR | 2 | 22.883 | 0.027 to 19451.428 | — | 31.3% | 0.228 | 0.0000 | — |
| BIMEKIZUMAB_PSORIATIC_AUTO_FULL | OR | 3 | 0.063 | 0.000 to 134302985772.156 | 0.000 to 280184794472114875793408.000 | 91.7% | 6.10e-06 | 130.4444 | Yes |
| BIMEKIZUMAB_PSORIATIC_AUTO_FULL_REVIEW | OR | 3 | 33.921 | 0.000 to 90571937077736223413085667328.000 | 0.000 to 235882163382787797234153499210245099429247076022079193088.000 | 90.3% | 3.23e-05 | 645.9421 | Yes |
| BIOLOGIC_ASTHMA | OR | 4 | — | — | — | 34.7% | 0.204 | 0.0088 | — |
| BIOLOGIC_ASTHMA_REVIEW | MD | 4 | -0.677 | -0.930 to -0.424 | -1.068 to -0.286 | 34.7% | 0.204 | 0.0088 | — |
| BLADDER_UROTHEL_FRONTLINE_IO_NMA_REVIEW | HR | 5 | 0.732 | 0.013 to 41.127 | 0.000 to 14069.619 | 86.8% | 4.18e-06 | 10.5153 | Yes |
| BOCOCIZUMAB_LIPID_AUTO_FULL | OR | 5 | 0.068 | 0.000 to 733333563.079 | 0.000 to 247755299445113463242752.000 | 86.9% | 3.69e-06 | 345.6787 | Yes |
| BOCOCIZUMAB_LIPID_AUTO_FULL_REVIEW | MD | 5 | 8.280 | -967.839 to 984.400 | -2382.703 to 2399.264 | 99.9% | 0.00e+00 | 618003.9906 | Yes |
| BOSENTAN_PAH_AUTO_FULL | OR | 2 | 0.134 | 0.001 to 16.815 | — | 0.0% | 0.623 | 0.0000 | Yes |
| BOSUTINIB_LEUKEMIA_AUTO_FULL | OR | 3 | 1.522 | 0.392 to 5.917 | 0.392 to 5.917 | 74.8% | 0.019 | 0.0000 | — |
| BPAL_MDRTB | OR | 3 | 2.961 | 0.454 to 19.304 | 0.090 to 97.351 | 84.4% | 0.003 | 0.4691 | — |
| BPAL_MDRTB_REVIEW | RR | 3 | 1.293 | 0.003 to 564.702 | 0.000 to 245752.204 | 88.0% | 2.40e-04 | 5.9844 | Yes |
| BRENTUXIMAB_HODGKIN_AUTO_FULL | OR | 2 | 0.464 | 0.036 to 5.936 | — | 0.0% | 0.637 | 0.0000 | Yes |
| BRENTUXIMAB_PTCL_AUTO_FULL | OR | 2 | 1.693 | 0.175 to 16.384 | — | 0.0% | 0.824 | 0.0000 | Yes |
| BREXPIPRAZOLE_AGITATION_AUTO_FULL | OR | 3 | 1.194 | 0.412 to 3.458 | 0.412 to 3.458 | 0.0% | 0.387 | 0.0000 | Yes |
| BREXPIPRAZOLE_AGITATION_AUTO_FULL_REVIEW | MD | 4 | -0.997 | -63.415 to 61.421 | -140.462 to 138.467 | 80.2% | 0.002 | 1535.7757 | Yes |
| BREXPIPRAZOLE_SCHIZO_AUTO_FULL | OR | 2 | 0.478 | 0.000 to 6596588.214 | — | 0.0% | 0.658 | 0.0000 | Yes |
| BREXPIPRAZOLE_SCHIZO_AUTO_FULL_REVIEW | MD | 4 | -0.006 | -0.294 to 0.282 | -0.294 to 0.282 | 80.2% | 0.002 | 0.0000 | — |
| BREXPIPRAZOLE_SCHIZ_AUTO_FULL | OR | 2 | 0.478 | 0.000 to 6596588.214 | — | 0.0% | 0.658 | 0.0000 | Yes |
| BREXPIPRAZOLE_SCHIZ_AUTO_FULL_REVIEW | MD | 4 | -0.006 | -0.294 to 0.282 | -0.294 to 0.282 | 80.2% | 0.002 | 0.0000 | — |
| BREXUCABTAGENE_LYMPHOMA_AUTO_FULL | OR | 2 | 5.207 | 0.000 to 43283547216.502 | — | 47.0% | 0.169 | 0.0000 | — |
| BREZ_PSORIASIS_AUTO_FULL | OR | 2 | 2.747 | 0.021 to 352.634 | — | 88.8% | 0.003 | 0.0000 | — |
| BRIGATINIB_ALK_NSCLC_AUTO_FULL | OR | 2 | 1.750 | 0.067 to 45.977 | — | 0.0% | 0.898 | 0.0000 | Yes |
| BRIVARACETAM_EPILEPSY_AUTO_FULL | OR | 4 | 0.742 | 0.264 to 2.084 | 0.264 to 2.084 | 0.0% | 0.977 | 0.0000 | Yes |
| BRIVARACETAM_EPILEPSY_AUTO_FULL_REVIEW | MD | 2 | -378.573 | -2457.477 to 1700.330 | — | 0.0% | 0.417 | 0.0000 | Yes |
| BRODALUMAB_PSORIASIS_AUTO_FULL | OR | 2 | 2.747 | 0.021 to 352.634 | — | 88.8% | 0.003 | 0.0000 | — |
| BRONCHIECTASIS_BROAD_NMA | OR | 8 | 0.934 | 0.463 to 1.884 | 0.137 to 6.385 | 89.4% | 7.53e-07 | 0.5726 | — |
| BRONCHIECTASIS_BROAD_NMA_REVIEW | RR | 4 | 0.891 | 0.000 to 14512228.231 | 0.000 to 11827638550952256.000 | 90.9% | 3.50e-07 | 108.8532 | Yes |
| BTKI_CLL_NMA | OR | 7 | 0.238 | 0.094 to 0.600 | 0.018 to 3.066 | 95.3% | 4.30e-24 | 0.9486 | — |
| BUDESONIDE_IBD_AUTO_FULL | OR | 2 | 1.234 | 0.000 to 2966303683761.440 | — | 72.1% | 0.058 | 10.0047 | Yes |
| BUPROPION_SMOKING_AUTO_FULL | OR | 2 | 0.348 | 0.000 to 809141221881216761856.000 | — | 70.5% | 0.066 | 29.7712 | Yes |
| BURADIRAGAB_AUTO_FULL | OR | 2 | 2.377 | 0.044 to 128.678 | — | 0.0% | 0.565 | 0.0000 | Yes |
| CABAZITAXEL_PROSTATE_AUTO_FULL | OR | 2 | 1.389 | 0.207 to 9.293 | — | 0.0% | 0.709 | 0.0000 | Yes |
| CABG_VS_PCI_LEFT_MAIN_NMA_REVIEW | HR | 5 | 1.334 | 0.758 to 2.350 | 0.349 to 5.094 | 36.6% | 0.177 | 0.1913 | Yes |
| CABOTEGRAVIR_HIV_ART | OR | 3 | 1.334 | 0.454 to 3.923 | 0.454 to 3.923 | 0.0% | 0.598 | 0.0000 | Yes |
| CABOTEGRAVIR_HIV_ART_REVIEW | RR | 3 | 1.329 | 0.302 to 5.846 | 0.302 to 5.846 | 0.0% | 0.601 | 0.0000 | Yes |
| CABOZANTINIB_RCC_AUTO_FULL | OR | 2 | 0.185 | 0.000 to 2692.306 | — | 0.0% | 0.532 | 0.0000 | Yes |
| CABOZANTINIB_RENAL_AUTO_FULL | OR | 2 | 0.185 | 0.000 to 2692.306 | — | 0.0% | 0.532 | 0.0000 | Yes |
| CABOZANTINIB_THYROID_AUTO_FULL | OR | 2 | 1.905 | 0.000 to 97072564864843472367986015207424.000 | — | 91.2% | 7.36e-04 | 65.9602 | Yes |
| CABP_NEW_ABX_NMA | OR | 10 | 1.207 | 1.070 to 1.362 | 1.070 to 1.362 | 0.0% | 0.782 | 0.0000 | Yes |
| CABP_NEW_ABX_NMA_REVIEW | RR | 4 | 1.010 | 0.971 to 1.051 | 0.971 to 1.051 | 0.0% | 0.890 | 0.0000 | Yes |
| CAB_PREP_HIV | OR | 1 | 0.340 | 0.183 to 0.631 | 0.006 to 18.729 | 0.0% | 1.000 | 0.0000 | — |
| CANAGLIFLOZIN_DKD_AUTO_FULL | OR | 2 | 0.808 | 0.000 to 91376943761653408.000 | — | 78.9% | 0.030 | 19.0316 | Yes |
| CANAKINUMAB_SJIA_AUTO_FULL | OR | 3 | 0.246 | 0.000 to 2540663158202777231295631901485583064866525377725317406261248.000 | 0.000 to 23938571514453200579573550312077428002733680427693707337948741587153963157819021469449070682006014025371022039207773208576.000 | 91.9% | 4.38e-06 | 3195.6789 | Yes |
| CANGRELOR_PCI | OR | 3 | 0.902 | 0.611 to 1.331 | 0.452 to 1.799 | 68.4% | 0.036 | 0.0176 | — |
| CANGRELOR_PCI_REVIEW | OR | 3 | 0.893 | 0.053 to 15.163 | 0.003 to 253.744 | 66.0% | 0.053 | 1.2907 | Yes |
| CAPLACIZUMAB_TTP_AUTO_FULL | OR | 3 | 2.033 | 0.000 to 3538406133293533045406564352.000 | 0.000 to 5997015453721832952501279249628456905311531116349358080.000 | 94.9% | 2.61e-09 | 637.1933 | Yes |
| CAPLACIZUMAB_TTP_AUTO_FULL_REVIEW | HR | 2 | 1.717 | 0.227 to 12.984 | — | 12.1% | 0.286 | 0.0000 | — |
| CAPMATINIB_LUNG_AUTO_FULL | OR | 2 | 4.361 | 0.002 to 12569.440 | — | 0.0% | 0.525 | 0.0000 | Yes |
| CARBAPENEM_RESISTANT_ABX | OR | 8 | 1.004 | 0.749 to 1.345 | 0.653 to 1.542 | 25.1% | 0.050 | 0.0176 | — |
| CARBAPENEM_RESISTANT_ABX_REVIEW | RR | 5 | 1.003 | 0.878 to 1.146 | 0.878 to 1.146 | 60.2% | 0.040 | 0.0000 | — |
| CARDIORENAL_DKD_NMA | OR | 6 | 0.746 | 0.653 to 0.851 | 0.566 to 0.982 | 59.5% | 0.034 | 0.0088 | — |
| CARIPRAZINE_DEPRESSION_AUTO_FULL_REVIEW | MD | 2 | -1.007 | -116.200 to 114.186 | — | 67.9% | 0.078 | 162.9400 | Yes |
| CART_B_CELL_LYMPHOMA | OR | 5 | 0.396 | 0.163 to 0.961 | 0.051 to 3.071 | 87.2% | 2.71e-06 | 0.4422 | — |
| CART_B_CELL_LYMPHOMA_REVIEW | HR | 3 | 0.531 | 0.000 to 8173967.829 | 0.000 to 124858539628643.562 | 94.2% | 3.54e-08 | 44.3550 | Yes |
| CART_DLBCL | OR | 3 | 0.469 | 0.096 to 2.295 | 0.024 to 9.276 | 84.0% | 0.002 | 0.3450 | — |
| CART_DLBCL_REVIEW | HR | 2 | 0.654 | 0.000 to 94502631907856540789374976.000 | — | 96.4% | 1.30e-07 | 44.9292 | Yes |
| CART_MM | OR | 2 | 0.318 | 0.042 to 2.380 | 0.042 to 2.433 | 1.1% | 0.315 | 0.0005 | — |
| CART_MM_REVIEW | HR | 2 | 0.357 | 0.000 to 284047242785000.750 | — | 86.3% | 0.007 | 14.5554 | Yes |
| CAR_T_LBCL_BROAD_NMA_REVIEW | HR | 2 | 0.654 | 0.000 to 94502631907856540789374976.000 | — | 96.4% | 1.30e-07 | 44.9292 | Yes |
| CASIRIVIMAB_COVID_AUTO_FULL | OR | 3 | 1.023 | 0.000 to 889485013.568 | 0.000 to 608721184023619456.000 | 55.8% | 0.104 | 67.5951 | Yes |
| CASPOFUNGIN_FUNGAL_AUTO_FULL | OR | 2 | 0.731 | 0.000 to 1768.392 | — | 10.3% | 0.291 | 0.0000 | — |
| CBD_SEIZURE | OR | 4 | 2.585 | 1.768 to 3.779 | 1.768 to 3.779 | 0.0% | 0.746 | 0.0000 | Yes |
| CBD_SEIZURE_REVIEW | RR | 4 | 1.879 | 1.250 to 2.823 | 1.250 to 2.823 | 0.0% | 0.607 | 0.0000 | Yes |
| CDK46_BREAST_CANCER | OR | 11 | 0.503 | 0.407 to 0.620 | 0.280 to 0.902 | 70.2% | 5.70e-05 | 0.0600 | — |
| CDK46_BREAST_CANCER_REVIEW | HR | 11 | 0.571 | 0.285 to 1.145 | 0.052 to 6.234 | 44.5% | 0.055 | 1.0530 | Yes |
| CDK46_MBC | OR | 3 | 0.451 | 0.335 to 0.607 | 0.335 to 0.607 | 0.0% | 0.630 | 0.0000 | Yes |
| CDK46_MBC_REVIEW | HR | 3 | 0.562 | 0.412 to 0.765 | 0.412 to 0.765 | 0.0% | 0.918 | 0.0000 | Yes |
| CD_BIOLOGICS_NMA | OR | 5 | 1.960 | 1.304 to 2.945 | 0.886 to 4.336 | 52.6% | 0.082 | 0.0602 | — |
| CEFEPIME_TAZ_AUTO_FULL | OR | 2 | 1.159 | 0.075 to 17.942 | — | 41.5% | 0.191 | 0.0000 | — |
| CEFTAROLINE_AUTO_FULL | OR | 4 | 0.335 | 0.000 to 7730527589570811904.000 | 0.000 to 6622004999592200427551464097219452262678528.000 | 97.9% | 3.72e-30 | 785.0380 | Yes |
| CEFTAROLINE_AUTO_FULL_REVIEW | RD | 3 | 7.211 | -1.381 to 15.802 | -1.381 to 15.802 | 0.0% | 0.677 | 0.0000 | Yes |
| CEFTAZIDIME_AVIBACTAM_AUTO_FULL | OR | 2 | 0.345 | 0.000 to 46332.913 | — | 0.0% | 0.493 | 0.0000 | Yes |
| CEFTOLOZANE_INFECTION_AUTO_FULL | OR | 2 | 0.504 | 0.000 to 344429259881203471200664531455486169950501955791215017328640.000 | — | 68.3% | 0.076 | 233.1256 | Yes |
| CEFTOLOZANE_INFECTION_AUTO_FULL_REVIEW | MD | 2 | 12.064 | -82.017 to 106.146 | — | 0.0% | 0.469 | 0.0000 | Yes |
| CEFTOLOZANE_TAZ_AUTO_FULL | OR | 3 | 0.945 | 0.502 to 1.780 | 0.502 to 1.780 | 0.0% | 0.900 | 0.0000 | Yes |
| CERITINIB_ALK_AUTO_FULL | OR | 3 | 4.438 | 0.000 to 3874273472946.312 | 0.000 to 3298511675548346506805248.000 | 83.7% | 0.002 | 122.3587 | Yes |
| CERITINIB_ALK_AUTO_FULL_REVIEW | HR | 2 | 0.523 | 0.137 to 1.993 | — | 0.0% | 0.586 | 0.0000 | Yes |
| CERVICAL_CANCER_IO_BROAD | OR | 6 | 0.565 | 0.419 to 0.762 | 0.288 to 1.110 | 66.9% | 0.009 | 0.0554 | — |
| CERVICAL_CANCER_IO_BROAD_REVIEW | HR | 5 | 0.732 | 0.631 to 0.850 | 0.631 to 0.850 | 0.0% | 0.428 | 0.0000 | Yes |
| CFTR_CF | OR | 3 | — | — | — | 79.0% | 0.004 | 4.7745 | — |
| CFTR_CF_REVIEW | MD | 3 | 11.671 | 5.685 to 17.657 | 0.525 to 22.816 | 79.0% | 0.004 | 4.7745 | — |
| CFTR_MODULATORS_NMA | OR | 3 | 0.794 | 0.293 to 2.156 | 0.293 to 2.156 | 0.0% | 0.960 | 0.0000 | Yes |
| CFTR_MODULATORS_NMA_REVIEW | MD | 3 | 6.810 | -8.235 to 21.854 | -23.097 to 36.717 | 98.9% | 3.90e-28 | 36.0887 | — |
| CGRP_MIGRAINE | OR | 3 | — | — | — | 0.0% | 0.599 | 0.0000 | Yes |
| CGRP_MIGRAINE_NMA | OR | 4 | 1.189 | 0.688 to 2.057 | 0.688 to 2.057 | 0.0% | 0.993 | 0.0000 | Yes |
| CGRP_MIGRAINE_NMA_REVIEW | MD | 4 | -1.898 | -26.653 to 22.858 | -57.247 to 53.452 | 97.9% | 2.79e-31 | 241.9738 | Yes |
| CGRP_MIGRAINE_PREVENT | OR | 15 | 3.339 | 2.411 to 4.624 | 0.971 to 11.480 | 89.4% | 1.20e-21 | 0.3085 | — |
| CGRP_MIGRAINE_PREVENT_REVIEW | RR | 13 | 2.293 | 0.182 to 28.881 | 0.000 to 29823.968 | 88.4% | 1.41e-16 | 17.5521 | Yes |
| CGRP_MIGRAINE_REVIEW | MD | 3 | -1.727 | -2.207 to -1.247 | -2.207 to -1.247 | 0.0% | 0.599 | 0.0000 | — |
| CHECKPOINT_ESOPHAGEAL_SCC | OR | 10 | 0.608 | 0.529 to 0.698 | 0.529 to 0.698 | 0.0% | 0.348 | 0.0000 | — |
| CHECKPOINT_ESOPHAGEAL_SCC_REVIEW | HR | 10 | 0.694 | 0.642 to 0.751 | 0.642 to 0.751 | 0.0% | 0.913 | 0.0000 | Yes |
| CHECKPOINT_MELANOMA_1L | OR | 10 | 0.578 | 0.500 to 0.668 | 0.419 to 0.798 | 39.3% | 0.097 | 0.0162 | — |
| CHECKPOINT_MELANOMA_1L_REVIEW | HR | 10 | 0.647 | 0.233 to 1.802 | 0.022 to 19.119 | 59.5% | 0.008 | 2.0349 | Yes |
| CHRONIC_URTICARIA_BIOLOGICS | OR | 10 | 4.060 | 2.309 to 7.141 | 0.693 to 23.789 | 91.2% | 9.17e-20 | 0.5485 | — |
| CHRONIC_URTICARIA_BIOLOGICS_REVIEW | RR | 10 | 2.062 | 0.131 to 32.541 | 0.000 to 19266.044 | 85.3% | 7.37e-10 | 14.8461 | Yes |
| CILOFEXOR_FXR_PSC_AUTO_FULL | OR | 2 | 0.954 | 0.064 to 14.277 | — | 0.0% | 0.319 | 0.0000 | Yes |
| CINRYZE_HAE_AUTO_FULL | OR | 3 | 3.059 | 0.165 to 56.715 | 0.165 to 56.715 | 0.0% | 0.507 | 0.0000 | Yes |
| CINRYZE_HAE_AUTO_FULL_REVIEW | MD | 2 | -2.469 | -12.421 to 7.484 | — | 75.9% | 0.042 | 0.0000 | — |
| CIPROFLOXACIN_UTI_AUTO_FULL | OR | 2 | 1.067 | 0.080 to 14.224 | — | 59.1% | 0.118 | 0.0000 | — |
| CLADRIBINE_MS_AUTO_FULL | OR | 2 | 1.218 | 0.000 to 3616.137 | — | 0.0% | 0.892 | 0.0000 | Yes |
| COLCHICINE_CVD | OR | 3 | 0.864 | 0.612 to 1.219 | 0.497 to 1.503 | 47.9% | 0.149 | 0.0101 | — |
| COLCHICINE_CVD_REVIEW | HR | 3 | 0.864 | 0.310 to 2.407 | 0.117 to 6.390 | 45.0% | 0.162 | 0.1596 | Yes |
| COMPLEMENT_C5_BROAD_NMA_REVIEW | RR | 3 | 1.033 | 0.602 to 1.773 | 0.602 to 1.773 | 73.1% | 0.024 | 0.0000 | — |
| CONCIZUMAB_HEMA_AUTO_FULL | OR | 3 | 0.424 | 0.014 to 12.432 | 0.014 to 12.432 | 0.0% | 0.606 | 0.0000 | Yes |
| COPD_BIOLOGICS_BROAD | OR | 10 | 0.627 | 0.534 to 0.737 | 0.410 to 0.960 | 58.3% | 0.008 | 0.0302 | — |
| COPD_BIOLOGICS_BROAD_REVIEW | RR | 6 | 0.811 | 0.202 to 3.253 | 0.021 to 31.727 | 56.7% | 0.042 | 1.7423 | Yes |
| COPD_TRIPLE | OR | 3 | 0.693 | 0.430 to 1.117 | 0.304 to 1.581 | 88.5% | 0.032 | 0.0244 | — |
| COPD_TRIPLE_REVIEW | RR | 3 | 0.742 | 0.591 to 0.932 | 0.591 to 0.932 | 70.9% | 0.032 | 0.0000 | — |
| COVID19_HOSPITALIZED_TX | OR | 9 | 0.407 | 0.217 to 0.764 | 0.070 to 2.374 | 92.7% | 1.20e-08 | 0.5099 | — |
| COVID19_HOSPITALIZED_TX_REVIEW | HR | 5 | 0.264 | 0.000 to 136526.005 | 0.000 to 25479011390656.016 | 89.3% | 1.54e-07 | 112.0609 | Yes |
| COVID19_VACCINES | OR | 12 | 0.219 | 0.127 to 0.376 | 0.034 to 1.405 | 95.9% | 1.03e-23 | 0.6541 | — |
| COVID19_VACCINES_REVIEW | RR | 3 | 0.335 | 0.000 to 59401.524 | 0.000 to 10369746983.302 | 86.8% | 5.20e-04 | 23.6283 | Yes |
| COVID_ORAL_ANTIVIRALS | OR | 2 | 0.293 | 0.000 to 33242.134 | 0.000 to 95515496.867 | 91.4% | 6.43e-04 | 1.5411 | — |
| COVID_ORAL_ANTIVIRALS_REVIEW | RR | 2 | 0.276 | 0.000 to 2507414469793688852048517586231409882634911744.000 | — | 91.4% | 6.43e-04 | 138.5843 | Yes |
| CRC_TARGETED_BROAD | OR | 4 | 0.545 | 0.376 to 0.789 | 0.312 to 0.954 | 29.3% | 0.257 | 0.0174 | — |
| CRC_TARGETED_BROAD_REVIEW | HR | 3 | 0.670 | 0.043 to 10.344 | 0.003 to 155.701 | 61.0% | 0.077 | 1.1989 | Yes |
| CRIZOTINIB_ALK_AUTO_FULL | OR | 2 | 0.638 | 0.002 to 227.289 | — | 43.6% | 0.183 | 0.0000 | — |
| CRYO_AF_ABLATION_NMA_REVIEW | RR | 2 | 1.566 | 0.000 to 56748918.264 | — | 71.3% | 0.062 | 3.7278 | Yes |
| CTEPH_NMA_REVIEW | MD | 4 | 27.243 | -398.523 to 453.009 | -924.169 to 978.655 | 90.5% | 6.35e-07 | 71475.9511 | Yes |
| CYTISINICLINE_SMOKING_AUTO_FULL | OR | 2 | 0.225 | 0.000 to 211252485494080045056.000 | — | 79.3% | 0.028 | 28.7883 | Yes |
| CYTISINICLINE_SMOKING_AUTO_FULL_REVIEW | OR | 2 | 4.774 | 0.000 to 3782049538650742980608.000 | — | 76.8% | 0.038 | 28.5627 | Yes |
| DABIGATRAN_AF_AUTO_FULL | OR | 2 | 1.246 | 0.331 to 4.684 | — | 0.0% | 0.318 | 0.0000 | Yes |
| DABIGATRAN_STROKE_AUTO_FULL | OR | 2 | 1.366 | 0.186 to 10.017 | — | 0.0% | 0.412 | 0.0000 | Yes |
| DABIGATRAN_VTE_AUTO_FULL | OR | 4 | 9.010 | 0.000 to 15638496192933305391978323917144064.000 | 0.000 to 1823794353794546311651881110113591748278170809002601928360163053676957532160.000 | 96.9% | 1.48e-20 | 2312.0222 | Yes |
| DACLATASVIR_HCV_AUTO_FULL | OR | 3 | 2.450 | 0.054 to 110.480 | 0.003 to 2003.311 | 45.8% | 0.158 | 1.6458 | Yes |
| DACOMITINIB_LUNG_AUTO_2_FULL | OR | 2 | 3.190 | 0.000 to 8586342177698866003968.000 | — | 65.6% | 0.088 | 29.8403 | Yes |
| DACOMITINIB_LUNG_AUTO_FULL | OR | 2 | 3.190 | 0.000 to 8586342177698866003968.000 | — | 65.6% | 0.088 | 29.8403 | Yes |
| DALFAMPRIDINE_MULTIPLE_SCLEROSIS_AUTO_FULL_REVIEW | MD | 2 | 0.020 | -0.123 to 0.163 | — | 66.9% | 0.082 | 0.0000 | — |
| DAPAGLIFLOZIN_T1D_AUTO_FULL_REVIEW | MD | 2 | 0.145 | -61.600 to 61.890 | — | 95.0% | 8.39e-06 | 47.2019 | Yes |
| DAPAGLIFLOZIN_T2D_CV_AUTO_FULL_REVIEW | MD | 3 | -0.131 | -2.119 to 1.858 | -3.967 to 3.706 | 88.1% | 2.31e-04 | 0.5815 | Yes |
| DAPRODUSTAT_ANAEMIA_AUTO_FULL | OR | 4 | 0.162 | 0.000 to 970039750100798797479793947312128.000 | 0.000 to 523631142553757366260031538288830048656803160143160816802719933996359221248.000 | 95.9% | 8.53e-16 | 2387.5456 | Yes |
| DAPRODUSTAT_ANAEMIA_AUTO_FULL_REVIEW | MD | 4 | 0.172 | -3.597 to 3.942 | -7.426 to 7.771 | 70.1% | 0.018 | 4.2974 | Yes |
| DAPT_DE_ESCALATION_PCI | OR | 10 | 0.711 | 0.555 to 0.910 | 0.350 to 1.441 | 81.4% | 5.83e-06 | 0.0858 | — |
| DAPT_DE_ESCALATION_PCI_REVIEW | HR | 8 | 0.716 | 0.053 to 9.719 | 0.000 to 1776.957 | 75.3% | 1.93e-04 | 9.7115 | Yes |
| DARBEPOETIN_CANCER_AUTO_FULL | OR | 2 | 0.940 | 0.396 to 2.232 | — | 0.0% | 0.735 | 0.0000 | Yes |
| DARIDOREXANT_INSOMNIA_AUTO_FULL_REVIEW | MD | 2 | 9.846 | -15.760 to 35.451 | — | 0.0% | 0.676 | 0.0000 | Yes |
| DASABUVIR_CHRONIC_HEPATITIS_AUTO_FULL | OR | 3 | 0.439 | 0.007 to 27.857 | 0.007 to 27.857 | 0.0% | 0.509 | 0.0000 | Yes |
| DASABUVIR_HEPATITIS_C_AUTO_FULL | OR | 2 | 0.572 | 0.000 to 177643.121 | — | 0.0% | 0.374 | 0.0000 | Yes |
| DEFEROXAMINE_IRON_AUTO_FULL_REVIEW | MD | 2 | 0.051 | -0.409 to 0.511 | — | 0.0% | 0.737 | 0.0000 | Yes |
| DELAMANID_TB_AUTO_FULL | OR | 2 | 0.591 | 0.067 to 5.198 | — | 0.0% | 0.805 | 0.0000 | Yes |
| DELANDISTROGENE_DMD_AUTO_FULL | OR | 2 | 1.620 | 0.000 to 11553.430 | — | 36.9% | 0.208 | 0.0000 | — |
| DELANDISTROGENE_DMD_AUTO_FULL_REVIEW | MD | 2 | 0.837 | -5.856 to 7.530 | — | 2.7% | 0.311 | 0.0000 | — |
| DELGOCITINIB_AD_AUTO_FULL | OR | 4 | 3.100 | 0.067 to 144.247 | 0.001 to 15267.239 | 66.2% | 0.031 | 5.6810 | Yes |
| DELGOCITINIB_AD_AUTO_FULL_REVIEW | RD | 3 | 15.109 | -82.894 to 113.112 | -179.888 to 210.106 | 73.6% | 0.023 | 1535.1248 | Yes |
| DELGOCITINIB_HAND_AUTO_FULL | OR | 4 | 3.100 | 0.067 to 144.247 | 0.001 to 15267.239 | 66.2% | 0.031 | 5.6810 | Yes |
| DELGOCITINIB_HAND_AUTO_FULL_REVIEW | RD | 3 | 15.109 | -82.894 to 113.112 | -179.888 to 210.106 | 73.6% | 0.023 | 1535.1248 | Yes |
| DENGUE_VACCINE_NEW_NMA_REVIEW | RR | 4 | 0.398 | 0.327 to 0.484 | 0.327 to 0.484 | 0.0% | 0.463 | 0.0000 | Yes |
| DENOSUMAB_BONE_MET_AUTO_FULL | OR | 5 | 1.279 | 0.699 to 2.342 | 0.325 to 5.034 | 46.2% | 0.114 | 0.1960 | Yes |
| DENOSUMAB_BONE_MET_AUTO_FULL_REVIEW | HR | 4 | 0.863 | 0.747 to 0.997 | 0.698 to 1.068 | 23.8% | 0.268 | 0.0024 | Yes |
| DENOSUMAB_OSTEO_AUTO_FULL | OR | 2 | 2.296 | 0.031 to 171.509 | — | 0.0% | 0.766 | 0.0000 | Yes |
| DENOSUMAB_OSTEO_AUTO_FULL_REVIEW | MD | 2 | 0.194 | -4.222 to 4.609 | — | 0.0% | 0.950 | 0.0000 | Yes |
| DEPRESSION_NEW_RAPID | OR | 9 | 1.979 | 1.105 to 3.544 | 0.361 to 10.851 | 86.0% | 2.42e-08 | 0.4807 | — |
| DEPRESSION_NEW_RAPID_REVIEW | RR | 7 | 1.630 | 1.394 to 1.905 | 1.394 to 1.905 | 0.0% | 0.485 | 0.0000 | Yes |
| DEPRESSION_PSYCHEDELIC_NMA_REVIEW | MD | 2 | -9.298 | -244.809 to 226.213 | — | 73.4% | 0.052 | 683.2256 | Yes |
| DERISOMALTOSE_IRON_DEFICIENCY_AUTO_FULL | OR | 4 | 0.272 | 0.000 to 24528142238177771520.000 | 0.000 to 109470441065205404691668327983230565060968448.000 | 95.2% | 1.34e-13 | 833.0677 | Yes |
| DERISOMALTOSE_IRON_DEFICIENCY_AUTO_FULL_REVIEW | RD | 2 | -66.421 | -126.789 to -6.052 | — | 0.0% | 0.900 | 0.0000 | Yes |
| DERUXTECAN_NONSMALL_CELL_AUTO_FULL | OR | 2 | 1.217 | 0.000 to 16277870697665529856.000 | — | 69.2% | 0.072 | 23.8353 | Yes |
| DIABETIC_MACULAR_EDEMA | OR | 3 | 1.091 | 0.862 to 1.382 | 0.862 to 1.382 | 0.0% | 0.957 | 0.0000 | Yes |
| DIABETIC_MACULAR_EDEMA_REVIEW | MD | 3 | 1.137 | -8.668 to 10.942 | -18.055 to 20.329 | 38.6% | 0.196 | 14.7028 | Yes |
| DIABETIC_RETINOPATHY | OR | 3 | 1.012 | 0.078 to 13.108 | 0.007 to 148.182 | 90.3% | 1.12e-06 | 0.9889 | — |
| DIABETIC_RETINOPATHY_REVIEW | RR | 2 | 1.148 | 0.000 to 8539967147808073655345158434844825354240.000 | — | 96.0% | 6.27e-07 | 104.3680 | Yes |
| DIMETHYL_FUMARATE_MS_AUTO_FULL | OR | 2 | 0.935 | 0.000 to 11079106508.908 | — | 70.4% | 0.066 | 6.6173 | Yes |
| DINUTUXIMAB_NEUROBLASTOMA_AUTO_FULL | OR | 2 | 0.633 | 0.014 to 28.896 | — | 65.5% | 0.088 | 0.0000 | — |
| DOAC_AF | OR | 4 | 0.809 | 0.665 to 0.984 | 0.603 to 1.086 | 35.9% | 0.173 | 0.0048 | — |
| DOAC_AF_NMA | OR | 4 | 0.754 | 0.657 to 0.865 | 0.657 to 0.865 | 0.0% | 0.533 | 0.0000 | Yes |
| DOAC_AF_REVIEW | HR | 4 | 0.793 | 0.670 to 0.939 | 0.670 to 0.939 | 31.5% | 0.223 | 0.0000 | — |
| DOAC_CANCER_VTE | OR | 4 | 0.639 | 0.247 to 1.656 | 0.151 to 2.714 | 54.2% | 0.068 | 0.1170 | — |
| DOAC_VTE_NMA | OR | 4 | 0.861 | 0.690 to 1.074 | 0.690 to 1.074 | 0.0% | 0.588 | 0.0000 | Yes |
| DOLUTEGRAVIR_ART_SSA | OR | 3 | 2.142 | 0.281 to 16.319 | 0.055 to 83.746 | 90.1% | 0.010 | 0.5032 | — |
| DOLUTEGRAVIR_ART_SSA_REVIEW | RR | 2 | 1.116 | 0.775 to 1.606 | — | 0.0% | 0.479 | 0.0000 | Yes |
| DONANEMAB_AD_AUTO_FULL | OR | 3 | 1.932 | 0.000 to 5621520727805411230625342893859666516770816.000 | 0.000 to 16226031513041895428858257249517699515188961436481212666891381726677539248169516269568.000 | 99.2% | 3.28e-55 | 1549.0701 | Yes |
| DONANEMAB_AD_AUTO_FULL_REVIEW | MD | 2 | 2.970 | -5.427 to 11.367 | — | 0.0% | 0.871 | 0.0000 | Yes |
| DONIDALORSEN_HAE_AUTO_FULL | OR | 2 | 0.071 | 0.000 to 443.535 | — | 0.0% | 0.601 | 0.0000 | Yes |
| DONIDALORSEN_HAE_AUTO_FULL_REVIEW | MD | 2 | 1.862 | -2.313 to 6.037 | — | 0.0% | 0.830 | 0.0000 | Yes |
| DORAVIRINE_HIV | OR | 3 | 1.055 | 0.356 to 3.127 | 0.179 to 6.210 | 67.0% | 0.075 | 0.1059 | — |
| DORAVIRINE_HIV_AUTO_FULL | OR | 2 | 1.087 | 0.011 to 108.199 | — | 0.0% | 0.660 | 0.0000 | Yes |
| DORAVIRINE_HIV_REVIEW | RR | 3 | 1.016 | 0.453 to 2.279 | 0.203 to 5.078 | 65.1% | 0.057 | 0.1046 | Yes |
| DORIPENEM_AUTO_FULL | OR | 2 | 0.683 | 0.000 to 195420.512 | — | 92.4% | 2.74e-04 | 0.0000 | — |
| DROTRECOGIN_SEPSIS_AUTO_FULL | OR | 2 | 0.505 | 0.000 to 2014055887223996741388132243463257194496.000 | — | 96.4% | 1.60e-07 | 102.9596 | Yes |
| DRY_EYE_NEW_NMA | OR | 10 | 2.770 | 2.128 to 3.606 | 1.307 to 5.873 | 76.1% | 1.26e-04 | 0.0967 | — |
| DRY_EYE_NEW_NMA_REVIEW | RR | 4 | 1.440 | 1.243 to 1.669 | 1.243 to 1.669 | 0.0% | 0.916 | 0.0000 | Yes |
| DUCHENNE_GENE_THERAPY | OR | 7 | 1.639 | 0.552 to 4.862 | 0.112 to 23.998 | 83.4% | 3.90e-06 | 1.0057 | — |
| DUCHENNE_GENE_THERAPY_REVIEW | RR | 5 | 1.795 | 1.235 to 2.609 | 1.235 to 2.609 | 0.0% | 0.873 | 0.0000 | Yes |
| DULOXETINE_DEPRESSION_AUTO_FULL | OR | 3 | 0.650 | 0.000 to 95262.787 | 0.000 to 13479468888.722 | 77.2% | 0.012 | 22.8387 | Yes |
| DULOXETINE_DEPRESSION_AUTO_FULL_REVIEW | MD | 3 | -0.062 | -2.303 to 2.179 | -2.303 to 2.179 | 92.7% | 1.12e-06 | 0.0000 | — |
| DUPILUMAB_AD | OR | 3 | 5.147 | 3.570 to 7.419 | 3.570 to 7.419 | 0.0% | 0.687 | 0.0000 | Yes |
| DUPILUMAB_AD_AUTO_FULL | OR | 2 | 0.206 | 0.000 to 4331.967 | — | 40.4% | 0.195 | 0.0000 | — |
| DUPILUMAB_AD_REVIEW | OR | 3 | 5.353 | 2.974 to 9.638 | 2.974 to 9.638 | 0.0% | 0.608 | 0.0000 | Yes |
| DUPILUMAB_COPD | OR | 2 | 0.057 | 0.002 to 1.786 | 0.001 to 4.969 | 33.9% | 0.219 | 0.0501 | — |
| DUPILUMAB_COPD_REVIEW | MD | 2 | 82.523 | 76.177 to 88.870 | — | 0.0% | 0.974 | 0.0000 | — |
| DUPILUMAB_PED_AD_AUTO_FULL | OR | 3 | 0.178 | 0.068 to 0.469 | 0.068 to 0.469 | 0.0% | 0.418 | 0.0000 | Yes |
| DURVALUMAB_ENDOMETRIAL_AUTO_FULL | OR | 3 | 1.483 | 0.337 to 6.531 | 0.248 to 8.871 | 22.4% | 0.276 | 0.0541 | — |
| DURVALUMAB_ENDOMETRIAL_AUTO_FULL_REVIEW | HR | 2 | 1.014 | 0.000 to 65583812519155520.000 | — | 86.5% | 0.007 | 18.5265 | Yes |
| DUTASTERIDE_BPH_AUTO_FULL_REVIEW | MD | 2 | -2.232 | -1303.130 to 1298.666 | — | 86.6% | 0.006 | 20925.8796 | Yes |
| ECALLANTIDE_HAE_AUTO_FULL | OR | 2 | 0.764 | 0.000 to 1115132804810747941815273358178236644168557653867364352.000 | — | 80.7% | 0.023 | 192.0837 | Yes |
| ECULIZUMAB_NMOSD_AUTO_FULL | OR | 2 | 0.659 | 0.000 to 6374180856338935361538964358284137993799299171201148024956161861213699318081027097410775027029012803346159053739187473469182229803433984.000 | — | 91.2% | 7.24e-04 | 1213.2587 | Yes |
| EDOXABAN_CANCER_VTE_AUTO_FULL | OR | 3 | 0.485 | 0.155 to 1.518 | 0.155 to 1.518 | 0.0% | 0.968 | 0.0000 | Yes |
| EDOXABAN_VTE_AUTO_FULL | OR | 3 | 0.485 | 0.155 to 1.518 | 0.155 to 1.518 | 0.0% | 0.968 | 0.0000 | Yes |
| EFGARTIGIMOD_ITP_AUTO_FULL | OR | 2 | 2.273 | 0.000 to 3468391199779545044802697397007747913875456.000 | — | 80.0% | 0.025 | 116.4869 | Yes |
| EFPEGLENATIDE_T2D_AUTO_FULL | OR | 2 | 0.283 | 0.001 to 114.460 | — | 65.4% | 0.089 | 0.0000 | — |
| EFSITORA_TYPE_2_AUTO_FULL | OR | 2 | 1.069 | 0.013 to 89.169 | — | 81.0% | 0.022 | 0.0000 | — |
| EFSITORA_TYPE_2_AUTO_FULL_REVIEW | MD | 4 | -0.061 | -0.162 to 0.040 | -0.162 to 0.040 | 0.0% | 0.752 | 0.0000 | Yes |
| ELAFIBRANOR_NASH_AUTO_FULL | OR | 2 | 2.580 | 0.000 to 16293771478698789468248823438471281854333874115872037417264911220736.000 | — | 85.9% | 0.008 | 292.5054 | Yes |
| ELAFIBRANOR_PBC_AUTO_FULL | OR | 2 | 2.580 | 0.000 to 16293771478698789468248823438471281854333874115872037417264911220736.000 | — | 85.9% | 0.008 | 292.5054 | Yes |
| ELAGOLIX_ENDOMETRIOSIS_AUTO_FULL | OR | 3 | 0.596 | 0.000 to 2341804514718.634 | 0.000 to 9084569995710963346571264.000 | 92.9% | 7.68e-07 | 136.1999 | Yes |
| ELAGOLIX_ENDO_AUTO_FULL | OR | 3 | 0.596 | 0.000 to 2341804514718.634 | 0.000 to 9084569995710963346571264.000 | 92.9% | 7.68e-07 | 136.1999 | Yes |
| ELAGOLIX_FIBROIDS_AUTO_FULL | OR | 6 | 0.208 | 0.000 to 16071648666216.771 | 0.000 to 1140416814193285585940060647261732864.000 | 95.9% | 1.28e-24 | 928.2139 | Yes |
| ELAGOLIX_FIBROIDS_AUTO_FULL_REVIEW | OR | 4 | 20.333 | 0.000 to 62808493428.056 | 0.000 to 32864023577574831554560.000 | 82.4% | 6.83e-04 | 188.3226 | Yes |
| ELAGOLIX_HMB_AUTO_FULL | OR | 3 | 0.160 | 0.000 to 91676168490932827041816495684681990144.000 | 0.000 to 51997890510280797402915754754333998638052138308139022066334362939585963491328.000 | 97.8% | 8.17e-21 | 1290.4494 | Yes |
| ELAGOLIX_HMB_AUTO_FULL_REVIEW | OR | 2 | 39.597 | 0.526 to 2982.470 | — | 13.5% | 0.282 | 0.0000 | — |
| ELAMIPRETIDE_AUTO_FULL_REVIEW | MD | 2 | -0.842 | -81.192 to 79.508 | — | 0.0% | 0.723 | 0.0000 | Yes |
| ELRANATAMAB_MM_REVIEW_FULL | OR | 2 | 2.983 | 0.053 to 167.310 | — | 0.0% | 0.998 | 0.0000 | Yes |
| ELUXADOLINE_IBSD_AUTO_FULL | OR | 3 | 0.928 | 0.587 to 1.469 | 0.587 to 1.469 | 0.0% | 0.961 | 0.0000 | Yes |
| ELVITEGRAVIR_HIV_AUTO_FULL | OR | 4 | 1.001 | 0.632 to 1.585 | 0.632 to 1.585 | 0.0% | 0.980 | 0.0000 | Yes |
| EMICIZUMAB_HEMA_AUTO_FULL | OR | 3 | 2.526 | 0.000 to 266798378721506046763554080870053228835612823068607990726656.000 | 0.000 to 26500094389819907372361380901150487816920561716225140121771052584033063051335767024232346523682080114440519344430514176.000 | 94.2% | 3.60e-08 | 2991.3874 | Yes |
| EMTRICITABINE_HIV_AUTO_FULL | OR | 2 | 2.186 | 0.000 to 141833024837856596249552097534256410001408.000 | — | 81.3% | 0.021 | 109.0719 | Yes |
| ENDOMETRIAL_IO_PARP | OR | 10 | 0.540 | 0.425 to 0.685 | 0.309 to 0.942 | 58.3% | 0.010 | 0.0496 | — |
| ENDOMETRIAL_IO_PARP_REVIEW | HR | 7 | 0.661 | 0.129 to 3.387 | 0.007 to 66.529 | 71.5% | 0.002 | 3.1059 | Yes |
| ENDOMETRIOSIS_NEW_GNRH_NMA_REVIEW | RR | 6 | 2.369 | 0.123 to 45.522 | 0.001 to 5859.680 | 78.6% | 2.82e-04 | 7.9166 | Yes |
| ENOXAPARIN_VTE_AUTO_FULL | OR | 2 | 0.696 | 0.126 to 3.860 | — | 0.0% | 0.820 | 0.0000 | Yes |
| ENSIFENTRINE_COPD | OR | 2 | 0.445 | 0.176 to 1.122 | 0.176 to 1.122 | 0.0% | 0.498 | 0.0000 | Yes |
| ENSIFENTRINE_COPD_REVIEW | MD | 2 | 90.500 | 46.028 to 134.972 | — | 0.0% | 0.757 | 0.0000 | — |
| EOE_BIOLOGIC_NMA | OR | 9 | 27.573 | 18.169 to 41.843 | 18.169 to 41.845 | 0.0% | 0.173 | 0.0000 | — |
| EOE_BIOLOGIC_NMA_REVIEW | RR | 2 | 5.874 | 0.501 to 68.913 | — | 0.0% | 0.353 | 0.0000 | Yes |
| EOSINOPHILIC_DISEASES_BROAD | OR | 10 | 8.458 | 3.388 to 21.115 | 0.631 to 113.342 | 91.7% | 3.89e-10 | 1.1527 | — |
| EOSINOPHILIC_DISEASES_BROAD_REVIEW | RR | 9 | 2.853 | 0.012 to 668.196 | 0.000 to 88119649.236 | 85.8% | 2.44e-09 | 50.3328 | Yes |
| EPILEPSY_NEW_AEDS | OR | 10 | 2.752 | 1.847 to 4.102 | 0.800 to 9.466 | 87.5% | 7.77e-11 | 0.2671 | — |
| EPILEPSY_NEW_AEDS_REVIEW | RR | 9 | 1.854 | 0.350 to 9.813 | 0.010 to 356.076 | 72.7% | 2.86e-04 | 4.6766 | Yes |
| EPILEPSY_NEW_AGENTS_NMA_REVIEW | RR | 8 | 2.688 | 0.324 to 22.300 | 0.005 to 1487.294 | 54.5% | 0.032 | 6.3340 | Yes |
| EPOETIN_ANEMIA_AUTO_FULL | OR | 2 | 0.940 | 0.396 to 2.232 | — | 0.0% | 0.735 | 0.0000 | Yes |
| EPOETIN_CANCER_AUTO_FULL | OR | 2 | 0.900 | 0.038 to 21.158 | — | 0.0% | 0.766 | 0.0000 | Yes |
| EPTINEZUMAB_CHRONIC_AUTO_FULL | OR | 3 | 15.689 | 0.000 to 7009471509605551385073516891199206488962564001773517799424.000 | 0.000 to 3055484178364328087230492713227694930548868330742633163227797196795611435733510166199328579728422539316744865972224.000 | 96.8% | 4.09e-14 | 2756.5916 | Yes |
| EPTINEZUMAB_CHRONIC_AUTO_FULL_REVIEW | MD | 3 | -2.988 | -4.101 to -1.875 | -4.101 to -1.875 | 0.0% | 0.544 | 0.0000 | Yes |
| EPTINEZUMAB_MIGRAINE_AUTO_FULL | OR | 3 | 15.689 | 0.000 to 7009471509605551385073516891199206488962564001773517799424.000 | 0.000 to 3055484178364328087230492713227694930548868330742633163227797196795611435733510166199328579728422539316744865972224.000 | 96.8% | 4.09e-14 | 2756.5916 | Yes |
| EPTINEZUMAB_MIGRAINE_AUTO_FULL_REVIEW | MD | 3 | -2.988 | -4.101 to -1.875 | -4.101 to -1.875 | 0.0% | 0.544 | 0.0000 | Yes |
| ERAVACYCLINE_INFECTION_AUTO_FULL | OR | 2 | 9.597 | 0.000 to 74451335234184678037290887399672750321256432749889787192967350576616925298154489237053811433898668888760000189456081838897655451511422976.000 | — | 99.4% | 5.60e-39 | 1212.7671 | Yes |
| ERDAFITINIB_BLADDER_AUTO_FULL | OR | 3 | 1.392 | 0.000 to 176379.945 | 0.000 to 12593168073.799 | 89.5% | 7.62e-05 | 20.9335 | Yes |
| ERTAPENEM_AUTO_FULL | OR | 2 | 0.879 | 0.061 to 12.753 | — | 0.0% | 0.958 | 0.0000 | Yes |
| ERTAPENEM_INFECT_AUTO_FULL | OR | 2 | 0.879 | 0.061 to 12.753 | — | 0.0% | 0.958 | 0.0000 | Yes |
| ERTUGLIFLOZIN_T2D_AUTO_FULL | OR | 4 | 1.334 | 0.829 to 2.147 | 0.829 to 2.147 | 0.0% | 0.422 | 0.0000 | Yes |
| ERTUGLIFLOZIN_T2D_AUTO_FULL_REVIEW | MD | 3 | 0.018 | -0.443 to 0.480 | -0.762 to 0.798 | 36.4% | 0.208 | 0.0214 | Yes |
| ESKETAMINE_TRD | OR | 2 | — | — | — | 0.0% | 0.874 | 0.0000 | Yes |
| ESKETAMINE_TRD_REVIEW | MD | 2 | -3.816 | -6.349 to -1.283 | — | 0.0% | 0.874 | 0.0000 | — |
| ESLICARBAZEPINE_EPILEPSY_AUTO_FULL | OR | 2 | 0.695 | 0.045 to 10.714 | — | 0.0% | 0.603 | 0.0000 | Yes |
| ESLICARBAZEPINE_EPILEPSY_AUTO_FULL_REVIEW | MD | 3 | 0.184 | -40.351 to 40.719 | -80.833 to 81.201 | 80.3% | 0.006 | 265.7959 | Yes |
| ESOPHAGEAL_PERIOP_IO_NMA_REVIEW | HR | 2 | 0.788 | 0.000 to 89594.519 | — | 73.6% | 0.052 | 1.6694 | Yes |
| ETANERCEPT_RA_AUTO_FULL | OR | 2 | 0.105 | 0.000 to 68069296129927337438226724592461299222426821166956607122955578022040033873048983471201038650924851518354063528900302357446086384749866065721105895745650688.000 | — | 98.9% | 1.83e-21 | 1594.3831 | Yes |
| ETELCALCETIDE_HYPERPARATHYROIDISM_SECO_AUTO_FULL | OR | 2 | 0.033 | 0.003 to 0.351 | — | 0.0% | 0.791 | 0.0000 | Yes |
| ETELCALCETIDE_HYPERPARATHYROIDISM_SECO_AUTO_FULL_REVIEW | OR | 2 | 31.582 | 2.674 to 373.014 | — | 0.0% | 0.893 | 0.0000 | Yes |
| ETEPLIRSEN_DMD_AUTO_FULL | OR | 2 | 0.851 | 0.000 to 23809270772695516826577984797007314824524055765884519997988916732346772216377243330412544.000 | — | 81.3% | 0.021 | 512.2597 | Yes |
| ETEPLIRSEN_DMD_AUTO_FULL_REVIEW | MD | 2 | 19.780 | -314.841 to 354.400 | — | 0.0% | 0.629 | 0.0000 | Yes |
| ETESEVIMAB_COVID_AUTO_FULL | OR | 3 | 1.400 | 0.466 to 4.212 | 0.466 to 4.212 | 0.0% | 0.791 | 0.0000 | Yes |
| ETESEVIMAB_COVID_AUTO_FULL_REVIEW | OR | 2 | 0.392 | 0.034 to 4.568 | — | 0.0% | 0.858 | 0.0000 | Yes |
| ETRASIMOD_UC | OR | 2 | 2.532 | 0.014 to 448.813 | 0.001 to 9325.765 | 75.6% | 0.043 | 0.2516 | — |
| ETRASIMOD_UC_AUTO_FULL | OR | 3 | 2.753 | 0.380 to 19.945 | 0.380 to 19.945 | 68.1% | 0.043 | 0.0000 | — |
| ETRASIMOD_UC_REVIEW | RR | 2 | 2.586 | 0.000 to 35680009807659924.000 | — | 75.6% | 0.043 | 17.0278 | Yes |
| ETRIPAMIL_PAROXYSMAL_SUPRAVENTRICU_AUTO_FULL | OR | 2 | 1.235 | 0.003 to 442.049 | — | 56.9% | 0.128 | 0.0000 | — |
| ETROLIZUMAB_UC_AUTO_FULL | OR | 3 | 3.466 | 0.000 to 10388948197441252884480.000 | 0.000 to 30859783238686739708635001438722760219033600.000 | 96.2% | 4.46e-12 | 396.1976 | Yes |
| EVEROLIMUS_BREAST_AUTO_FULL | OR | 3 | 0.915 | 0.442 to 1.895 | 0.442 to 1.895 | 0.0% | 0.998 | 0.0000 | Yes |
| EVEROLIMUS_TUBEROUS_AUTO_FULL | OR | 2 | 20.168 | 0.000 to 3622882340.875 | — | 37.3% | 0.207 | 0.0000 | — |
| EVINACUMAB_HOFH_AUTO_FULL | OR | 2 | 5.541 | 0.006 to 5521.771 | — | 0.0% | 0.363 | 0.0000 | Yes |
| EVOBRUTINIB_MS_AUTO_FULL | OR | 3 | 0.828 | 0.000 to 2156709.319 | 0.000 to 5479136065327.849 | 84.3% | 0.002 | 35.2865 | Yes |
| EVOBRUTINIB_MS_AUTO_FULL_REVIEW | MD | 3 | -0.005 | -0.049 to 0.039 | -0.049 to 0.039 | 0.0% | 0.877 | 0.0000 | Yes |
| EVOLOCUMAB_ASCVD_AUTO_2_FULL | OR | 2 | 2.681 | 0.010 to 706.843 | — | 0.0% | 0.601 | 0.0000 | Yes |
| EVOLOCUMAB_ASCVD_AUTO_2_FULL_REVIEW | MD | 2 | 5.610 | -882.520 to 893.741 | — | 84.8% | 0.010 | 9749.9629 | Yes |
| EVOLOCUMAB_DYSLIPIDEMIA_AUTO_FULL | OR | 2 | 1.039 | 0.001 to 1750.673 | — | 70.1% | 0.068 | 0.6786 | Yes |
| EVOLOCUMAB_MIXED_DYSLIPIDEMIA_AUTO_FULL | OR | 3 | 0.935 | 0.372 to 2.351 | 0.372 to 2.351 | 89.2% | 9.76e-05 | 0.0000 | — |
| EVOLOCUMAB_MIXED_DYSLIPIDEMIA_AUTO_FULL_REVIEW | MD | 3 | -0.703 | -2016.894 to 2015.488 | -4032.055 to 4030.649 | 97.8% | 9.06e-21 | 658289.0637 | Yes |
| EVT_BASILAR | OR | 3 | 2.130 | 0.703 to 6.451 | 0.305 to 14.864 | 66.6% | 0.045 | 0.1376 | — |
| EVT_BASILAR_REVIEW | RR | 3 | 1.757 | 0.000 to 10766.685 | 0.000 to 64866962.652 | 81.4% | 0.005 | 12.2916 | Yes |
| EVT_EXTENDED_WINDOW | OR | 3 | 3.320 | 0.633 to 17.405 | 0.148 to 74.474 | 81.8% | 0.002 | 0.3744 | — |
| EVT_EXTENDED_WINDOW_REVIEW | RR | 2 | 3.054 | 0.288 to 32.437 | — | 0.0% | 0.341 | 0.0000 | Yes |
| EVT_LARGECORE | OR | 6 | 2.549 | 1.597 to 4.068 | 0.988 to 6.571 | 47.2% | 0.102 | 0.1027 | — |
| EVT_LARGECORE_REVIEW | RR | 4 | 2.636 | 1.724 to 4.032 | 1.724 to 4.032 | 0.0% | 0.959 | 0.0000 | Yes |
| EZETIMIBE_LIPID_AUTO_FULL_REVIEW | MD | 2 | 8.877 | -2080.630 to 2098.385 | — | 96.1% | 3.53e-07 | 54063.5729 | Yes |
| FARICIMAB_DME_AUTO_FULL | OR | 3 | 0.896 | 0.000 to 174950.910 | 0.000 to 33297040661.592 | 68.5% | 0.042 | 23.9810 | Yes |
| FARICIMAB_DME_AUTO_FULL_REVIEW | MD | 2 | 0.724 | -10.036 to 11.483 | — | 46.3% | 0.172 | 0.0000 | — |
| FARICIMAB_NAMD | OR | 2 | — | — | — | 0.0% | 0.496 | 0.0000 | Yes |
| FARICIMAB_NAMD_REVIEW | MD | 2 | 0.362 | -4.082 to 4.807 | — | 0.0% | 0.496 | 0.0000 | — |
| FARICIMAB_RVO_AUTO_FULL | OR | 2 | 0.811 | 0.081 to 8.113 | — | 0.0% | 0.447 | 0.0000 | Yes |
| FARICIMAB_RVO_AUTO_FULL_REVIEW | MD | 2 | -0.521 | -8.892 to 7.850 | — | 0.0% | 0.882 | 0.0000 | Yes |
| FASINUMAB_OA_AUTO_FULL | OR | 2 | 0.884 | 0.000 to 17149753846814.201 | — | 77.1% | 0.037 | 11.5482 | Yes |
| FASINUMAB_OA_AUTO_FULL_REVIEW | MD | 2 | -0.050 | -88.201 to 88.101 | — | 96.4% | 1.33e-07 | 96.2243 | Yes |
| FCM_HF | OR | 5 | 0.592 | 0.480 to 0.731 | 0.392 to 0.895 | 45.8% | 0.129 | 0.0164 | — |
| FCM_HF_REVIEW | HR | 3 | 0.873 | 0.612 to 1.245 | 0.612 to 1.245 | 50.6% | 0.132 | 0.0000 | — |
| FEBUXOSTAT_GOUT_AUTO_FULL | OR | 2 | 0.701 | 0.001 to 608.950 | — | 93.2% | 1.29e-04 | 0.0000 | — |
| FENFLURAMINE_SEIZURE | OR | 3 | 9.049 | 0.564 to 145.085 | 0.060 to 1375.253 | 73.6% | 0.017 | 0.9474 | — |
| FENFLURAMINE_SEIZURE_REVIEW | RR | 2 | 3.374 | 0.024 to 481.352 | — | 48.7% | 0.163 | 0.0000 | — |
| FENOFIBRATE_DR_AUTO_FULL | OR | 2 | 0.663 | 0.192 to 2.297 | — | 0.0% | 0.872 | 0.0000 | Yes |
| FERUMOXYTOL_IDA_AUTO_FULL | OR | 3 | 2.435 | 0.496 to 11.959 | 0.496 to 11.959 | 0.0% | 0.607 | 0.0000 | Yes |
| FESOTERODINE_OAB_AUTO_FULL_REVIEW | MD | 2 | -0.420 | -25.718 to 24.878 | — | 75.2% | 0.045 | 7.8893 | Yes |
| FEZOLINETANT_HOT_FLASHES_AUTO_FULL | OR | 3 | 0.128 | 0.000 to 56074471757207264.000 | 0.000 to 23175881985193478780593254954958848.000 | 93.5% | 1.94e-07 | 266.8715 | Yes |
| FEZOLINETANT_HOT_FLASHES_AUTO_FULL_REVIEW | MD | 2 | 2.082 | -21.080 to 25.243 | — | 93.6% | 7.85e-05 | 0.0000 | — |
| FEZOLINETANT_VMS | OR | 2 | — | — | — | 39.4% | 0.199 | 0.1050 | — |
| FEZOLINETANT_VMS_REVIEW | MD | 2 | -2.167 | -6.799 to 2.465 | — | 39.4% | 0.199 | 0.1050 | — |
| FGFR_INHIBITORS_SOLID | OR | 3 | 0.500 | 0.397 to 0.630 | 0.397 to 0.630 | 0.0% | 0.604 | 0.0000 | — |
| FIDAXOMICIN_CDIFF_AUTO_FULL | OR | 3 | 0.956 | 0.378 to 2.421 | 0.378 to 2.421 | 48.2% | 0.145 | 0.0000 | — |
| FIDAXOMICIN_CDI_AUTO_FULL | OR | 3 | 0.712 | 0.000 to 349390.435 | 0.000 to 159325054290.666 | 69.3% | 0.038 | 27.6168 | Yes |
| FILGOTINIB_RA_AUTO_FULL | OR | 3 | 1.606 | 0.952 to 2.710 | 0.952 to 2.710 | 0.0% | 0.840 | 0.0000 | Yes |
| FINERENONE | OR | 4 | 0.847 | 0.800 to 0.897 | 0.800 to 0.897 | 0.0% | 0.890 | 0.0000 | Yes |
| FITUSIRAN_HEMA_AUTO_FULL | OR | 3 | 47.758 | 0.000 to 27785658357826662400.000 | 0.000 to 14725678988385483475464265827216261120.000 | 78.1% | 0.010 | 270.3199 | Yes |
| FITUSIRAN_HEM_AUTO_FULL | OR | 3 | 47.758 | 0.000 to 27785658357826662400.000 | 0.000 to 14725678988385483475464265827216261120.000 | 78.1% | 0.010 | 270.3199 | Yes |
| FLUTICASONE_ASTHMA_AUTO_FULL | OR | 2 | 1.849 | 0.000 to 49629253353099810466521365197357056.000 | — | 85.9% | 0.008 | 77.6999 | Yes |
| FLUTICASONE_ASTHMA_AUTO_FULL_REVIEW | MD | 3 | -0.175 | -0.441 to 0.091 | -0.441 to 0.091 | 62.0% | 0.072 | 0.0000 | — |
| FONDAPARINUX_AUTO_FULL | OR | 4 | 0.716 | 0.387 to 1.326 | 0.387 to 1.326 | 0.0% | 0.627 | 0.0000 | Yes |
| FONDAPARINUX_VTE_AUTO_FULL | OR | 2 | 1.874 | 0.000 to 164098.597 | — | 0.0% | 0.512 | 0.0000 | Yes |
| FOSAPREPITANT_CINV_AUTO_FULL | OR | 2 | 3.035 | 0.058 to 158.563 | — | 57.0% | 0.127 | 0.0000 | — |
| FRAGILITY_FRACTURE | OR | 4 | 0.329 | 0.184 to 0.589 | 0.107 to 1.014 | 74.4% | 0.008 | 0.0914 | — |
| FRAGILITY_FRACTURE_REVIEW | RR | 4 | 0.308 | 0.001 to 81.337 | 0.000 to 78116.651 | 76.5% | 0.005 | 12.2174 | Yes |
| GALCANEZUMAB_MIGRAINE_AUTO_FULL | OR | 5 | 0.570 | 0.001 to 237.808 | 0.000 to 1442359.014 | 83.3% | 7.92e-05 | 23.4775 | Yes |
| GALCANEZUMAB_MIGRAINE_AUTO_FULL_REVIEW | MD | 4 | -0.233 | -50.729 to 50.264 | -113.141 to 112.676 | 98.2% | 1.02e-36 | 1006.9518 | Yes |
| GANTENERUMAB_AD_AUTO_FULL | OR | 3 | 1.865 | 0.005 to 638.665 | 0.000 to 116071.305 | 67.6% | 0.046 | 4.7423 | Yes |
| GANTENERUMAB_AD_AUTO_FULL_REVIEW | MD | 2 | -0.186 | -0.788 to 0.416 | — | 93.9% | 5.13e-05 | 0.0000 | — |
| GASTRIC_FRONTLINE_IO_NMA_REVIEW | HR | 3 | 0.791 | 0.653 to 0.957 | 0.653 to 0.957 | 0.0% | 0.960 | 0.0000 | Yes |
| GEFAPIXANT_COUGH_AUTO_FULL | OR | 4 | 1.657 | 0.000 to 1793973656.647 | 0.000 to 226842964820662255616.000 | 85.7% | 1.05e-04 | 169.5323 | Yes |
| GEFAPIXANT_COUGH_AUTO_FULL_REVIEW | MD | 4 | -0.001 | -0.172 to 0.170 | -0.172 to 0.170 | 63.7% | 0.041 | 0.0000 | — |
| GEPOTIDACIN_URINARY_TRACT_AUTO_FULL | OR | 2 | 1.153 | 0.415 to 3.208 | — | 0.0% | 0.796 | 0.0000 | Yes |
| GLASDEGIB_AML_AUTO_FULL | OR | 3 | 0.211 | 0.018 to 2.508 | 0.018 to 2.508 | 85.7% | 9.06e-04 | 0.0000 | — |
| GLOMERULONEPHRITIS_BIOLOGICS | OR | 9 | 3.015 | 2.154 to 4.220 | 1.245 to 7.299 | 66.5% | 0.002 | 0.1257 | — |
| GLOMERULONEPHRITIS_BIOLOGICS_REVIEW | RR | 6 | 1.949 | 0.029 to 132.827 | 0.000 to 137001.211 | 69.0% | 0.006 | 16.1520 | Yes |
| GLP1_CVOT | OR | 10 | 0.853 | 0.797 to 0.913 | 0.740 to 0.983 | 37.0% | 0.109 | 0.0030 | — |
| GLP1_CVOT_NMA | OR | 8 | 0.861 | 0.784 to 0.944 | 0.711 to 1.041 | 45.7% | 0.088 | 0.0050 | — |
| GLP1_MASH | OR | 3 | 6.031 | 1.048 to 34.701 | 0.217 to 167.758 | 81.0% | 0.001 | 0.4320 | — |
| GLP1_MASH_REVIEW | OR | 2 | 10.117 | 0.212 to 481.805 | — | 0.0% | 0.910 | 0.0000 | Yes |
| GOSERELIN_PROSTATE_AUTO_FULL | OR | 2 | 6.146 | 0.000 to 704819934345312272744559488138317103229549195258073286715637760.000 | — | 69.0% | 0.073 | 250.9054 | Yes |
| GRANISETRON_CINV_AUTO_FULL | OR | 2 | 2.556 | 0.000 to 2217662959311.253 | — | 76.4% | 0.040 | 9.3191 | Yes |
| GRAZOPREVIR_HEPATITIS_C_AUTO_FULL | OR | 2 | 0.292 | 0.000 to 2764273.833 | — | 0.0% | 0.450 | 0.0000 | Yes |
| GUANFACINE_ADHD_AUTO_FULL | OR | 3 | 0.578 | 0.000 to 8451789.605 | 0.000 to 95279536103995.922 | 88.9% | 1.26e-04 | 43.1847 | Yes |
| GUANFACINE_ADHD_AUTO_FULL_REVIEW | MD | 4 | 0.507 | -60.152 to 61.166 | -134.115 to 135.130 | 94.2% | 3.18e-11 | 1426.1212 | Yes |
| GUSELKUMAB_ARTHRITIS_PSORIATIC_AUTO_FULL | OR | 3 | 0.565 | 0.000 to 376882488352.154 | 0.000 to 247584813829044435943424.000 | 88.5% | 1.68e-04 | 120.0325 | Yes |
| GUSELKUMAB_ARTHRITIS_PSORIATIC_AUTO_FULL_REVIEW | MD | 2 | 26.243 | -363.941 to 416.426 | — | 69.1% | 0.072 | 1870.8185 | Yes |
| GUSELKUMAB_PSORIASIS_AUTO_FULL | OR | 4 | 0.838 | 0.000 to 21384233694013333634702361424297984.000 | 0.000 to 69559035483026041981039544225157734769726626623725719878500217878337533509632.000 | 91.3% | 1.63e-07 | 2477.5265 | Yes |
| GUSELKUMAB_PSORIASIS_AUTO_FULL_REVIEW | MD | 2 | 33.691 | -1555.961 to 1623.344 | — | 79.7% | 0.026 | 31197.7984 | Yes |
| GVHD_NEW_AGENTS | OR | 4 | 1.622 | 0.598 to 4.395 | 0.201 to 13.083 | 83.3% | 1.48e-04 | 0.3322 | — |
| GVHD_NEW_AGENTS_REVIEW | RR | 4 | 1.316 | 0.004 to 461.451 | 0.000 to 640313.539 | 86.8% | 4.55e-05 | 13.5409 | Yes |
| GnRH_ANTAGONISTS_GYN | OR | 9 | 10.881 | 6.534 to 18.122 | 2.552 to 46.386 | 83.2% | 2.36e-06 | 0.3464 | — |
| HAE_PROPHYLAXIS | OR | 9 | 0.177 | 0.107 to 0.293 | 0.078 to 0.404 | 18.1% | 0.308 | 0.0801 | — |
| HAE_PROPHYLAXIS_REVIEW | RR | 2 | 0.286 | 0.000 to 68997820540490878593389476155195779973120.000 | — | 95.4% | 3.34e-06 | 112.4170 | Yes |
| HALOPERIDOL_DELIRIUM_AUTO_FULL | OR | 3 | 0.660 | 0.197 to 2.212 | 0.197 to 2.212 | 0.0% | 0.477 | 0.0000 | Yes |
| HAP_VAP_NEW_ABX_NMA | OR | 10 | 0.802 | 0.589 to 1.093 | 0.357 to 1.802 | 65.2% | 0.004 | 0.1092 | — |
| HAP_VAP_NEW_ABX_NMA_REVIEW | RR | 2 | 0.995 | 0.674 to 1.469 | — | 0.0% | 0.526 | 0.0000 | Yes |
| HBV_FUNCTIONAL_CURE | OR | 10 | 14.204 | 8.189 to 24.638 | 8.189 to 24.639 | 0.0% | 0.335 | 0.0000 | — |
| HBV_FUNCTIONAL_CURE_REVIEW | RR | 2 | 6.161 | 0.078 to 485.594 | — | 0.0% | 0.406 | 0.0000 | Yes |
| HCC_1L | OR | 4 | 0.906 | 0.515 to 1.592 | 0.288 to 2.850 | 78.0% | 0.003 | 0.0983 | — |
| HCC_1L_REVIEW | RR | 4 | 0.780 | 0.666 to 0.913 | 0.666 to 0.913 | 0.0% | 0.480 | 0.0000 | Yes |
| HCV_DAA_NEW_NMA | OR | 9 | 12.483 | 0.652 to 238.828 | 0.002 to 88097.149 | 97.5% | 9.24e-19 | 13.1300 | — |
| HCV_DAA_NEW_NMA_REVIEW | RR | 7 | 1.042 | 0.508 to 2.139 | 0.137 to 7.960 | 81.1% | 1.87e-05 | 0.6040 | Yes |
| HDM_AIT_AUTO_FULL_REVIEW | MD | 3 | 0.011 | -0.948 to 0.969 | -0.948 to 0.969 | 0.0% | 0.837 | 0.0000 | Yes |
| HEAD_NECK_CRT_NEW_NMA_REVIEW | HR | 5 | 1.509 | 0.000 to 83157.166 | 0.000 to 612193447182.234 | 87.7% | 1.43e-06 | 77.2182 | Yes |
| HEAD_NECK_IO_BROAD | OR | 9 | 0.608 | 0.514 to 0.720 | 0.418 to 0.885 | 35.4% | 0.173 | 0.0211 | — |
| HEAD_NECK_IO_BROAD_REVIEW | HR | 7 | 0.736 | 0.657 to 0.826 | 0.657 to 0.826 | 0.0% | 0.896 | 0.0000 | Yes |
| HEMOPHILIA_FACTOR_PROPHYLAXIS | OR | 8 | 0.178 | 0.117 to 0.270 | 0.089 to 0.355 | 21.0% | 0.283 | 0.0541 | — |
| HEMOPHILIA_FACTOR_PROPHYLAXIS_REVIEW | RR | 8 | 0.237 | 0.000 to 1713.551 | 0.000 to 88888180949.097 | 86.0% | 1.45e-08 | 112.9084 | Yes |
| HEMOPHILIA_GENE_THERAPY | OR | 3 | 23.594 | 8.458 to 65.820 | 8.458 to 65.820 | 0.0% | 0.923 | 0.0000 | Yes |
| HEMOPHILIA_NEW_AGENTS_NMA | OR | 10 | 0.179 | 0.090 to 0.355 | 0.037 to 0.850 | 59.6% | 0.008 | 0.3840 | — |
| HEMOPHILIA_NEW_AGENTS_NMA_REVIEW | RR | 8 | 0.291 | 0.001 to 63.314 | 0.000 to 2952627.130 | 80.2% | 9.50e-06 | 41.3635 | Yes |
| HEPATITIS_B_TAF_TDF | OR | 2 | 0.913 | 0.243 to 3.427 | 0.243 to 3.427 | 0.0% | 0.464 | 0.0000 | Yes |
| HEPATITIS_B_TAF_TDF_REVIEW | RR | 2 | 0.997 | 0.735 to 1.352 | — | 0.0% | 0.359 | 0.0000 | Yes |
| HEPATITIS_HCV_DAA | OR | 3 | 0.078 | 0.034 to 0.180 | 0.034 to 0.180 | 0.0% | 0.771 | 0.0000 | — |
| HEPA_VACCINE_AUTO_FULL | OR | 3 | 0.954 | 0.298 to 3.052 | 0.298 to 3.052 | 0.0% | 0.882 | 0.0000 | Yes |
| HEP_D_BULEVIRTIDE_NMA_REVIEW | RR | 4 | 3.203 | 1.518 to 6.756 | 1.518 to 6.756 | 52.5% | 0.097 | 0.0000 | — |
| HER2_LOW_ADC | OR | 4 | 0.597 | 0.331 to 1.075 | 0.180 to 1.978 | 79.4% | 0.002 | 0.1076 | — |
| HER2_LOW_ADC_REVIEW | RR | 4 | 0.604 | 0.505 to 0.723 | 0.505 to 0.723 | 14.9% | 0.318 | 0.0000 | — |
| HFNC_NIV_RESP_FAILURE | OR | 9 | 0.707 | 0.607 to 0.825 | 0.547 to 0.914 | 20.7% | 0.264 | 0.0079 | — |
| HFNC_NIV_RESP_FAILURE_REVIEW | HR | 3 | 0.811 | 0.562 to 1.170 | 0.562 to 1.170 | 48.0% | 0.146 | 0.0000 | — |
| HF_QUADRUPLE_NMA | OR | 6 | 0.779 | 0.738 to 0.822 | 0.738 to 0.822 | 0.0% | 0.685 | 0.0000 | Yes |
| HF_QUADRUPLE_NMA_REVIEW | RR | 6 | 0.794 | 0.745 to 0.846 | 0.745 to 0.846 | 0.0% | 0.729 | 0.0000 | Yes |
| HFpEF_DRUGS_NMA | OR | 10 | 0.951 | 0.649 to 1.394 | 0.288 to 3.142 | 96.4% | 5.55e-14 | 0.2507 | — |
| HFpEF_DRUGS_NMA_REVIEW | HR | 7 | 0.832 | 0.774 to 0.895 | 0.774 to 0.895 | 0.0% | 0.720 | 0.0000 | Yes |
| HIDRADENITIS_SUPPURATIVA | OR | 3 | 2.184 | 0.603 to 7.909 | 0.202 to 23.678 | 80.3% | 0.005 | 0.2174 | — |
| HIDRADENITIS_SUPPURATIVA_REVIEW | RR | 3 | 1.602 | 0.002 to 1387.296 | 0.000 to 1186251.175 | 84.7% | 0.001 | 7.3952 | Yes |
| HIFPH_CKD_ANEMIA | OR | 5 | 1.007 | 0.874 to 1.160 | 0.767 to 1.321 | 48.0% | 0.113 | 0.0070 | — |
| HIFPH_CKD_ANEMIA_REVIEW | HR | 5 | 1.007 | 0.707 to 1.435 | 0.436 to 2.325 | 31.5% | 0.212 | 0.0745 | Yes |
| HIGH_EFFICACY_MS | OR | 4 | 0.343 | 0.272 to 0.433 | 0.272 to 0.433 | 0.0% | 0.488 | 0.0000 | Yes |
| HIGH_EFFICACY_MS_REVIEW | RR | 4 | 0.517 | 0.416 to 0.642 | 0.416 to 0.642 | 0.0% | 0.973 | 0.0000 | Yes |
| HIPEC_PERITONEAL_NMA_REVIEW | HR | 4 | 0.961 | 0.709 to 1.302 | 0.709 to 1.302 | 0.0% | 0.408 | 0.0000 | Yes |
| HIP_FX_DISPLACED_NMA | OR | 10 | 0.682 | 0.615 to 0.757 | 0.615 to 0.757 | 0.0% | 0.887 | 0.0000 | Yes |
| HIV_ART_TIMING | OR | 3 | 0.467 | 0.062 to 3.525 | 0.010 to 22.377 | 93.7% | 1.32e-06 | 0.5880 | — |
| HIV_LA_PREP | OR | 4 | 0.135 | 0.026 to 0.694 | 0.009 to 2.004 | 55.3% | 0.063 | 0.4545 | — |
| HIV_LA_PREP_REVIEW | HR | 2 | 0.294 | 0.003 to 35.030 | — | 38.6% | 0.202 | 0.0000 | — |
| HIV_PREP_INJECTABLE | OR | 3 | 0.282 | 0.041 to 1.923 | 0.011 to 7.056 | 67.0% | 0.064 | 0.3611 | — |
| HIV_PREP_INJECTABLE_REVIEW | HR | 2 | 0.202 | 0.000 to 920066261609962752.000 | — | 70.8% | 0.064 | 22.7063 | Yes |
| HIV_TB_COINFECTION_ART_TIMING | OR | 3 | 0.670 | 0.443 to 1.012 | 0.443 to 1.012 | 0.0% | 0.488 | 0.0000 | Yes |
| HIV_TB_COINFECTION_ART_TIMING_REVIEW | HR | 3 | 0.696 | 0.437 to 1.110 | 0.437 to 1.110 | 13.4% | 0.315 | 0.0000 | — |
| HPV_DOSE_REDUCTION | OR | 2 | 0.028 | 0.009 to 0.087 | 0.009 to 0.087 | 0.0% | 0.896 | 0.0000 | — |
| HPV_VACCINE_SCHEDULES | OR | 3 | 0.047 | 0.011 to 0.197 | 0.011 to 0.197 | 0.0% | 0.485 | 0.0000 | Yes |
| HPV_VACCINE_SCHEDULES_REVIEW | RR | 3 | 0.048 | 0.009 to 0.259 | 0.009 to 0.259 | 0.0% | 0.514 | 0.0000 | Yes |
| HYDROCORTISONE_SEPTIC_SHOCK | OR | 3 | 0.864 | 0.606 to 1.231 | 0.491 to 1.518 | 39.4% | 0.230 | 0.0104 | — |
| HYDROCORTISONE_SEPTIC_SHOCK_REVIEW | RR | 3 | 0.915 | 0.766 to 1.094 | 0.766 to 1.094 | 0.0% | 0.386 | 0.0000 | Yes |
| HYPOFRAC_BREAST_RT_NMA_REVIEW | HR | 3 | 0.989 | 0.606 to 1.613 | 0.606 to 1.613 | 0.0% | 0.489 | 0.0000 | Yes |
| HZV_LIVE_AUTO_FULL | OR | 2 | 1.757 | 0.000 to 135959741.744 | — | 0.0% | 0.487 | 0.0000 | Yes |
| HZV_LIVE_AUTO_FULL_REVIEW | MD | 2 | 0.093 | -4.984 to 5.171 | — | 56.8% | 0.128 | 0.0000 | — |
| IBD_BIOLOGICS | OR | 12 | 2.706 | 1.906 to 3.844 | 0.893 to 8.200 | 82.7% | 5.98e-08 | 0.2283 | — |
| IBD_BIOLOGICS_REVIEW | RR | 12 | 2.192 | 0.034 to 139.691 | 0.000 to 6975911.699 | 79.4% | 1.48e-07 | 42.7175 | Yes |
| IBRUTINIB_SMALL_LYMPHOCYTIC_AUTO_FULL | OR | 2 | 3.616 | 0.191 to 68.351 | — | 15.1% | 0.278 | 0.0000 | — |
| ICAGEN_AUTO_FULL | OR | 3 | 0.485 | 0.155 to 1.518 | 0.155 to 1.518 | 0.0% | 0.968 | 0.0000 | Yes |
| ICATIBANT_HAE_AUTO_FULL | OR | 3 | 0.867 | 0.116 to 6.457 | 0.116 to 6.457 | 8.8% | 0.334 | 0.0000 | — |
| ICATIBANT_HAE_AUTO_FULL_REVIEW | MD | 3 | -0.132 | -0.749 to 0.485 | -0.749 to 0.485 | 84.2% | 0.002 | 0.0000 | — |
| ICH_MIS_HEMATOMA_NMA_REVIEW | RR | 4 | 0.879 | 0.795 to 0.972 | 0.795 to 0.972 | 0.6% | 0.389 | 0.0000 | — |
| ICLEPERTIN_SCHIZOPHRENIA_AUTO_FULL_REVIEW | MD | 3 | 0.128 | -1.212 to 1.469 | -1.212 to 1.469 | 27.0% | 0.254 | 0.0000 | — |
| ICODEC_DIABETES_MELLITUS_AUTO_FULL | OR | 5 | 0.404 | 0.001 to 305.523 | 0.000 to 3423884.348 | 84.1% | 4.57e-05 | 27.3127 | Yes |
| ICODEC_DIABETES_MELLITUS_AUTO_FULL_REVIEW | MD | 5 | -1.476 | -36.748 to 33.795 | -87.815 to 84.862 | 94.9% | 3.13e-16 | 805.6247 | Yes |
| ICU_SEDATION | OR | 3 | 0.944 | 0.681 to 1.307 | 0.641 to 1.389 | 11.3% | 0.280 | 0.0023 | — |
| IDALOPIRDINE_ALZHEIMERS_DISEASE_AUTO_FULL | OR | 3 | 0.828 | 0.434 to 1.579 | 0.434 to 1.579 | 0.0% | 0.385 | 0.0000 | Yes |
| IDALOPIRDINE_ALZHEIMERS_DISEASE_AUTO_FULL_REVIEW | MD | 3 | -0.111 | -1.307 to 1.085 | -1.307 to 1.085 | 0.0% | 0.411 | 0.0000 | Yes |
| IDELALISIB_LEUKEMIA_AUTO_FULL | OR | 3 | 1.673 | 0.223 to 12.573 | 0.223 to 12.573 | 71.2% | 0.031 | 0.0000 | — |
| IDURSULFASE_MPS2_AUTO_FULL | OR | 2 | 2.552 | 0.000 to 77975535.864 | — | 0.0% | 0.721 | 0.0000 | Yes |
| IGAN_TARGETED_BROAD_NMA | OR | 10 | 0.446 | 0.379 to 0.526 | 0.324 to 0.615 | 22.8% | 0.359 | 0.0149 | — |
| IGAN_TARGETED_BROAD_NMA_REVIEW | RR | 4 | 0.602 | 0.500 to 0.724 | 0.500 to 0.724 | 0.0% | 0.935 | 0.0000 | Yes |
| IL23_PSA | OR | 4 | 3.484 | 1.939 to 6.262 | 1.102 to 11.020 | 72.0% | 0.010 | 0.0970 | — |
| IL23_PSA_REVIEW | RR | 4 | 2.155 | 0.058 to 79.807 | 0.001 to 6855.785 | 73.3% | 0.011 | 5.1344 | Yes |
| IL23_PSORIASIS | OR | 3 | 71.208 | 33.534 to 151.207 | 33.534 to 151.207 | 0.0% | 0.739 | 0.0000 | Yes |
| IL23_PSORIASIS_REVIEW | OR | 3 | 39.354 | 10.239 to 151.253 | 10.239 to 151.253 | 0.0% | 0.441 | 0.0000 | Yes |
| IL_PSORIASIS_NMA | OR | 18 | 30.595 | 10.996 to 85.132 | 0.424 to 2209.980 | 98.0% | 1.52e-63 | 3.8798 | — |
| IL_PSORIASIS_NMA_REVIEW | OR | 16 | 45.546 | 0.000 to 26238728.452 | 0.000 to 25268056181592014421229568.000 | 95.2% | 6.14e-58 | 619.2248 | Yes |
| INCLISIRAN | OR | 3 | — | — | — | 93.8% | 1.85e-06 | 40.7299 | — |
| INCLISIRAN_HOFH_AUTO_FULL | OR | 3 | 0.934 | 0.592 to 1.473 | 0.592 to 1.473 | 29.6% | 0.242 | 0.0000 | — |
| INCLISIRAN_HOFH_AUTO_FULL_REVIEW | MD | 3 | -30.531 | -712.601 to 651.539 | -1393.797 to 1332.735 | 87.7% | 2.99e-04 | 75260.0372 | Yes |
| INCLISIRAN_LIPID_KIDNEY_AUTO_FULL | OR | 3 | 0.934 | 0.592 to 1.473 | 0.592 to 1.473 | 29.6% | 0.242 | 0.0000 | — |
| INCLISIRAN_LIPID_KIDNEY_AUTO_FULL_REVIEW | MD | 3 | -30.531 | -712.601 to 651.539 | -1393.797 to 1332.735 | 87.7% | 2.99e-04 | 75260.0372 | Yes |
| INCLISIRAN_REVIEW | MD | 3 | -47.416 | -63.922 to -30.910 | -79.454 to -15.377 | 93.8% | 1.85e-06 | 40.7299 | — |
| INCRETINS_T2D_NMA | OR | 17 | 0.738 | 0.698 to 0.781 | 0.698 to 0.781 | 0.0% | 1.000 | 0.0000 | Yes |
| INCRETINS_T2D_NMA_REVIEW | MD | 17 | -0.788 | -6.083 to 4.508 | -23.253 to 21.678 | 98.8% | 9.65e-280 | 106.0674 | Yes |
| INCRETIN_HFpEF | OR | 3 | 0.436 | 0.121 to 1.571 | 0.103 to 1.837 | 9.4% | 0.194 | 0.0230 | — |
| INDACATEROL_COPD_AUTO_FULL_REVIEW | MD | 4 | 0.024 | -1.560 to 1.607 | -3.517 to 3.564 | 88.9% | 6.08e-06 | 0.9899 | Yes |
| INDACATEROL_GLYCOPYR_COPD_AUTO_FULL_REVIEW | MD | 4 | 0.024 | -1.560 to 1.607 | -3.517 to 3.564 | 88.9% | 6.08e-06 | 0.9899 | Yes |
| INFLIXIMAB_RA_AUTO_FULL | OR | 2 | 1.315 | 0.000 to 599972759278446976.000 | — | 86.2% | 0.007 | 20.4432 | Yes |
| INFLUENZA_RECOMBINANT_AUTO_FULL | OR | 2 | 0.737 | 0.069 to 7.834 | — | 53.1% | 0.144 | 0.0000 | — |
| INOTERSEN_ATTR_PN_AUTO_FULL_REVIEW | MD | 2 | -22.290 | -54.237 to 9.656 | — | 7.2% | 0.299 | 0.0000 | — |
| INOTERSEN_HATTR_AUTO_FULL_REVIEW | MD | 2 | -22.290 | -54.237 to 9.656 | — | 7.2% | 0.299 | 0.0000 | — |
| INSULIN_ICODEC | OR | 3 | — | — | — | 0.0% | 0.964 | 0.0000 | Yes |
| INSULIN_ICODEC_REVIEW | MD | 3 | -0.208 | -0.243 to -0.173 | -0.243 to -0.173 | 0.0% | 0.964 | 0.0000 | — |
| INTENSIVE_BP | OR | 3 | 0.808 | 0.660 to 0.989 | 0.660 to 0.989 | 0.0% | 0.584 | 0.0000 | Yes |
| IO_CHEMO_NSCLC_1L | OR | 4 | 0.542 | 0.342 to 0.860 | 0.235 to 1.249 | 60.8% | 0.060 | 0.0477 | — |
| IO_CHEMO_NSCLC_1L_REVIEW | HR | 4 | 0.681 | 0.112 to 4.148 | 0.012 to 38.074 | 54.4% | 0.087 | 1.2760 | Yes |
| IPF_ANTIFIBROTICS_NMA | OR | 10 | 0.306 | 0.145 to 0.647 | 0.030 to 3.173 | 94.8% | 3.46e-14 | 0.9594 | — |
| IPF_ANTIFIBROTICS_NMA_REVIEW | MD | 6 | -0.080 | -0.361 to 0.202 | -0.821 to 0.662 | 49.3% | 0.079 | 0.0713 | Yes |
| IPILIMUMAB_RENAL_AUTO_FULL | OR | 2 | 1.946 | 0.000 to 7722.851 | — | 0.0% | 0.860 | 0.0000 | Yes |
| IRON_ISOMALTOSIDE_IDA_AUTO_FULL | OR | 2 | 0.234 | 0.000 to 192677717477028938033715598835701309218122279116101549561968136990694825362209904150269264154610639078162432.000 | — | 97.4% | 7.88e-10 | 764.6691 | Yes |
| ISOMALTOSIDE_IRON_DEFICIENCY_AUTO_FULL | OR | 4 | 0.272 | 0.000 to 24528142238177771520.000 | 0.000 to 109470441065205404691668327983230565060968448.000 | 95.2% | 1.34e-13 | 833.0677 | Yes |
| ISOMALTOSIDE_IRON_DEFICIENCY_AUTO_FULL_REVIEW | RD | 2 | -66.421 | -126.789 to -6.052 | — | 0.0% | 0.900 | 0.0000 | Yes |
| ITP_NEW_AGENTS | OR | 9 | 10.118 | 3.961 to 25.843 | 0.895 to 114.320 | 71.4% | 0.004 | 0.9402 | — |
| ITP_NEW_AGENTS_REVIEW | RR | 3 | 2.818 | 0.971 to 8.174 | 0.971 to 8.174 | 52.3% | 0.123 | 0.0000 | — |
| ITP_NEW_THERAPY_NMA | OR | 10 | 10.809 | 7.093 to 16.471 | 5.478 to 21.325 | 12.8% | 0.485 | 0.0556 | Yes |
| ITP_NEW_THERAPY_NMA_REVIEW | RR | 3 | 4.669 | 1.549 to 14.072 | 1.549 to 14.072 | 0.0% | 0.435 | 0.0000 | Yes |
| IVERMECTIN_LF_AUTO_FULL | OR | 3 | 0.565 | 0.120 to 2.663 | 0.120 to 2.663 | 55.6% | 0.105 | 0.0000 | — |
| IV_IRON_HF | OR | 4 | 0.657 | 0.417 to 1.036 | 0.247 to 1.750 | 82.6% | 3.10e-05 | 0.0743 | — |
| IXEKIZUMAB_AS_AUTO_FULL | OR | 2 | 0.688 | 0.000 to 34838131307760398560079130918912.000 | — | 89.9% | 0.002 | 65.9342 | Yes |
| IXEKIZUMAB_AS_AUTO_FULL_REVIEW | OR | 2 | 3.051 | 0.066 to 141.197 | — | 30.0% | 0.232 | 0.0000 | — |
| IXEKIZUMAB_AXIAL_AUTO_FULL | OR | 5 | 0.357 | 0.001 to 224.211 | 0.000 to 2218351.367 | 87.0% | 3.43e-06 | 26.3543 | Yes |
| IXEKIZUMAB_AXIAL_AUTO_FULL_REVIEW | OR | 5 | 3.106 | 1.841 to 5.241 | 1.841 to 5.241 | 18.0% | 0.300 | 0.0000 | — |
| IXEKIZUMAB_PSA_AUTO_FULL | OR | 3 | 0.481 | 0.000 to 141502191.013 | 0.000 to 39235235293347608.000 | 92.7% | 1.04e-06 | 61.3679 | Yes |
| IXEKIZUMAB_PSORIASIS_AUTO_FULL | OR | 4 | 0.303 | 0.006 to 14.513 | 0.000 to 1058.512 | 72.4% | 0.013 | 5.0949 | Yes |
| JAKI_AD | OR | 4 | 13.148 | 5.269 to 32.811 | 2.458 to 70.337 | 62.3% | 0.060 | 0.1951 | — |
| JAKI_RA_NMA | OR | 4 | 3.630 | 2.747 to 4.797 | 2.438 to 5.406 | 26.2% | 0.250 | 0.0080 | — |
| JAKI_RA_NMA_REVIEW | OR | 3 | 3.779 | 2.626 to 5.438 | 2.626 to 5.438 | 19.8% | 0.287 | 0.0000 | — |
| JAK_RA | OR | 12 | 3.452 | 2.819 to 4.227 | 1.814 to 6.572 | 72.2% | 5.36e-06 | 0.0771 | — |
| JAK_RA_REVIEW | RR | 12 | 1.723 | 0.507 to 5.852 | 0.021 to 140.919 | 81.7% | 9.14e-09 | 3.6955 | Yes |
| JAK_UC | OR | 3 | 3.260 | 0.608 to 17.464 | 0.173 to 61.425 | 71.3% | 0.037 | 0.3135 | — |
| JAK_UC_REVIEW | OR | 3 | 3.421 | 0.000 to 40372644.158 | 0.000 to 459422777926810.000 | 72.0% | 0.028 | 42.8409 | Yes |
| KARXT_SCHIZO_AUTO_FULL | OR | 2 | 2.343 | 0.068 to 80.232 | — | 0.0% | 0.685 | 0.0000 | Yes |
| KARXT_SCHIZO_AUTO_FULL_REVIEW | MD | 2 | -8.999 | -28.932 to 10.933 | — | 0.0% | 0.702 | 0.0000 | Yes |
| KARXT_SCZ | OR | 2 | — | — | — | 0.0% | 0.691 | 0.0000 | Yes |
| KARXT_SCZ_REVIEW | MD | 2 | -8.952 | -16.552 to -1.353 | — | 0.0% | 0.691 | 0.0000 | — |
| KNEE_OA_INTRAARTICULAR_NMA_REVIEW | MD | 3 | -0.634 | -1.016 to -0.252 | -1.016 to -0.252 | 0.0% | 0.459 | 0.0000 | Yes |
| KRAS_G12C | OR | 2 | 0.619 | 0.272 to 1.406 | 0.272 to 1.406 | 0.0% | 0.494 | 0.0000 | — |
| KRAS_G12C_REVIEW | HR | 2 | 0.619 | 0.186 to 2.053 | — | 0.0% | 0.494 | 0.0000 | Yes |
| LANADELUMAB_HAE_AUTO_FULL | OR | 2 | 1.355 | 0.000 to 1074726.850 | — | 0.0% | 0.552 | 0.0000 | Yes |
| LAPATINIB_BREAST_AUTO_FULL | OR | 2 | 2.178 | 0.000 to 10174863614499184.000 | — | 78.9% | 0.029 | 16.0680 | Yes |
| LASMIDITAN_ACUTE_AUTO_FULL | OR | 5 | 0.818 | 0.696 to 0.962 | 0.696 to 0.962 | 0.0% | 0.911 | 0.0000 | Yes |
| LASMIDITAN_ACUTE_AUTO_FULL_REVIEW | OR | 3 | 2.329 | 0.000 to 420648.316 | 0.000 to 75132731959.403 | 86.2% | 7.31e-04 | 23.7127 | Yes |
| LASMIDITAN_MIGRAINE_AUTO_FULL | OR | 5 | 0.818 | 0.696 to 0.962 | 0.696 to 0.962 | 0.0% | 0.911 | 0.0000 | Yes |
| LASMIDITAN_MIGRAINE_AUTO_FULL_REVIEW | OR | 3 | 2.329 | 0.000 to 420648.316 | 0.000 to 75132731959.403 | 86.2% | 7.31e-04 | 23.7127 | Yes |
| LASMIDITAN_MIG_AUTO_FULL | OR | 5 | 0.818 | 0.696 to 0.962 | 0.696 to 0.962 | 0.0% | 0.911 | 0.0000 | Yes |
| LASMIDITAN_MIG_AUTO_FULL_REVIEW | OR | 3 | 2.329 | 0.000 to 420648.316 | 0.000 to 75132731959.403 | 86.2% | 7.31e-04 | 23.7127 | Yes |
| LEBRIKIZUMAB_AD | OR | 3 | 3.843 | 1.459 to 10.126 | 0.980 to 15.078 | 34.1% | 0.214 | 0.0502 | — |
| LEBRIKIZUMAB_AD_AUTO_FULL | OR | 3 | 0.515 | 0.079 to 3.377 | 0.018 to 14.537 | 44.1% | 0.167 | 0.4115 | Yes |
| LEBRIKIZUMAB_AD_REVIEW | RR | 3 | 2.683 | 0.030 to 240.165 | 0.000 to 20195.864 | 48.5% | 0.144 | 3.2129 | Yes |
| LEDIPASVIR_HCV_AUTO_FULL | OR | 2 | 0.115 | 0.000 to 3447689.607 | — | 18.1% | 0.269 | 0.0000 | — |
| LEFAMULIN_CABP_AUTO_FULL | OR | 2 | 0.877 | 0.083 to 9.286 | — | 0.0% | 0.429 | 0.0000 | Yes |
| LEFAMULIN_CAP_AUTO_FULL | OR | 2 | 0.877 | 0.083 to 9.286 | — | 0.0% | 0.429 | 0.0000 | Yes |
| LENACAPAVIR_HIV_AUTO_FULL | OR | 2 | 1.756 | 0.000 to 15839877530548536461170791252103612850147748116123069972480.000 | — | 66.3% | 0.085 | 218.3669 | Yes |
| LENACAPAVIR_PREP | OR | 2 | 0.062 | 0.000 to 1709.112 | 0.000 to 69098.471 | 38.1% | 0.204 | 0.5532 | — |
| LENACAPAVIR_PREP_REVIEW | RR | 2 | 0.074 | 0.000 to 701.897 | — | 38.1% | 0.204 | 0.0000 | — |
| LESINURAD_GOUT_AUTO_FULL | OR | 2 | 4.709 | 0.000 to 3037735586571011273533535068276275081737172497693815724834816.000 | — | 73.8% | 0.051 | 233.6686 | Yes |
| LEVOMILNACIPRAN_DEPRESSION_AUTO_FULL_REVIEW | MD | 5 | -1.632 | -23.931 to 20.666 | -56.143 to 52.879 | 53.4% | 0.073 | 320.9617 | Yes |
| LIGELIZUMAB_URTICARIA_AUTO_2_FULL | OR | 3 | 0.804 | 0.488 to 1.324 | 0.488 to 1.324 | 0.0% | 0.490 | 0.0000 | Yes |
| LIGELIZUMAB_URTICARIA_AUTO_2_FULL_REVIEW | MD | 3 | 0.570 | -2.233 to 3.373 | -2.233 to 3.373 | 0.0% | 0.651 | 0.0000 | Yes |
| LIGELIZUMAB_URTICARIA_AUTO_FULL | OR | 3 | 0.804 | 0.488 to 1.324 | 0.488 to 1.324 | 0.0% | 0.490 | 0.0000 | Yes |
| LIGELIZUMAB_URTICARIA_AUTO_FULL_REVIEW | MD | 3 | 0.570 | -2.233 to 3.373 | -2.233 to 3.373 | 0.0% | 0.651 | 0.0000 | Yes |
| LINEZOLID_MRSA_AUTO_FULL | OR | 2 | 1.262 | 0.293 to 5.439 | — | 0.0% | 0.573 | 0.0000 | Yes |
| LIPID_HUB | OR | 5 | 0.887 | 0.717 to 1.098 | 0.569 to 1.383 | 76.7% | 9.27e-04 | 0.0196 | — |
| LISINOPRIL_HTN_AUTO_FULL_REVIEW | MD | 2 | 1.294 | -63.618 to 66.206 | — | 90.4% | 0.001 | 0.0000 | — |
| LIXISENATIDE_T2D_AUTO_FULL | OR | 2 | 3.940 | 0.000 to 33298362358460742478331904.000 | — | 80.4% | 0.024 | 40.6783 | Yes |
| LORATADINE_RHIN_AUTO_FULL_REVIEW | MD | 3 | 0.053 | -0.668 to 0.774 | -0.668 to 0.774 | 96.5% | 3.75e-13 | 0.0000 | — |
| LUPUS_NEW_BIOLOGICS | OR | 10 | 2.118 | 1.694 to 2.647 | 1.356 to 3.308 | 36.0% | 0.086 | 0.0292 | — |
| LUPUS_NEW_BIOLOGICS_REVIEW | RR | 9 | 1.419 | 1.267 to 1.590 | 1.150 to 1.752 | 1.9% | 0.419 | 0.0059 | Yes |
| LURASIDONE_SCHIZ_AUTO_FULL_REVIEW | MD | 2 | 1.292 | -275.316 to 277.900 | — | 78.7% | 0.030 | 944.2484 | Yes |
| LU_PSMA_MCRPC | OR | 2 | 0.242 | 0.071 to 0.822 | 0.071 to 0.822 | 0.0% | 0.446 | 0.0000 | Yes |
| LU_PSMA_MCRPC_REVIEW | HR | 2 | 0.419 | 0.115 to 1.524 | — | 0.0% | 0.735 | 0.0000 | Yes |
| LYMPHOMA_BISPECIFIC_CD20 | OR | 3 | 1.935 | 1.619 to 2.314 | 1.619 to 2.314 | 0.0% | 0.894 | 0.0000 | Yes |
| MAGROLIMAB_AML_AUTO_FULL | OR | 3 | 0.842 | 0.463 to 1.528 | 0.463 to 1.528 | 0.0% | 0.915 | 0.0000 | Yes |
| MALARIA_ACT | OR | 5 | 0.668 | 0.509 to 0.876 | 0.509 to 0.876 | 0.0% | 0.948 | 0.0000 | Yes |
| MALARIA_ACT_REVIEW | RR | 5 | 0.676 | 0.364 to 1.253 | 0.364 to 1.253 | 0.0% | 0.952 | 0.0000 | Yes |
| MALARIA_VACCINE | OR | 3 | 0.301 | 0.049 to 1.864 | 0.009 to 10.630 | 98.8% | 2.86e-25 | 0.5068 | — |
| MALARIA_VACCINES | OR | 3 | 0.192 | 0.032 to 1.150 | 0.005 to 6.763 | 98.6% | 7.88e-51 | 0.5118 | — |
| MALARIA_VACCINES_REVIEW | HR | 3 | 0.333 | 0.000 to 2260110.481 | 0.000 to 15289691184343.549 | 98.3% | 1.15e-25 | 40.0899 | Yes |
| MALARIA_VACCINE_REVIEW | HR | 2 | 0.247 | 0.095 to 0.641 | — | 0.0% | 0.680 | 0.0000 | Yes |
| MARIBAVIR_CMV_AUTO_FULL | OR | 4 | 0.655 | 0.000 to 13144532.588 | 0.000 to 12083462218904892.000 | 94.7% | 3.48e-12 | 110.5886 | Yes |
| MASH_DRUGS | OR | 10 | 3.270 | 2.325 to 4.599 | 1.210 to 8.840 | 76.4% | 2.88e-07 | 0.1705 | — |
| MASH_DRUGS_REVIEW | RR | 9 | 2.075 | 0.148 to 29.185 | 0.001 to 8748.107 | 77.6% | 1.99e-05 | 11.7864 | Yes |
| MASTOCYTOSIS_NEW_NMA_REVIEW | RR | 2 | 1.891 | 0.058 to 61.996 | — | 70.1% | 0.067 | 0.0000 | — |
| MAVACAMTEN_HCM | OR | 3 | 6.629 | 0.628 to 69.976 | 0.085 to 515.086 | 77.1% | 0.008 | 0.7235 | — |
| MAVACAMTEN_OHCM_AUTO_FULL | OR | 2 | 2.554 | 0.058 to 113.057 | — | 6.5% | 0.301 | 0.0000 | — |
| MDRTB_BPAL | OR | 3 | 0.258 | 0.176 to 0.377 | 0.176 to 0.377 | 0.0% | 0.730 | 0.0000 | — |
| MDR_TB_SHORTENED | OR | 3 | 0.299 | 0.042 to 2.144 | 0.010 to 9.043 | 70.8% | 0.042 | 0.4181 | — |
| MDR_TB_SHORTENED_REVIEW | RR | 2 | 0.444 | 0.003 to 64.957 | — | 52.4% | 0.147 | 0.0000 | — |
| MDS_NEW_AGENTS | OR | 10 | 1.668 | 1.061 to 2.621 | 0.424 to 6.564 | 83.7% | 2.80e-09 | 0.3269 | — |
| MDS_NEW_AGENTS_REVIEW | RR | 6 | 1.645 | 0.015 to 178.123 | 0.000 to 392495.655 | 68.0% | 0.008 | 19.8832 | Yes |
| MELANOMA_NEOADJUVANT | OR | 3 | 0.844 | 0.006 to 120.138 | 0.000 to 6991.111 | 96.6% | 0.003 | 3.0687 | — |
| MELANOMA_NEOADJUVANT_REVIEW | HR | 2 | 0.431 | 0.000 to 1101479859868.364 | — | 78.5% | 0.031 | 10.0734 | Yes |
| MELPHALAN_FLUFENAMIDE_AUTO_FULL | OR | 3 | 1.408 | 0.633 to 3.131 | 0.633 to 3.131 | 0.0% | 0.539 | 0.0000 | Yes |
| MEMANTINE_DEMENTIA_AUTO_FULL_REVIEW | MD | 2 | 0.708 | -6.260 to 7.676 | — | 0.0% | 0.713 | 0.0000 | Yes |
| MENACWY_BOOSTER_AUTO_FULL | OR | 3 | 5.888 | 0.000 to 42130960024366933383323928762515456.000 | 0.000 to 294371003181437672886907219648413429098135811216723758415085551222784.000 | 94.1% | 4.68e-08 | 984.3285 | Yes |
| MENACYW_HEALTHY_VOLUNTEERS_AUTO_FULL | OR | 2 | 0.559 | 0.063 to 5.003 | — | 60.5% | 0.112 | 0.0000 | — |
| MENVEO_MEN_AUTO_FULL | OR | 4 | 1.770 | 0.000 to 394122660941999040.000 | 0.000 to 1051187412943295803656817066665465348096.000 | 94.9% | 1.07e-12 | 629.4723 | Yes |
| MENVEO_MEN_AUTO_FULL_REVIEW | MD | 3 | 15.757 | 1.376 to 30.139 | 1.376 to 30.139 | 0.0% | 0.947 | 0.0000 | Yes |
| MEN_ACWY_AUTO_FULL | OR | 4 | 0.552 | 0.000 to 9506102764376963072.000 | 0.000 to 5484978390023114151816694815741496004706304.000 | 97.7% | 2.15e-28 | 774.0955 | Yes |
| MEN_ACWY_AUTO_FULL_REVIEW | MD | 2 | -6.634 | -65.782 to 52.515 | — | 0.0% | 0.897 | 0.0000 | Yes |
| MEROPENEM_AUTO_FULL | OR | 3 | 0.286 | 0.000 to 134698268344502681600.000 | 0.000 to 59154227273104224101834123219177746464768.000 | 78.4% | 0.010 | 366.4753 | Yes |
| METFORMIN_T2D_AUTO_FULL | OR | 3 | 1.813 | 0.693 to 4.739 | 0.693 to 4.739 | 78.9% | 0.009 | 0.0000 | — |
| METFORMIN_T2D_AUTO_FULL_REVIEW | MD | 2 | -0.604 | -1.514 to 0.306 | — | 0.0% | 0.947 | 0.0000 | Yes |
| METHYLNALTREXONE_OIC_AUTO_FULL | OR | 2 | 0.813 | 0.005 to 121.574 | — | 74.7% | 0.047 | 0.0000 | — |
| MIGRAINE_ACUTE | OR | 4 | 2.113 | 1.579 to 2.829 | 1.470 to 3.038 | 13.5% | 0.327 | 0.0046 | — |
| MIGRAINE_ACUTE_REVIEW | RR | 4 | 1.845 | 1.470 to 2.316 | 1.470 to 2.316 | 0.0% | 0.473 | 0.0000 | Yes |
| MIPOMERSEN_HOFH_AUTO_FULL | OR | 2 | 0.816 | 0.000 to 11983.635 | — | 0.0% | 0.497 | 0.0000 | Yes |
| MIPOMERSEN_HOFH_AUTO_FULL_REVIEW | MD | 2 | 33.327 | -1347.597 to 1414.251 | — | 91.1% | 7.75e-04 | 23597.7857 | Yes |
| MIRIKIZUMAB_CROHN_AUTO_FULL | OR | 2 | 1.567 | 0.000 to 58821917321824051542943854592850542541352073924013847065500827731757220361734616968505371476832061185064960.000 | — | 99.4% | 1.64e-38 | 745.9496 | Yes |
| MIRIKIZUMAB_PSO_AUTO_FULL | OR | 3 | 0.035 | 0.000 to 2060573382798963370913104396288.000 | 0.000 to 118048277925769509825539339024544043475462518049308521625812992.000 | 98.4% | 2.59e-27 | 866.7350 | Yes |
| MIRIKIZUMAB_PSO_AUTO_FULL_REVIEW | RD | 2 | 68.253 | -479.706 to 616.212 | — | 83.7% | 0.013 | 3710.5855 | Yes |
| MIRIKIZUMAB_UC | OR | 2 | 2.469 | 0.267 to 22.789 | 0.130 to 46.824 | 37.6% | 0.206 | 0.0230 | — |
| MIRIKIZUMAB_UC_REVIEW | OR | 2 | 2.463 | 0.257 to 23.607 | — | 40.7% | 0.194 | 0.0000 | — |
| MIRVETUXIMAB_FALLOPIAN_TUBE_AUTO_FULL | OR | 2 | 3.134 | 0.096 to 102.707 | — | 54.5% | 0.138 | 0.0000 | — |
| MIRVETUXIMAB_FALLOPIAN_TUBE_AUTO_FULL_REVIEW | MD | 2 | 0.656 | -87.841 to 89.153 | — | 76.5% | 0.039 | 96.5887 | Yes |
| MIS_COLECTOMY_VS_OPEN_NMA | OR | 10 | 0.848 | 0.740 to 0.973 | 0.716 to 1.005 | 5.8% | 0.330 | 0.0020 | — |
| MIS_COLECTOMY_VS_OPEN_NMA_REVIEW | HR | 2 | 0.901 | 0.000 to 40633.732 | — | 58.6% | 0.120 | 1.3902 | Yes |
| MIS_GASTRECTOMY_NMA | OR | 10 | 0.840 | 0.770 to 0.915 | 0.770 to 0.915 | 0.0% | 0.985 | 0.0000 | Yes |
| MIS_PANCREATIC_WHIPPLE_NMA_REVIEW | RR | 5 | 0.968 | 0.005 to 181.218 | 0.000 to 346470.514 | 59.6% | 0.042 | 17.6630 | Yes |
| MITAPIVAT_PYRUVATE_AUTO_FULL | OR | 2 | 1.893 | 0.042 to 85.596 | — | 0.0% | 0.889 | 0.0000 | Yes |
| MITRACLIP_TEER | OR | 7 | 0.666 | 0.492 to 0.901 | 0.343 to 1.291 | 50.6% | 0.062 | 0.0579 | — |
| MITRACLIP_TEER_REVIEW | HR | 4 | 0.751 | 0.006 to 95.830 | 0.000 to 37718.058 | 66.0% | 0.032 | 9.2469 | Yes |
| MITRAL_FUNCMR | OR | 3 | 0.669 | 0.202 to 2.221 | 0.072 to 6.189 | 83.8% | 0.004 | 0.1895 | — |
| MITRAL_FUNCMR_REVIEW | HR | 3 | 0.744 | 0.000 to 9068.368 | 0.000 to 109533556.504 | 87.1% | 4.23e-04 | 14.3252 | Yes |
| MM_1L | OR | 4 | 0.470 | 0.395 to 0.560 | 0.395 to 0.560 | 0.0% | 0.738 | 0.0000 | Yes |
| MM_1L_DARA | OR | 8 | 1.380 | 0.718 to 2.652 | 0.205 to 9.278 | 94.6% | 9.95e-24 | 0.5731 | — |
| MM_1L_DARA_REVIEW | HR | 3 | 0.501 | 0.349 to 0.720 | 0.349 to 0.720 | 0.0% | 0.422 | 0.0000 | Yes |
| MM_1L_REVIEW | RR | 4 | 0.534 | 0.421 to 0.677 | 0.421 to 0.677 | 0.0% | 0.702 | 0.0000 | Yes |
| MM_BISPECIFIC_TRISPECIFIC | OR | 2 | 1.606 | 1.037 to 2.487 | 1.037 to 2.487 | 0.0% | 0.793 | 0.0000 | Yes |
| MM_NDMM_QUAD_NMA | OR | 10 | 0.545 | 0.468 to 0.634 | 0.391 to 0.758 | 33.2% | 0.192 | 0.0169 | — |
| MM_NDMM_QUAD_NMA_REVIEW | HR | 9 | 0.548 | 0.256 to 1.176 | 0.051 to 5.890 | 50.0% | 0.043 | 0.9508 | Yes |
| MOMELOTINIB_AUTO_FULL | OR | 2 | 0.885 | 0.065 to 12.040 | — | 0.0% | 0.674 | 0.0000 | Yes |
| MOMELOTINIB_MF_AUTO_2_FULL | OR | 2 | 0.885 | 0.065 to 12.040 | — | 0.0% | 0.674 | 0.0000 | Yes |
| MOMELOTINIB_MF_AUTO_FULL | OR | 2 | 0.885 | 0.065 to 12.040 | — | 0.0% | 0.674 | 0.0000 | Yes |
| MOMETASONE_CRS_AUTO_FULL | OR | 2 | 0.516 | 0.000 to 446682458600783389612195734437971446320849626964672064477359767552.000 | — | 91.3% | 6.75e-04 | 285.2593 | Yes |
| MOMETASONE_CRS_AUTO_FULL_REVIEW | MD | 2 | -2.071 | -5.007 to 0.865 | — | 49.6% | 0.159 | 0.0000 | — |
| MONTELUKAST_RHIN_AUTO_FULL_REVIEW | MD | 2 | 0.073 | -0.327 to 0.472 | — | 0.0% | 0.637 | 0.0000 | Yes |
| MOXIFLOXACIN_RESPI_AUTO_FULL | OR | 2 | 0.986 | 0.051 to 19.154 | — | 0.0% | 0.843 | 0.0000 | Yes |
| MRNA1273_VACCINE_AUTO_FULL | OR | 2 | 0.531 | 0.000 to 2487.148 | — | 0.0% | 0.618 | 0.0000 | Yes |
| MRNA1273_VACCINE_AUTO_FULL_REVIEW | MD | 2 | 0.960 | -4.999 to 6.919 | — | 0.0% | 0.845 | 0.0000 | Yes |
| MS_ANTI_CD20_NMA_REVIEW | RR | 6 | 0.555 | 0.468 to 0.658 | 0.468 to 0.658 | 0.0% | 0.865 | 0.0000 | Yes |
| MS_BTKI | OR | 10 | 0.835 | 0.621 to 1.122 | 0.354 to 1.970 | 79.8% | 1.10e-06 | 0.1269 | — |
| MS_BTKI_REVIEW | HR | 8 | 0.996 | 0.301 to 3.291 | 0.028 to 35.334 | 50.0% | 0.051 | 2.0227 | Yes |
| MS_BTK_INHIB_NMA | OR | 10 | 0.740 | 0.623 to 0.878 | 0.471 to 1.162 | 59.8% | 0.008 | 0.0341 | — |
| MS_BTK_INHIB_NMA_REVIEW | RR | 3 | 0.811 | 0.001 to 657.786 | 0.000 to 528702.840 | 77.9% | 0.011 | 7.2581 | Yes |
| MS_S1P_BROAD | OR | 8 | 1.176 | 0.503 to 2.747 | 0.099 to 13.920 | 97.3% | 3.39e-24 | 0.9635 | — |
| MS_S1P_BROAD_REVIEW | HR | 4 | 0.652 | 0.056 to 7.605 | 0.003 to 156.522 | 62.5% | 0.046 | 2.3701 | Yes |
| MYASTHENIA_GRAVIS_BIOLOGICS | OR | 8 | 3.298 | 2.250 to 4.835 | 1.383 to 7.868 | 47.4% | 0.068 | 0.1090 | — |
| MYASTHENIA_GRAVIS_BIOLOGICS_REVIEW | RR | 6 | 1.882 | 0.108 to 32.642 | 0.001 to 3503.574 | 69.1% | 0.006 | 7.3471 | Yes |
| MYELOFIBROSIS_NEW_JAKI | OR | 9 | 2.917 | 1.491 to 5.706 | 0.583 to 14.600 | 75.9% | 4.30e-05 | 0.4031 | — |
| MYELOFIBROSIS_NEW_JAKI_REVIEW | RR | 8 | 2.064 | 0.017 to 245.334 | 0.000 to 3363326.503 | 75.9% | 1.42e-04 | 32.5084 | Yes |
| NABIXIMOLS_ADVANCED_CANCER_AUTO_FULL | OR | 2 | 2.057 | 0.028 to 153.720 | — | 0.0% | 0.489 | 0.0000 | Yes |
| NALDEMEDINE_OIC_AUTO_FULL | OR | 3 | 0.850 | 0.000 to 2232295.439 | 0.000 to 5071820839025.758 | 90.4% | 2.85e-05 | 34.9423 | Yes |
| NALMEFENE_AUD_AUTO_FULL | OR | 2 | 0.792 | 0.000 to 1298428382387909.000 | — | 86.1% | 0.007 | 15.1752 | Yes |
| NEMOLIZUMAB_AD_AUTO_FULL | OR | 2 | 0.234 | 0.004 to 12.875 | — | 58.1% | 0.123 | 0.0000 | — |
| NEMOLIZUMAB_AD_AUTO_FULL_REVIEW | MD | 2 | -3.792 | -2089.505 to 2081.921 | — | 93.5% | 8.53e-05 | 53849.8403 | Yes |
| NEMOLIZUMAB_PRURIGO_NODULARIS_AUTO_FULL | OR | 2 | 6.819 | 0.283 to 164.428 | — | 0.0% | 0.872 | 0.0000 | Yes |
| NEOADJUVANT_IO_BREAST | OR | 10 | 1.440 | 1.090 to 1.902 | 0.630 to 3.288 | 80.1% | 1.03e-07 | 0.1182 | — |
| NEOADJUVANT_IO_BREAST_REVIEW | RR | 4 | 1.409 | 1.121 to 1.771 | 1.121 to 1.771 | 4.8% | 0.369 | 0.0000 | — |
| NEOADJUVANT_IO_NSCLC | OR | 3 | 0.579 | 0.424 to 0.790 | 0.424 to 0.790 | 0.0% | 0.541 | 0.0000 | Yes |
| NEOADJUVANT_IO_NSCLC_REVIEW | HR | 3 | 0.623 | 0.445 to 0.872 | 0.445 to 0.872 | 0.0% | 0.653 | 0.0000 | Yes |
| NEONATAL_NEC_NMA_REVIEW | RR | 4 | 0.735 | 0.536 to 1.006 | 0.536 to 1.006 | 0.0% | 0.406 | 0.0000 | Yes |
| NERATINIB_BREAST_AUTO_FULL | OR | 3 | 0.797 | 0.222 to 2.866 | 0.222 to 2.866 | 0.0% | 0.727 | 0.0000 | Yes |
| NETARSUDIL_GLAUCOMA_AUTO_FULL_REVIEW | MD | 2 | 0.015 | -2.965 to 2.995 | — | 0.0% | 0.935 | 0.0000 | Yes |
| NETARSUDIL_OCULAR_HYPERTENSION_AUTO_FULL_REVIEW | MD | 2 | 0.015 | -2.965 to 2.995 | — | 0.0% | 0.935 | 0.0000 | Yes |
| NEUROENDOCRINE_PITUITARY_NMA_REVIEW | RR | 2 | 3.765 | 0.000 to 3167009445886685945111976607744.000 | — | 86.8% | 0.006 | 58.7098 | Yes |
| NICOTINE_PATCH_AUTO_FULL | OR | 2 | 1.020 | 0.000 to 31893228748921236357120.000 | — | 86.7% | 0.006 | 33.1762 | Yes |
| NIRSEVIMAB_INFANT_RSV | OR | 3 | 0.224 | 0.146 to 0.345 | 0.146 to 0.345 | 0.0% | 0.721 | 0.0000 | Yes |
| NIVOLUMAB_HCC_AUTO_FULL | OR | 2 | 1.321 | 0.065 to 26.789 | — | 0.0% | 0.829 | 0.0000 | Yes |
| NMOSD_BIOLOGICS | OR | 6 | 0.196 | 0.061 to 0.629 | 0.020 to 1.907 | 69.9% | 0.014 | 0.5782 | — |
| NMOSD_BIOLOGICS_REVIEW | HR | 4 | 0.230 | 0.000 to 639626.221 | 0.000 to 57537153147535.703 | 67.6% | 0.026 | 86.7910 | Yes |
| NPC_NASOPHARYNGEAL_IO | OR | 7 | 0.374 | 0.284 to 0.491 | 0.281 to 0.496 | 1.2% | 0.292 | 0.0009 | — |
| NPC_NASOPHARYNGEAL_IO_REVIEW | HR | 5 | 0.572 | 0.077 to 4.274 | 0.004 to 77.291 | 49.4% | 0.095 | 2.5978 | Yes |
| NSCLC_PD1_1L | OR | 11 | 0.495 | 0.357 to 0.685 | 0.188 to 1.299 | 84.1% | 1.51e-06 | 0.1664 | — |
| NSCLC_PD1_1L_REVIEW | HR | 11 | 0.642 | 0.151 to 2.736 | 0.004 to 96.459 | 67.5% | 6.51e-04 | 4.6362 | Yes |
| NSCLC_PERIOP_IO_NMA | OR | 10 | 0.654 | 0.481 to 0.888 | 0.331 to 1.292 | 73.5% | 4.70e-05 | 0.0723 | — |
| NSCLC_PERIOP_IO_NMA_REVIEW | HR | 9 | 0.689 | 0.251 to 1.891 | 0.029 to 16.319 | 54.8% | 0.024 | 1.6920 | Yes |
| NSCLC_TARGETED_RARE_DRIVER | OR | 3 | 2.565 | 1.156 to 5.690 | 0.857 to 7.675 | 30.5% | 0.228 | 0.0306 | — |
| NUSINERSEN_SMA_AUTO_FULL | OR | 4 | 1.636 | 0.091 to 29.511 | 0.091 to 29.511 | 0.0% | 0.738 | 0.0000 | Yes |
| OAB_BETA3_NMA | OR | 10 | 1.362 | 1.297 to 1.430 | 1.297 to 1.430 | 0.0% | 0.988 | 0.0000 | Yes |
| OAB_BETA3_NMA_REVIEW | RR | 5 | 1.174 | 1.073 to 1.284 | 1.073 to 1.284 | 0.0% | 0.928 | 0.0000 | Yes |
| OBESITY_DRUGS | OR | 3 | 15.788 | 1.629 to 152.984 | 0.174 to 1428.919 | 98.2% | 2.24e-25 | 0.8179 | — |
| OBESITY_DRUGS_REVIEW | OR | 2 | 25.982 | 0.000 to 2299230699240448000.000 | — | 89.6% | 0.002 | 18.8382 | Yes |
| OBESITY_DUAL_TRIPLE_AGONIST | OR | 10 | 8.214 | 4.773 to 14.134 | 1.703 to 39.612 | 93.6% | 1.20e-15 | 0.4261 | — |
| OBESITY_DUAL_TRIPLE_AGONIST_REVIEW | RR | 5 | 3.640 | 0.007 to 1794.387 | 0.000 to 14220426.128 | 71.4% | 0.007 | 24.8979 | Yes |
| OBETICHOLIC_NASH_AUTO_FULL | OR | 2 | 1.752 | 0.000 to 646186954366985189720064.000 | — | 89.1% | 0.002 | 36.4272 | Yes |
| OBICETRAPIB_LIPID_AUTO_FULL_REVIEW | MD | 4 | -6.320 | -916.845 to 904.205 | -2042.260 to 2029.620 | 99.2% | 4.75e-77 | 327409.2712 | Yes |
| OBINUTUZUMAB_LN_AUTO_FULL | OR | 2 | 1.621 | 0.118 to 22.343 | — | 0.0% | 0.540 | 0.0000 | Yes |
| ODEVIXIBAT_PFIC_REVIEW_FULL | OR | 2 | 17.518 | 0.000 to 3335499560.468 | — | 57.8% | 0.124 | 0.0000 | — |
| OFATUMUMAB_CLL_AUTO_FULL | OR | 2 | 2.917 | 0.003 to 2657.711 | — | 81.4% | 0.020 | 0.0000 | — |
| OLANZAPINE_CINV_AUTO_FULL | OR | 3 | 1.141 | 0.000 to 2008971985834270.750 | 0.000 to 3475200751130110792177098424320.000 | 93.0% | 5.74e-07 | 199.5629 | Yes |
| OLAPARIB_GASTRIC_AUTO_FULL | OR | 2 | 1.650 | 0.005 to 562.961 | — | 0.0% | 0.708 | 0.0000 | Yes |
| OLAPARIB_OVARIAN2_AUTO_FULL | OR | 3 | 0.496 | 0.005 to 49.707 | 0.000 to 1908.134 | 58.4% | 0.090 | 2.5346 | Yes |
| OLAPARIB_OVARIAN2_AUTO_FULL_REVIEW | HR | 2 | 0.796 | 0.169 to 3.751 | — | 16.1% | 0.275 | 0.0000 | — |
| OLAPARIB_OVARIAN_AUTO_FULL | OR | 3 | 0.496 | 0.005 to 49.707 | 0.000 to 1908.134 | 58.4% | 0.090 | 2.5346 | Yes |
| OLAPARIB_OVARIAN_AUTO_FULL_REVIEW | HR | 2 | 0.796 | 0.169 to 3.751 | — | 16.1% | 0.275 | 0.0000 | — |
| OLAPARIB_PANCREATIC2_AUTO_FULL | OR | 2 | 0.692 | 0.000 to 14591098394736421937657251194994688.000 | — | 84.8% | 0.010 | 77.2111 | Yes |
| OLAPARIB_PANCREATIC_AUTO_FULL | OR | 2 | 0.692 | 0.000 to 14591098394736421937657251194994688.000 | — | 84.8% | 0.010 | 77.2111 | Yes |
| OLAPARIB_PROSTATE_AUTO_FULL | OR | 2 | 0.677 | 0.028 to 16.558 | — | 71.4% | 0.061 | 0.0000 | — |
| OLMESARTAN_HTN_AUTO_FULL | OR | 3 | 1.009 | 0.663 to 1.534 | 0.663 to 1.534 | 0.0% | 0.458 | 0.0000 | Yes |
| OLMESARTAN_HTN_AUTO_FULL_REVIEW | MD | 3 | -3.143 | -124.712 to 118.426 | -246.235 to 239.949 | 94.4% | 1.90e-08 | 2393.7244 | Yes |
| OLOKIZUMAB_RA_AUTO_FULL | OR | 3 | 0.964 | 0.000 to 4064.665 | 0.000 to 16692792.879 | 62.7% | 0.068 | 11.2426 | Yes |
| OLOKIZUMAB_RA_AUTO_FULL_REVIEW | RD | 3 | 0.286 | 0.093 to 0.479 | 0.093 to 0.479 | 48.4% | 0.144 | 0.0000 | — |
| OMALIZUMAB_FOOD_ALLERGY_AUTO_FULL | OR | 3 | 1.649 | 0.000 to 9428864812480969310208.000 | 0.000 to 44625627984312588927264581900072565019246592.000 | 82.0% | 0.004 | 404.6680 | Yes |
| OMALIZUMAB_NASAL_AUTO_FULL | OR | 4 | 1.567 | 0.218 to 11.241 | 0.045 to 54.632 | 48.2% | 0.122 | 0.8620 | Yes |
| OMALIZUMAB_NASAL_AUTO_FULL_REVIEW | MD | 4 | 0.203 | -23.186 to 23.591 | -52.092 to 52.497 | 97.0% | 2.89e-21 | 216.0067 | Yes |
| OMALIZUMAB_URTICARIA_AUTO_FULL | OR | 3 | 0.803 | 0.496 to 1.300 | 0.496 to 1.300 | 0.0% | 0.805 | 0.0000 | Yes |
| OMALIZUMAB_URTICARIA_AUTO_FULL_REVIEW | MD | 3 | 0.136 | -2.187 to 2.459 | -2.187 to 2.459 | 0.0% | 0.391 | 0.0000 | Yes |
| OMARIGLIPTIN_TYPE_2_AUTO_FULL | OR | 7 | 1.034 | 0.565 to 1.894 | 0.211 to 5.062 | 34.1% | 0.168 | 0.3601 | Yes |
| OMARIGLIPTIN_TYPE_2_AUTO_FULL_REVIEW | MD | 6 | -0.378 | -5.522 to 4.765 | -13.984 to 13.227 | 94.8% | 3.05e-19 | 24.0104 | Yes |
| OMBITASVIR_CHRONIC_HEPATITIS_AUTO_FULL | OR | 3 | 0.439 | 0.007 to 27.857 | 0.007 to 27.857 | 0.0% | 0.509 | 0.0000 | Yes |
| OMBITASVIR_HEPATITIS_C_AUTO_FULL | OR | 2 | 0.572 | 0.000 to 177643.121 | — | 0.0% | 0.374 | 0.0000 | Yes |
| OMECAMTIV_HEARTFAIL_AUTO_FULL | OR | 2 | 1.092 | 0.555 to 2.149 | — | 27.4% | 0.241 | 0.0000 | — |
| OMECAMTIV_HEARTFAIL_AUTO_FULL_REVIEW | MD | 2 | -0.448 | -4.191 to 3.296 | — | 0.0% | 0.822 | 0.0000 | Yes |
| OMECAMTIV_HFREF_AUTO_FULL | OR | 2 | 1.092 | 0.555 to 2.149 | — | 27.4% | 0.241 | 0.0000 | — |
| OMECAMTIV_HFREF_AUTO_FULL_REVIEW | MD | 2 | -0.448 | -4.191 to 3.296 | — | 0.0% | 0.822 | 0.0000 | Yes |
| OMECAMTIV_HF_AUTO_FULL | OR | 2 | 1.092 | 0.555 to 2.149 | — | 27.4% | 0.241 | 0.0000 | — |
| OMECAMTIV_HF_AUTO_FULL_REVIEW | MD | 2 | -0.448 | -4.191 to 3.296 | — | 0.0% | 0.822 | 0.0000 | Yes |
| OMEGA3_HIGHDOSE_CV | OR | 4 | 0.901 | 0.701 to 1.158 | 0.542 to 1.497 | 79.7% | 9.27e-04 | 0.0192 | — |
| ONTAMALIMAB_IBD_AUTO_FULL | OR | 4 | 0.363 | 0.000 to 9067477.377 | 0.000 to 11048062320216744.000 | 71.9% | 0.014 | 113.5889 | Yes |
| OPIOID_INDUCED_CONSTIPATION | OR | 10 | 2.936 | 2.255 to 3.822 | 1.351 to 6.382 | 74.6% | 1.30e-05 | 0.1042 | — |
| ORTERONEL_PROSTATE_CANCER_AUTO_FULL | OR | 2 | 0.441 | 0.109 to 1.783 | — | 0.0% | 0.798 | 0.0000 | Yes |
| ORTERONEL_PROSTATE_CANCER_AUTO_FULL_REVIEW | HR | 2 | 0.786 | 0.000 to 11974.661 | — | 75.1% | 0.045 | 1.1434 | Yes |
| OSILODROSTAT_CUSHING_AUTO_FULL | OR | 2 | 0.419 | 0.000 to 860026023938606834126363890639561058029804733496219649971000815816676432985861805691487924852968560234915636779916057412934590479683377760890120083332214067307254099961100663422692123713032290051411990462371810037598318501025093255168.000 | — | 98.1% | 4.65e-13 | 3605.2259 | Yes |
| OSILODROSTAT_CUSHING_AUTO_FULL_REVIEW | OR | 2 | 19.816 | 0.016 to 24443.411 | — | 0.0% | 0.337 | 0.0000 | Yes |
| OSIMERTINIB_EGFR_NSCLC | OR | 4 | 0.281 | 0.121 to 0.651 | 0.049 to 1.622 | 84.7% | 2.85e-04 | 0.2335 | — |
| OSIMERTINIB_EGFR_NSCLC_REVIEW | HR | 3 | 0.385 | 0.000 to 3280658.301 | 0.000 to 27781384547744.516 | 91.8% | 5.20e-06 | 41.2462 | Yes |
| OSTEOPOROSIS_BROAD_NMA_REVIEW | RR | 5 | 0.371 | 0.017 to 8.092 | 0.000 to 692.149 | 80.2% | 4.61e-04 | 6.1260 | Yes |
| OTESECONAZOLE_VVC_AUTO_FULL | OR | 3 | 0.080 | 0.031 to 0.206 | 0.031 to 0.206 | 0.0% | 0.692 | 0.0000 | Yes |
| OTILIMAB_ARTHRITIS_RHEUMATOID_AUTO_FULL | OR | 4 | 0.926 | 0.760 to 1.128 | 0.760 to 1.128 | 0.0% | 0.693 | 0.0000 | Yes |
| OTILIMAB_ARTHRITIS_RHEUMATOID_AUTO_FULL_REVIEW | OR | 3 | 1.793 | 0.008 to 396.655 | 0.000 to 84255.247 | 64.2% | 0.061 | 4.6766 | Yes |
| OVARIAN_PARP | OR | 10 | 0.318 | 0.213 to 0.473 | 0.093 to 1.081 | 85.3% | 1.53e-10 | 0.2621 | — |
| OVARIAN_PARP_REVIEW | HR | 9 | 0.412 | 0.029 to 5.954 | 0.000 to 1900.463 | 78.7% | 9.38e-06 | 12.0417 | Yes |
| OZANIMOD_CROHN_DISEASE_AUTO_FULL | OR | 4 | 1.287 | 0.207 to 8.013 | 0.024 to 69.761 | 50.9% | 0.106 | 1.2439 | Yes |
| OZANIMOD_CROHN_DISEASE_AUTO_FULL_REVIEW | OR | 3 | 1.398 | 0.004 to 500.947 | 0.000 to 173162.479 | 63.6% | 0.064 | 5.5601 | Yes |
| PACRITINIB_MF_AUTO_2_FULL | OR | 2 | 0.621 | 0.004 to 105.623 | — | 0.0% | 0.460 | 0.0000 | Yes |
| PACRITINIB_MF_AUTO_FULL | OR | 2 | 0.621 | 0.004 to 105.623 | — | 0.0% | 0.460 | 0.0000 | Yes |
| PAH_SOTATERCEPT_BROAD | OR | 10 | 1.043 | 0.530 to 2.055 | 0.138 to 7.898 | 91.6% | 1.60e-12 | 0.7108 | — |
| PAH_SOTATERCEPT_BROAD_REVIEW | RR | 3 | 1.375 | 0.000 to 33073414.420 | 0.000 to 783783974099984.500 | 89.1% | 9.96e-05 | 46.7552 | Yes |
| PAH_THERAPY | OR | 4 | 0.485 | 0.147 to 1.603 | 0.040 to 5.816 | 90.9% | 4.40e-05 | 0.4681 | — |
| PAH_THERAPY_REVIEW | RR | 4 | 0.413 | 0.000 to 16756.489 | 0.000 to 8198184796.972 | 72.8% | 0.012 | 44.3961 | Yes |
| PALBOCICLIB_BREAST_AUTO_FULL | OR | 3 | 1.191 | 0.714 to 1.986 | 0.714 to 1.986 | 0.0% | 0.657 | 0.0000 | Yes |
| PALFORZIA_PEANUT_AUTO_FULL | OR | 3 | 6.939 | 0.000 to 28520545211697518163070815468601212928.000 | 0.000 to 106708446562522319702230484497273519991418548829431896718281833499081048064.000 | 88.9% | 1.19e-04 | 1150.0735 | Yes |
| PALIFERMIN_MUCOSITIS_AUTO_FULL_REVIEW | MD | 2 | -0.148 | -3.051 to 2.754 | — | 88.3% | 0.004 | 0.0000 | — |
| PALOPEGTERIPARATIDE_HPP_AUTO_FULL | OR | 2 | 10.515 | 0.000 to 441159946258278510653752955367826042853710345519842797622884927662039234601355581366374705922048.000 | — | 88.7% | 0.003 | 587.2045 | Yes |
| PARITAPREVIR_CHRONIC_HEPATITIS_AUTO_FULL | OR | 2 | 0.185 | 0.000 to 2750037.100 | — | 0.0% | 0.548 | 0.0000 | Yes |
| PARITAPREVIR_HEPATITIS_C_AUTO_FULL | OR | 2 | 0.572 | 0.000 to 177643.121 | — | 0.0% | 0.374 | 0.0000 | Yes |
| PARP_ARPI_MCRPC | OR | 3 | 0.452 | 0.387 to 0.527 | 0.387 to 0.527 | 0.0% | 0.856 | 0.0000 | Yes |
| PARP_ARPI_MCRPC_REVIEW | HR | 3 | 0.664 | 0.500 to 0.881 | 0.500 to 0.881 | 0.0% | 0.700 | 0.0000 | Yes |
| PARP_OVARIAN | OR | 3 | 0.183 | 0.014 to 2.353 | 0.001 to 23.349 | 93.6% | 8.40e-05 | 0.9171 | — |
| PARP_OVARIAN_REVIEW | HR | 2 | 0.604 | 0.241 to 1.512 | — | 0.0% | 0.732 | 0.0000 | Yes |
| PASIREOTIDE_ACROMEGALY_AUTO_FULL | OR | 2 | 0.749 | 0.014 to 40.283 | — | 0.0% | 0.872 | 0.0000 | Yes |
| PASIREOTIDE_CUSHING_AUTO_FULL | OR | 3 | 1.970 | 0.000 to 6647596215336365457408.000 | 0.000 to 21934592592009263577359440498672738286698496.000 | 90.8% | 1.96e-05 | 397.9552 | Yes |
| PATISIRAN_ATTR_PN_AUTO_FULL | OR | 3 | 3.686 | 0.249 to 54.640 | 0.249 to 54.640 | 69.2% | 0.039 | 0.0000 | — |
| PATISIRAN_ATTR_PN_AUTO_FULL_REVIEW | MD | 3 | -23.345 | -93.163 to 46.474 | -151.922 to 105.232 | 89.7% | 5.84e-05 | 629.6989 | Yes |
| PATISIRAN_HATTR_AUTO_FULL | OR | 3 | 3.686 | 0.249 to 54.640 | 0.249 to 54.640 | 69.2% | 0.039 | 0.0000 | — |
| PATISIRAN_HATTR_AUTO_FULL_REVIEW | MD | 3 | -23.345 | -93.163 to 46.474 | -151.922 to 105.232 | 89.7% | 5.84e-05 | 629.6989 | Yes |
| PATISIRAN_POLYNEUROPATHY | OR | 2 | — | — | — | 36.9% | 0.208 | 5.4851 | — |
| PATISIRAN_POLYNEUROPATHY_REVIEW | MD | 2 | -31.331 | -65.948 to 3.286 | — | 36.9% | 0.208 | 5.4852 | — |
| PBC_NEW_AGENTS | OR | 8 | 18.166 | 11.781 to 28.011 | 11.781 to 28.011 | 0.0% | 0.661 | 0.0000 | Yes |
| PBC_NEW_AGENTS_REVIEW | RR | 2 | 7.887 | 0.181 to 342.739 | — | 0.0% | 0.630 | 0.0000 | Yes |
| PBC_PPAR | OR | 2 | 5.502 | 0.000 to 62405.807 | 0.000 to 16808893.412 | 75.1% | 0.045 | 0.8412 | — |
| PCSK9 | OR | 2 | 0.844 | 0.838 to 0.851 | 0.838 to 0.851 | 0.0% | 0.984 | 0.0000 | Yes |
| PCSK9_INHIBITORS_CV | OR | 10 | 6.351 | 1.256 to 32.119 | 0.031 to 1305.115 | 99.8% | 5.90e-279 | 5.0286 | — |
| PCSK9_INHIBITORS_CV_REVIEW | RR | 4 | 2.657 | 0.000 to 116574571791.722 | 0.000 to 1651606547335308554272768.000 | 98.2% | 1.63e-36 | 237.0749 | Yes |
| PCSK9_LIPID_NMA | OR | 4 | 0.872 | 0.816 to 0.933 | 0.791 to 0.962 | 22.7% | 0.346 | 0.0005 | — |
| PCV13_VACCINE_AUTO_FULL | OR | 5 | 1.302 | 0.371 to 4.565 | 0.083 to 20.297 | 51.2% | 0.084 | 0.7744 | Yes |
| PCV15_VACCINE_AUTO_FULL | OR | 3 | 0.848 | 0.344 to 2.090 | 0.344 to 2.090 | 0.0% | 0.850 | 0.0000 | Yes |
| PD1_RCC_1L | OR | 9 | 0.668 | 0.541 to 0.825 | 0.379 to 1.179 | 70.6% | 8.21e-04 | 0.0523 | — |
| PD1_RCC_1L_REVIEW | HR | 7 | 0.662 | 0.014 to 31.676 | 0.000 to 37192.135 | 90.0% | 4.27e-11 | 17.4756 | Yes |
| PEDIATRIC_HF_DAPA_NMA_REVIEW | HR | 2 | 0.823 | 0.204 to 3.314 | — | 0.0% | 0.643 | 0.0000 | Yes |
| PEDIATRIC_OBESITY_GLP1_NMA_REVIEW | MD | 2 | -11.200 | -685.681 to 663.282 | — | 96.6% | 6.18e-08 | 5633.5156 | Yes |
| PEDIATRIC_PSORIASIS_BIOLOGIC_NMA_REVIEW | RR | 4 | 6.601 | 4.029 to 10.817 | 4.029 to 10.817 | 0.0% | 0.659 | 0.0000 | Yes |
| PEGCETACOPLAN_GA | OR | 2 | — | — | — | 11.8% | 0.287 | 0.0019 | — |
| PEGCETACOPLAN_GA_REVIEW | MD | 4 | -0.295 | -0.441 to -0.149 | -0.441 to -0.149 | 0.0% | 0.615 | 0.0000 | — |
| PEGCETACOPLAN_PNH_AUTO_FULL | OR | 2 | 22.497 | 0.002 to 298776.546 | — | 42.7% | 0.187 | 0.0000 | — |
| PEGLOTICASE_GOUT_AUTO_FULL | OR | 2 | 4.431 | 0.063 to 309.875 | — | 0.0% | 0.359 | 0.0000 | Yes |
| PEMBROLIZUMAB_HEAD_NECK_AUTO_FULL | OR | 2 | 0.651 | 0.012 to 34.900 | — | 0.0% | 0.537 | 0.0000 | Yes |
| PEMBROLIZUMAB_HNSCC_AUTO_FULL | OR | 2 | 0.651 | 0.012 to 34.900 | — | 0.0% | 0.537 | 0.0000 | Yes |
| PEMBROLIZUMAB_KIDNEY_ADJ_AUTO_2_FULL | OR | 2 | 0.431 | 0.000 to 9488128.075 | — | 0.0% | 0.812 | 0.0000 | Yes |
| PEMBROLIZUMAB_KIDNEY_ADJ_AUTO_FULL | OR | 2 | 0.431 | 0.000 to 9488128.075 | — | 0.0% | 0.812 | 0.0000 | Yes |
| PEMBROLIZUMAB_NSCLC_1L_AUTO_FULL | OR | 2 | 3.721 | 0.320 to 43.302 | — | 8.3% | 0.296 | 0.0000 | — |
| PEMBROLIZUMAB_NSCLC_1L_AUTO_FULL_REVIEW | HR | 2 | 0.678 | 0.000 to 125435.771 | — | 73.2% | 0.053 | 1.8116 | Yes |
| PEMBROLIZUMAB_PROSTATIC_NEOPLASMS_AUTO_FULL | OR | 3 | 1.771 | 0.000 to 150097949527.438 | 0.000 to 12596069715655350288384.000 | 89.6% | 6.38e-05 | 102.5533 | Yes |
| PEMBROLIZUMAB_PROSTATIC_NEOPLASMS_AUTO_FULL_REVIEW | HR | 3 | 0.969 | 0.777 to 1.208 | 0.777 to 1.208 | 0.0% | 0.554 | 0.0000 | Yes |
| PEMBROLIZUMAB_RCC_AUTO_FULL | OR | 2 | 0.431 | 0.000 to 9488128.075 | — | 0.0% | 0.812 | 0.0000 | Yes |
| PEMBROLIZUMAB_RENAL_AUTO_FULL | OR | 2 | 0.431 | 0.000 to 9488128.075 | — | 0.0% | 0.812 | 0.0000 | Yes |
| PEMIGATINIB_BTC_AUTO_FULL | OR | 2 | 6.578 | 0.011 to 3830.105 | — | 0.0% | 0.650 | 0.0000 | Yes |
| PEMIGATINIB_CHOLANGIO_AUTO_FULL | OR | 2 | 6.578 | 0.011 to 3830.105 | — | 0.0% | 0.650 | 0.0000 | Yes |
| PERIPHERAL_DCB_PAD_NMA | OR | 8 | 2.201 | 1.555 to 3.116 | 1.026 to 4.721 | 60.0% | 0.017 | 0.0825 | — |
| PERIPHERAL_DCB_PAD_NMA_REVIEW | RR | 3 | 1.355 | 0.029 to 62.648 | 0.001 to 2858.773 | 81.6% | 0.004 | 2.3709 | Yes |
| PFA_AF_PULSED_FIELD | OR | 3 | 0.556 | 0.021 to 14.415 | 0.001 to 352.100 | 97.7% | 7.02e-19 | 1.6753 | — |
| PFIC_CHOLESTATIC_PRURITUS_NMA_REVIEW | RR | 2 | 3.796 | 0.033 to 432.617 | — | 0.0% | 0.816 | 0.0000 | Yes |
| PFO_STROKE_CLOSURE_NMA | OR | 10 | 0.484 | 0.319 to 0.734 | 0.300 to 0.782 | 3.9% | 0.231 | 0.0109 | — |
| PFO_STROKE_CLOSURE_NMA_REVIEW | HR | 5 | 0.422 | 0.178 to 1.002 | 0.178 to 1.002 | 49.6% | 0.094 | 0.0000 | — |
| PHENTERMINE_TOPIRAMATE_OBESITY_AUTO_FULL_REVIEW | MD | 2 | -0.031 | -0.809 to 0.748 | — | 90.0% | 0.002 | 0.0000 | — |
| PHYSICAL_REHAB_OLDER | OR | 3 | 0.904 | 0.436 to 1.873 | 0.296 to 2.756 | 27.1% | 0.296 | 0.0385 | — |
| PHYSICAL_REHAB_OLDER_REVIEW | MD | 2 | 1.487 | -2.033 to 5.007 | — | 0.0% | 0.776 | 0.0000 | Yes |
| PI3K_AKT_BC | OR | 3 | 0.443 | 0.190 to 1.031 | 0.109 to 1.800 | 60.8% | 0.082 | 0.0677 | — |
| PI3K_AKT_BC_REVIEW | HR | 3 | 0.577 | 0.378 to 0.879 | 0.378 to 0.879 | 55.9% | 0.103 | 0.0000 | — |
| PIBRENTASVIR_HEPATITIS_C_AUTO_FULL | OR | 2 | 1.768 | 0.000 to 6221583662851226774141927424.000 | — | 54.7% | 0.137 | 47.5786 | Yes |
| PIOGLITAZONE_T2D_AUTO_FULL_REVIEW | MD | 2 | 3.149 | -50.590 to 56.887 | — | 74.2% | 0.049 | 0.0000 | — |
| PITAVASTATIN_AUTO_FULL | OR | 2 | 1.224 | 0.109 to 13.779 | — | 0.0% | 0.955 | 0.0000 | Yes |
| PITAVASTATIN_AUTO_FULL_REVIEW | MD | 2 | -2.103 | -128.560 to 124.355 | — | 63.3% | 0.099 | 195.4091 | Yes |
| PLAZOMICIN_INFECTION_AUTO_FULL | OR | 3 | 0.651 | 0.082 to 5.141 | 0.082 to 5.141 | 76.2% | 0.015 | 0.0000 | — |
| PLECANATIDE_IBS_AUTO_FULL | OR | 3 | 0.523 | 0.338 to 0.808 | 0.338 to 0.808 | 0.0% | 0.445 | 0.0000 | Yes |
| PNH_NEW_COMPLEMENT | OR | 5 | 10.104 | 0.307 to 332.290 | 0.004 to 24970.750 | 94.3% | 5.30e-07 | 6.3349 | — |
| PNH_NEW_COMPLEMENT_REVIEW | RR | 3 | 1.034 | 0.681 to 1.571 | 0.681 to 1.571 | 83.1% | 0.003 | 0.0000 | — |
| POLYCYTHEMIA_VERA | OR | 3 | 4.327 | 0.104 to 180.306 | 0.005 to 3575.478 | 85.0% | 0.002 | 1.6857 | — |
| POLYCYTHEMIA_VERA_REVIEW | RR | 2 | 2.839 | 0.000 to 17331674254332421618095039268651427094855680.000 | — | 89.0% | 0.003 | 120.0649 | Yes |
| PONESIMOD_MS_AUTO_FULL | OR | 2 | 1.015 | 0.041 to 24.912 | — | 36.7% | 0.209 | 0.0000 | — |
| PONESIMOD_MS_AUTO_FULL_REVIEW | MD | 2 | -0.076 | -0.562 to 0.409 | — | 60.3% | 0.112 | 0.0000 | — |
| POSACONAZOLE_FUNGAL_AUTO_FULL | OR | 2 | 0.699 | 0.000 to 1549.151 | — | 0.0% | 0.573 | 0.0000 | Yes |
| POSTOP_AKI_PREVENTION | OR | 7 | 0.597 | 0.453 to 0.786 | 0.311 to 1.147 | 57.3% | 0.019 | 0.0586 | — |
| PPH_BUNDLE | OR | 3 | 0.662 | 0.173 to 2.538 | 0.046 to 9.625 | 98.4% | 8.26e-41 | 0.2895 | — |
| PPSV23_VACCINE_AUTO_FULL | OR | 2 | 1.651 | 0.079 to 34.462 | — | 0.0% | 0.999 | 0.0000 | Yes |
| PRADER_HUMAN_GH_AUTO_FULL | OR | 2 | 1.212 | 0.003 to 580.169 | — | 56.2% | 0.131 | 0.0000 | — |
| PREVNAR15_PNEUMO_AUTO_FULL | OR | 8 | 1.389 | 0.500 to 3.861 | 0.090 to 21.547 | 73.4% | 4.39e-04 | 1.1572 | Yes |
| PREVNAR15_PNEUMO_AUTO_FULL_REVIEW | MD | 2 | 2.270 | -489.249 to 493.789 | — | 73.3% | 0.053 | 2975.7860 | Yes |
| PRIMROSE_ELAGOLIX_AUTO_FULL | OR | 6 | 0.208 | 0.000 to 16071648666216.771 | 0.000 to 1140416814193285585940060647261732864.000 | 95.9% | 1.28e-24 | 928.2139 | Yes |
| PRIMROSE_ELAGOLIX_AUTO_FULL_REVIEW | OR | 4 | 20.333 | 0.000 to 62808493428.056 | 0.000 to 32864023577574831554560.000 | 82.4% | 6.83e-04 | 188.3226 | Yes |
| PROPOSED_RHEUMATOID_ARTHRITIS_AUTO_FULL | OR | 4 | 0.934 | 0.662 to 1.319 | 0.662 to 1.319 | 0.0% | 0.882 | 0.0000 | Yes |
| PROSTATE_AR_NEXT_GEN | OR | 11 | 0.496 | 0.412 to 0.597 | 0.278 to 0.883 | 79.0% | 7.67e-07 | 0.0602 | — |
| PROSTATE_AR_NEXT_GEN_REVIEW | HR | 10 | 0.523 | 0.034 to 7.974 | 0.000 to 4373.894 | 89.2% | 3.28e-14 | 14.4888 | Yes |
| PROSTATE_MRI_PSMA_DIAG_NMA_REVIEW | RR | 2 | 1.727 | 0.590 to 5.053 | — | 0.0% | 0.571 | 0.0000 | Yes |
| PROSTATE_PARP_HRR_BROAD | OR | 7 | 0.532 | 0.373 to 0.758 | 0.221 to 1.279 | 78.4% | 2.48e-04 | 0.1076 | — |
| PROSTATE_PARP_HRR_BROAD_REVIEW | HR | 5 | 0.598 | 0.511 to 0.698 | 0.511 to 0.698 | 0.0% | 0.418 | 0.0000 | Yes |
| PROSTATE_RADIOLIGAND_BROAD | OR | 9 | 0.405 | 0.198 to 0.830 | 0.047 to 3.510 | 92.9% | 7.12e-15 | 0.7798 | — |
| PROSTATE_RADIOLIGAND_BROAD_REVIEW | HR | 5 | 0.473 | 0.073 to 3.049 | 0.005 to 44.413 | 54.8% | 0.065 | 2.2259 | Yes |
| PROTON_RADIOTHERAPY_NMA_REVIEW | RR | 2 | 0.754 | 0.068 to 8.351 | — | 64.2% | 0.095 | 0.0000 | — |
| PRURIGO_NODULARIS_NMA_REVIEW | RR | 4 | 2.307 | 0.003 to 1546.658 | 0.000 to 4741276.247 | 73.3% | 0.011 | 16.6803 | Yes |
| PSA_BIOLOGICS | OR | 4 | 4.500 | 2.766 to 7.322 | 1.944 to 10.416 | 53.0% | 0.102 | 0.0461 | — |
| PSA_BIOLOGICS_REVIEW | RR | 4 | 2.417 | 0.002 to 2800.667 | 0.000 to 17053777.912 | 82.5% | 6.46e-04 | 19.6388 | Yes |
| PYROXAMINE_AUTO_FULL | OR | 2 | 0.431 | 0.101 to 1.845 | — | 0.0% | 0.581 | 0.0000 | Yes |
| PYROXAMINE_AUTO_FULL_REVIEW | MD | 3 | -0.352 | -0.578 to -0.127 | -0.578 to -0.127 | 0.0% | 0.732 | 0.0000 | Yes |
| RABEPRAZOLE_GERD_AUTO_FULL | OR | 2 | 0.981 | 0.217 to 4.439 | — | 0.0% | 0.609 | 0.0000 | Yes |
| RABIES_VACCINE_AUTO_FULL | OR | 3 | 1.150 | 0.144 to 9.175 | 0.144 to 9.175 | 0.0% | 0.464 | 0.0000 | Yes |
| RALTEGRAVIR_HIV_AUTO_FULL | OR | 3 | 1.424 | 0.329 to 6.161 | 0.329 to 6.161 | 0.0% | 0.480 | 0.0000 | Yes |
| RAMUCIRUMAB_COLORECTAL_AUTO_FULL | OR | 2 | 1.074 | 0.107 to 10.737 | — | 0.0% | 0.485 | 0.0000 | Yes |
| RAMUCIRUMAB_GASTRIC_AUTO_FULL | OR | 2 | 1.267 | 0.209 to 7.673 | — | 0.0% | 0.637 | 0.0000 | Yes |
| RAMUCIRUMAB_HCC_AUTO_FULL | OR | 2 | 3.743 | 0.000 to 566786.089 | — | 0.0% | 0.710 | 0.0000 | Yes |
| RAMUCIRUMAB_LUNG_AUTO_FULL | OR | 2 | 1.363 | 0.015 to 122.420 | — | 0.0% | 0.466 | 0.0000 | Yes |
| RAMUCIRUMAB_LUNG_AUTO_FULL_REVIEW | HR | 2 | 0.648 | 0.148 to 2.835 | — | 26.2% | 0.244 | 0.0000 | — |
| RANIBIZUMAB_DR_AUTO_FULL | OR | 2 | 1.155 | 0.008 to 168.805 | — | 0.0% | 0.640 | 0.0000 | Yes |
| RANIBIZUMAB_DR_AUTO_FULL_REVIEW | MD | 2 | 5.724 | -7.826 to 19.274 | — | 0.0% | 0.928 | 0.0000 | Yes |
| RAVULIZUMAB_PNH_AUTO_FULL | OR | 4 | 0.630 | 0.000 to 3582354066362718020826038272.000 | 0.000 to 67101557678398971384644827464432352508865570305751100730376192.000 | 89.0% | 5.00e-06 | 1610.8143 | Yes |
| RAVULIZUMAB_PNH_AUTO_FULL_REVIEW | MD | 3 | -54.109 | -2084.002 to 1975.783 | -4109.762 to 4001.544 | 75.7% | 0.016 | 665910.1438 | Yes |
| RCC_1L | OR | 4 | 0.602 | 0.430 to 0.843 | 0.332 to 1.093 | 52.7% | 0.096 | 0.0239 | — |
| RCC_1L_REVIEW | HR | 2 | 0.446 | 0.000 to 6505.663 | — | 65.6% | 0.088 | 1.1265 | Yes |
| RELUGOLIX_FIBROIDS_AUTO_2_FULL | OR | 6 | 7.796 | 0.000 to 11044628936.716 | 0.000 to 12312197598627290331217920.000 | 90.3% | 7.08e-10 | 402.6398 | Yes |
| RELUGOLIX_FIBROIDS_AUTO_FULL | OR | 4 | 1.458 | 0.474 to 4.481 | 0.474 to 4.481 | 73.3% | 0.011 | 0.0000 | — |
| RELUGOLIX_HEAVY_MENSTRUAL_AUTO_FULL | OR | 3 | 8.015 | 0.000 to 1297886410459709952.000 | 0.000 to 207186099998927718239074954374021120.000 | 94.4% | 1.94e-08 | 254.3314 | Yes |
| REMDESIVIR_COVID_AUTO_FULL | OR | 2 | 1.089 | 0.033 to 35.638 | — | 75.5% | 0.043 | 0.0000 | — |
| RENAL_DENERV | OR | 4 | — | — | — | 0.0% | 0.390 | 0.0000 | — |
| RENAL_DENERV_REVIEW | MD | 6 | -4.776 | -6.693 to -2.858 | -6.693 to -2.858 | 0.0% | 0.529 | 0.0000 | — |
| RESLIZUMAB_ASTHMA_AUTO_FULL | OR | 3 | 0.536 | 0.000 to 42988641225006.898 | 0.000 to 3256562033254251742996987904.000 | 94.6% | 9.11e-09 | 165.7036 | Yes |
| RESLIZUMAB_ASTHMA_AUTO_FULL_REVIEW | MD | 3 | 0.236 | -15.058 to 15.530 | -30.335 to 30.808 | 79.9% | 0.007 | 37.8495 | Yes |
| RETIFANLIMAB_SKIN_AUTO_FULL | OR | 2 | 2.819 | 0.000 to 354639.513 | — | 0.0% | 0.639 | 0.0000 | Yes |
| RIFAPENTINE_TB_AUTO_FULL | OR | 2 | 0.389 | 0.000 to 379.412 | — | 0.0% | 0.976 | 0.0000 | Yes |
| RIMEGEPANT_MIGRAINE_AUTO_FULL | OR | 2 | 0.557 | 0.039 to 8.003 | — | 0.0% | 0.766 | 0.0000 | Yes |
| RIOCIGUAT_PAH_AUTO_FULL | OR | 3 | 2.548 | 0.738 to 8.800 | 0.738 to 8.800 | 0.0% | 0.731 | 0.0000 | Yes |
| RIOCIGUAT_PAH_AUTO_FULL_REVIEW | MD | 3 | 26.984 | -598.854 to 652.821 | -1224.116 to 1278.083 | 88.3% | 1.92e-04 | 63392.8122 | Yes |
| RISANKIZUMAB_CD | OR | 3 | 2.399 | 0.630 to 9.129 | 0.196 to 29.343 | 83.6% | 0.002 | 0.2422 | — |
| RISANKIZUMAB_CD_REVIEW | OR | 3 | 2.420 | 1.248 to 4.696 | 1.248 to 4.696 | 34.8% | 0.216 | 0.0000 | — |
| RISANKIZUMAB_CROHNS_DISEASE_AUTO_FULL | OR | 2 | 0.217 | 0.024 to 1.931 | — | 0.0% | 0.423 | 0.0000 | Yes |
| RISANKIZUMAB_PSA_AUTO_FULL | OR | 2 | 0.370 | 0.089 to 1.533 | — | 0.0% | 0.877 | 0.0000 | Yes |
| RISANKIZUMAB_PSORIASIS_AUTO_FULL | OR | 3 | 0.249 | 0.000 to 18127561404639.434 | 0.000 to 1295861293295882505631563776.000 | 89.0% | 1.09e-04 | 164.9654 | Yes |
| RISDIPLAM_SMA_AUTO_FULL | OR | 2 | 1.815 | 0.000 to 792037.403 | — | 0.0% | 0.984 | 0.0000 | Yes |
| RISPERIDONE_SCHIZO_AUTO_FULL_REVIEW | MD | 2 | -0.260 | -14.475 to 13.956 | — | 0.0% | 0.587 | 0.0000 | Yes |
| RITUXIMAB_LYMPHOMA_AUTO_FULL | OR | 2 | 0.554 | 0.000 to 148101.256 | — | 0.0% | 0.704 | 0.0000 | Yes |
| RITUXIMAB_MG_AUTO_FULL | OR | 2 | 2.606 | 0.000 to 2660997238795953790961844224.000 | — | 69.7% | 0.069 | 47.5480 | Yes |
| RIVAROXABAN_ACS_AUTO_FULL | OR | 2 | 1.042 | 0.114 to 9.539 | — | 81.8% | 0.019 | 0.0000 | — |
| RIVAROXABAN_VASC | OR | 4 | 0.839 | 0.723 to 0.974 | 0.650 to 1.083 | 46.6% | 0.134 | 0.0042 | — |
| RNA_INTERFERENCE_BROAD_NMA_REVIEW | MD | 8 | -47.863 | -322.877 to 227.151 | -872.876 to 777.150 | 99.6% | 0.00e+00 | 108203.8001 | Yes |
| ROCKLATAN_GLAUCOMA_AUTO_FULL_REVIEW | MD | 2 | 0.015 | -2.965 to 2.995 | — | 0.0% | 0.935 | 0.0000 | Yes |
| ROFLUMILAST_COPD_AUTO_FULL_REVIEW | MD | 2 | 0.103 | -4.822 to 5.028 | — | 94.7% | 1.32e-05 | 0.0000 | — |
| ROFLUMILAST_PSORIASIS_AUTO_FULL | OR | 2 | 1.068 | 0.000 to 49919957975034918507949001537212919429614751683113385984.000 | — | 94.8% | 1.10e-05 | 203.4324 | Yes |
| ROFLUMILAST_TOP_PSO_AUTO_FULL | OR | 2 | 1.068 | 0.000 to 49919957975034918507949001537212919429614751683113385984.000 | — | 94.8% | 1.10e-05 | 203.4324 | Yes |
| ROLAPITANT_CINV_AUTO_FULL | OR | 2 | 1.650 | 0.288 to 9.445 | — | 9.9% | 0.292 | 0.0000 | — |
| ROLAPITANT_CINV_AUTO_FULL_REVIEW | OR | 2 | 1.635 | 0.235 to 11.374 | — | 24.3% | 0.250 | 0.0000 | — |
| ROMOSOZUMAB_OP | OR | 3 | 0.308 | 0.044 to 2.159 | 0.015 to 6.326 | 76.9% | 0.022 | 0.2887 | — |
| ROMOSOZUMAB_OP_REVIEW | RR | 3 | 0.200 | 0.000 to 4109182382.511 | 0.000 to 78154205921137311744.000 | 76.8% | 0.013 | 90.9813 | Yes |
| ROMOSOZUMAB_OSTEO_AUTO_FULL_REVIEW | MD | 2 | 1.700 | -1164.410 to 1167.810 | — | 99.8% | 3.23e-92 | 16844.8566 | Yes |
| ROP_ANTI_VEGF_NMA_REVIEW | RR | 3 | 0.553 | 0.146 to 2.097 | 0.146 to 2.097 | 34.2% | 0.219 | 0.0000 | — |
| ROSUVASTATIN_AUTO_FULL_REVIEW | MD | 2 | -0.270 | -8.324 to 7.784 | — | 88.7% | 0.003 | 0.0000 | — |
| ROTAVIRUS_VACCINE_AFRICA | OR | 3 | 0.494 | 0.233 to 1.049 | 0.140 to 1.749 | 57.0% | 0.094 | 0.0557 | — |
| ROTAVIRUS_VACCINE_AFRICA_REVIEW | RR | 3 | 0.437 | 0.002 to 91.133 | 0.000 to 18474.404 | 66.2% | 0.052 | 4.5890 | Yes |
| ROTAVIRUS_VACCINE_AUTO_FULL | OR | 3 | 0.098 | 0.000 to 87870635128776919535027223892107260190733107200.000 | 0.000 to 78080732269272526083870131329338494649054947864114232079609051727480839978591672314581135392768.000 | 98.6% | 2.03e-32 | 1975.3765 | Yes |
| ROXADUSTAT_ANEMIA_CKD_AUTO_FULL | OR | 2 | 0.768 | 0.000 to 342931606252968458914769529313689600.000 | — | 93.3% | 1.14e-04 | 83.4070 | Yes |
| ROXADUSTAT_ANEMIA_CKD_AUTO_FULL_REVIEW | MD | 2 | 0.239 | -2.420 to 2.897 | — | 93.0% | 1.59e-04 | 0.0000 | — |
| ROXADUSTAT_RENAL_ANEMIA_AUTO_FULL | OR | 2 | 0.768 | 0.000 to 342931606252968458914769529313689600.000 | — | 93.3% | 1.14e-04 | 83.4070 | Yes |
| ROXADUSTAT_RENAL_ANEMIA_AUTO_FULL_REVIEW | MD | 2 | 0.239 | -2.420 to 2.897 | — | 93.0% | 1.59e-04 | 0.0000 | — |
| ROZANOLIXIZUMAB_MG_AUTO_FULL | OR | 3 | 0.330 | 0.000 to 400461.013 | 0.000 to 419756094443.523 | 66.9% | 0.049 | 31.3623 | Yes |
| RSVPREF3_VACCINE_AUTO_FULL | OR | 2 | 0.693 | 0.091 to 5.285 | — | 0.0% | 0.871 | 0.0000 | Yes |
| RSVPREF3_VACCINE_AUTO_FULL_REVIEW | MD | 2 | -28.204 | -712.308 to 655.900 | — | 0.0% | 0.433 | 0.0000 | Yes |
| RSV_VACCINE_OLDER | OR | 3 | 0.215 | 0.080 to 0.582 | 0.061 to 0.766 | 19.5% | 0.306 | 0.0335 | — |
| RSV_VACCINE_OLDER_REVIEW | RR | 3 | 0.214 | 0.076 to 0.600 | 0.076 to 0.600 | 22.6% | 0.275 | 0.0000 | — |
| RUCAPARIB_PROSTATE2_AUTO_FULL | OR | 3 | 2.142 | 0.000 to 15685.818 | 0.000 to 55561834.076 | 79.7% | 0.007 | 11.4646 | Yes |
| RUCAPARIB_PROSTATE_AUTO_FULL | OR | 3 | 2.142 | 0.000 to 15685.818 | 0.000 to 55561834.076 | 79.7% | 0.007 | 11.4646 | Yes |
| RUFINAMIDE_EPILEPSY_AUTO_FULL | OR | 2 | 9.400 | 0.000 to 20315139701007593359434626445682603830421787360865034822483968.000 | — | 76.5% | 0.039 | 238.0345 | Yes |
| RUXOLITINIB_AD_AUTO_FULL | OR | 2 | 0.160 | 0.010 to 2.670 | — | 0.0% | 0.579 | 0.0000 | Yes |
| SACUBITRIL_HEARTFAIL_AUTO_FULL_REVIEW | MD | 3 | -0.048 | -0.658 to 0.561 | -1.171 to 1.074 | 70.4% | 0.034 | 0.0480 | Yes |
| SACUBITRIL_VALSARTAN_HF_AUTO_FULL_REVIEW | MD | 3 | -0.048 | -0.658 to 0.561 | -1.171 to 1.074 | 70.4% | 0.034 | 0.0480 | Yes |
| SAPROPTERIN_PKU_AUTO_FULL_REVIEW | MD | 2 | 6.899 | -1361.554 to 1375.352 | — | 97.1% | 4.87e-09 | 23191.2237 | Yes |
| SARILUMAB_COVID_AUTO_FULL | OR | 2 | 1.782 | 0.009 to 343.459 | — | 57.1% | 0.127 | 0.0000 | — |
| SARILUMAB_RA_AUTO_FULL | OR | 3 | 0.737 | 0.000 to 46952494.025 | 0.000 to 2867915511856473.500 | 77.2% | 0.012 | 52.1648 | Yes |
| SATRALIZUMAB_NMOSD_AUTO_FULL | OR | 2 | 2.569 | 0.000 to 63701.021 | — | 0.0% | 0.882 | 0.0000 | Yes |
| SATRALIZUMAB_NMOSD_AUTO_FULL_REVIEW | HR | 2 | 0.421 | 0.014 to 13.086 | — | 0.0% | 0.761 | 0.0000 | Yes |
| SAXAGLIPTIN_T2D_AUTO_FULL | OR | 2 | 1.152 | 0.000 to 67267591013491760168960.000 | — | 89.8% | 0.002 | 33.9985 | Yes |
| SBRT_OLIGOMETS_NMA | OR | 10 | 0.536 | 0.393 to 0.730 | 0.275 to 1.042 | 31.5% | 0.216 | 0.0677 | — |
| SBRT_OLIGOMETS_NMA_REVIEW | HR | 2 | 0.479 | 0.043 to 5.284 | — | 0.0% | 0.521 | 0.0000 | Yes |
| SBRT_PROSTATE_LOCAL_NMA_REVIEW | HR | 3 | 0.965 | 0.716 to 1.301 | 0.716 to 1.301 | 0.0% | 0.718 | 0.0000 | Yes |
| SCD_NEW_THERAPY_BROAD_NMA_REVIEW | RR | 3 | 1.233 | 0.000 to 313417085276.206 | 0.000 to 79121437260424260091904.000 | 94.8% | 3.73e-09 | 111.7211 | Yes |
| SCLC_IO | OR | 10 | 0.587 | 0.526 to 0.656 | 0.526 to 0.656 | 0.0% | 0.833 | 0.0000 | Yes |
| SCLC_IO_REVIEW | HR | 9 | 0.747 | 0.677 to 0.823 | 0.677 to 0.823 | 0.0% | 0.917 | 0.0000 | Yes |
| SEBELIPASE_LAL_AUTO_FULL | OR | 2 | 0.731 | 0.000 to 14059466005672178654975163906203718937785223196107885113560718570285692932561256140767232.000 | — | 78.0% | 0.033 | 509.9070 | Yes |
| SECUKINUMAB_AXIAL_AUTO_FULL | OR | 2 | 0.954 | 0.074 to 12.365 | — | 0.0% | 0.841 | 0.0000 | Yes |
| SECUKINUMAB_AXIAL_AUTO_FULL_REVIEW | OR | 2 | 3.157 | 0.200 to 49.906 | — | 4.1% | 0.307 | 0.0000 | — |
| SECUKINUMAB_AXSPA_AUTO_FULL | OR | 2 | 0.954 | 0.074 to 12.365 | — | 0.0% | 0.841 | 0.0000 | Yes |
| SECUKINUMAB_AXSPA_AUTO_FULL_REVIEW | OR | 2 | 3.157 | 0.200 to 49.906 | — | 4.1% | 0.307 | 0.0000 | — |
| SECUKINUMAB_PSORIASIS_AUTO_FULL | OR | 5 | 1.380 | 0.005 to 404.883 | 0.000 to 1504138.043 | 78.3% | 0.001 | 20.8829 | Yes |
| SECUKINUMAB_PSORIASIS_AUTO_FULL_REVIEW | RD | 3 | 27.894 | -570.537 to 626.326 | -1168.704 to 1224.492 | 90.9% | 1.70e-05 | 57999.1257 | Yes |
| SELADELPAR_PBC_AUTO_FULL | OR | 2 | 0.518 | 0.000 to 35526557216156952641588695564591154247537869374058263317765603344061017836757821541292408300601371183966628618229261316044244074049551785686040167055360.000 | — | 88.6% | 0.003 | 1511.9612 | Yes |
| SELEXIPAG_PAH_AUTO_FULL | OR | 2 | 4.210 | 0.480 to 36.967 | — | 0.0% | 0.576 | 0.0000 | Yes |
| SELEXIPAG_PAH_AUTO_FULL_REVIEW | MD | 2 | 1.704 | -44.583 to 47.992 | — | 0.0% | 0.560 | 0.0000 | Yes |
| SEMAGLUTIDE_NASH_AUTO_FULL | OR | 3 | 0.849 | 0.000 to 331264820905.147 | 0.000 to 120575287779115923406848.000 | 83.7% | 0.002 | 115.0347 | Yes |
| SEMAGLUTIDE_OBESITY | OR | 3 | — | — | — | 60.6% | 0.084 | 0.8489 | — |
| SEMAGLUTIDE_OBESITY_REVIEW | MD | 3 | -11.841 | -14.866 to -8.816 | -16.827 to -6.854 | 60.6% | 0.084 | 0.8489 | — |
| SEPSIS_RESUSCITATION | OR | 3 | 0.957 | 0.737 to 1.244 | 0.737 to 1.244 | 0.0% | 0.572 | 0.0000 | Yes |
| SER109_CDI_AUTO_FULL | OR | 2 | 0.425 | 0.000 to 658425142990962853811104776192.000 | — | 81.4% | 0.020 | 59.6871 | Yes |
| SEVERE_ASTHMA_BIOLOGICS | OR | 11 | 0.639 | 0.230 to 1.778 | 0.020 to 20.774 | 98.4% | 1.43e-55 | 2.2304 | — |
| SEVERE_ASTHMA_BIOLOGICS_REVIEW | RR | 8 | 0.528 | 0.181 to 1.537 | 0.022 to 12.828 | 35.8% | 0.143 | 1.6168 | Yes |
| SEVERE_ASTHMA_NMA | OR | 5 | 0.493 | 0.438 to 0.554 | 0.437 to 0.555 | 0.2% | 0.617 | 0.0000 | — |
| SGLT2I_HF_NMA | OR | 6 | 0.714 | 0.604 to 0.845 | 0.502 to 1.017 | 71.4% | 0.012 | 0.0146 | — |
| SGLT2_BROAD_OUTCOMES_NMA | OR | 10 | 0.786 | 0.703 to 0.879 | 0.566 to 1.091 | 78.0% | 6.07e-06 | 0.0186 | — |
| SGLT2_BROAD_OUTCOMES_NMA_REVIEW | HR | 10 | 0.773 | 0.304 to 1.968 | 0.035 to 17.074 | 67.3% | 0.001 | 1.7014 | Yes |
| SGLT2_CKD | OR | 3 | 0.679 | 0.517 to 0.893 | 0.450 to 1.025 | 41.6% | 0.181 | 0.0051 | — |
| SGLT2_HF | OR | 5 | 0.709 | 0.563 to 0.892 | 0.437 to 1.149 | 79.2% | 0.005 | 0.0234 | — |
| SGLT2_MACE_CVOT | OR | 4 | 0.906 | 0.798 to 1.028 | 0.755 to 1.087 | 27.7% | 0.234 | 0.0017 | — |
| SGLT2_MACE_CVOT_REVIEW | HR | 4 | 0.909 | 0.822 to 1.005 | 0.822 to 1.005 | 0.0% | 0.499 | 0.0000 | Yes |
| SIMEPREVIR_HCV_AUTO_FULL | OR | 5 | 0.667 | 0.000 to 70683375983272.562 | 0.000 to 13971797062943338278876555463622656.000 | 75.3% | 0.003 | 674.8674 | Yes |
| SIRUKUMAB_ARTHRITIS_RHEUMATOID_AUTO_FULL | OR | 5 | 0.857 | 0.000 to 2214.729 | 0.000 to 192817197.695 | 89.0% | 2.50e-07 | 39.9692 | Yes |
| SITAGLIPTIN_T2D_AUTO_FULL_REVIEW | MD | 2 | -0.602 | -3.859 to 2.655 | — | 87.9% | 0.004 | 0.0000 | — |
| SMA_TREATMENTS_BROAD | OR | 4 | 6.381 | 2.543 to 16.012 | 2.543 to 16.012 | 0.0% | 0.169 | 0.0000 | — |
| SMA_TREATMENTS_BROAD_REVIEW | RR | 3 | 2.288 | 0.009 to 576.224 | 0.000 to 138740.942 | 60.6% | 0.079 | 4.8998 | Yes |
| SORAFENIB_HCC_AUTO_FULL | OR | 3 | 1.426 | 0.502 to 4.054 | 0.502 to 4.054 | 0.0% | 0.908 | 0.0000 | Yes |
| SORAFENIB_LIVER_AUTO_FULL | OR | 3 | 1.426 | 0.502 to 4.054 | 0.502 to 4.054 | 0.0% | 0.908 | 0.0000 | Yes |
| SORAVTANSINE_EPITHELIAL_OVARIAN_AUTO_FULL | OR | 2 | 3.134 | 0.096 to 102.707 | — | 54.5% | 0.138 | 0.0000 | — |
| SORAVTANSINE_EPITHELIAL_OVARIAN_AUTO_FULL_REVIEW | MD | 2 | 0.656 | -87.841 to 89.153 | — | 76.5% | 0.039 | 96.5887 | Yes |
| SORAVTANSINE_FALLOPIAN_TUBE_AUTO_FULL | OR | 2 | 3.134 | 0.096 to 102.707 | — | 54.5% | 0.138 | 0.0000 | — |
| SORAVTANSINE_FALLOPIAN_TUBE_AUTO_FULL_REVIEW | MD | 2 | 0.656 | -87.841 to 89.153 | — | 76.5% | 0.039 | 96.5887 | Yes |
| SOTAGLIFLOZIN_HF | OR | 2 | 0.602 | 0.054 to 6.672 | 0.011 to 32.560 | 87.3% | 0.005 | 0.0628 | — |
| SOTAGLIFLOZIN_HF_AUTO_FULL | OR | 2 | 0.837 | 0.017 to 40.630 | — | 0.0% | 0.806 | 0.0000 | Yes |
| SOTAGLIFLOZIN_HF_AUTO_FULL_REVIEW | HR | 2 | 0.717 | 0.293 to 1.756 | — | 0.0% | 0.512 | 0.0000 | Yes |
| SOTAGLIFLOZIN_HF_REVIEW | HR | 2 | 0.717 | 0.293 to 1.756 | — | 0.0% | 0.512 | 0.0000 | Yes |
| SOTAGLIFLOZIN_T1D_AUTO_FULL | OR | 2 | 0.431 | 0.101 to 1.845 | — | 0.0% | 0.581 | 0.0000 | Yes |
| SOTAGLIFLOZIN_T1D_AUTO_FULL_REVIEW | MD | 3 | -0.352 | -0.578 to -0.127 | -0.578 to -0.127 | 0.0% | 0.732 | 0.0000 | Yes |
| SOTATERCEPT_PAH_AUTO_2_FULL | OR | 2 | 0.806 | 0.012 to 52.759 | — | 0.0% | 0.815 | 0.0000 | Yes |
| SOTATERCEPT_PAH_AUTO_FULL | OR | 2 | 0.806 | 0.012 to 52.759 | — | 0.0% | 0.815 | 0.0000 | Yes |
| SPESOLIMAB_GPP_AUTO_FULL | OR | 3 | 0.452 | 0.005 to 41.281 | 0.005 to 41.281 | 0.0% | 0.498 | 0.0000 | Yes |
| SPESOLIMAB_GPP_AUTO_FULL_REVIEW | RD | 2 | 0.283 | -20.217 to 20.782 | — | 81.0% | 0.022 | 5.1899 | Yes |
| SPONDYLOARTHRITIS | OR | 4 | 2.411 | 0.890 to 6.536 | 0.293 to 19.862 | 85.7% | 5.60e-05 | 0.3408 | — |
| SPONDYLOARTHRITIS_REVIEW | RR | 4 | 1.783 | 0.001 to 4687.248 | 0.000 to 78486752.559 | 88.4% | 9.89e-06 | 24.4631 | Yes |
| STROKE_THROMBECTOMY_BROAD | OR | 11 | 2.650 | 2.010 to 3.493 | 1.239 to 5.664 | 55.9% | 0.008 | 0.1009 | — |
| STROKE_THROMBECTOMY_BROAD_REVIEW | RR | 10 | 2.039 | 0.291 to 14.299 | 0.003 to 1274.001 | 57.1% | 0.013 | 7.3564 | Yes |
| STROKE_THROMBECTOMY_LATE_NMA | OR | 10 | 2.694 | 2.160 to 3.360 | 1.872 to 3.875 | 18.6% | 0.229 | 0.0163 | — |
| STROKE_THROMBECTOMY_LATE_NMA_REVIEW | RR | 8 | 2.272 | 1.492 to 3.460 | 0.734 to 7.032 | 15.3% | 0.310 | 0.1966 | Yes |
| SUNITINIB_RCC_AUTO_FULL | OR | 3 | 1.111 | 0.398 to 3.099 | 0.398 to 3.099 | 0.0% | 0.487 | 0.0000 | Yes |
| SUNITINIB_RENAL_AUTO_FULL | OR | 2 | 0.737 | 0.004 to 146.643 | — | 0.0% | 0.998 | 0.0000 | Yes |
| T1D_CLOSED_LOOP_NMA_REVIEW | MD | 3 | 10.704 | 7.289 to 14.119 | 7.289 to 14.119 | 0.0% | 0.753 | 0.0000 | Yes |
| TADALAFIL_BPH_AUTO_FULL | OR | 2 | 0.752 | 0.047 to 12.069 | — | 0.0% | 0.385 | 0.0000 | Yes |
| TADALAFIL_BPH_AUTO_FULL_REVIEW | MD | 2 | -0.010 | -0.406 to 0.385 | — | 92.6% | 2.34e-04 | 0.0000 | — |
| TALAZOPARIB_BREAST_AUTO_FULL | OR | 2 | 1.025 | 0.000 to 2679.540 | — | 0.0% | 0.715 | 0.0000 | Yes |
| TALIGLUCERASE_GAUCHER_AUTO_FULL_REVIEW | MD | 2 | 151.997 | -4960.768 to 5264.761 | — | 0.0% | 0.873 | 0.0000 | Yes |
| TANEZUMAB_OA_AUTO_FULL | OR | 7 | 0.806 | 0.000 to 1685.800 | 0.000 to 1953248823.361 | 85.4% | 2.73e-07 | 68.2206 | Yes |
| TANEZUMAB_OA_AUTO_FULL_REVIEW | MD | 5 | -0.936 | -6.497 to 4.626 | -14.540 to 12.669 | 64.6% | 0.023 | 19.9980 | Yes |
| TAPINAROF_ATOPIC_DERMATITIS_AUTO_FULL | OR | 2 | 4.527 | 0.417 to 49.085 | — | 0.0% | 0.495 | 0.0000 | Yes |
| TAVAPADON_PARKINSON_DISEASE_AUTO_FULL_REVIEW | MD | 2 | 5.199 | -785.086 to 795.482 | — | 99.1% | 5.54e-25 | 7736.1195 | Yes |
| TAVR_LOWRISK | OR | 3 | 0.630 | 0.381 to 1.043 | 0.381 to 1.043 | 0.0% | 0.491 | 0.0000 | Yes |
| TAVR_LOWRISK_REVIEW | HR | 3 | 0.644 | 0.368 to 1.126 | 0.368 to 1.126 | 0.0% | 0.457 | 0.0000 | Yes |
| TAVR_LOW_RISK | OR | 4 | 0.777 | 0.450 to 1.341 | 0.282 to 2.142 | 56.4% | 0.073 | 0.0722 | — |
| TAVR_LOW_RISK_REVIEW | HR | 3 | 0.639 | 0.367 to 1.113 | 0.367 to 1.113 | 0.0% | 0.430 | 0.0000 | Yes |
| TB_BPaL_NEW_NMA_REVIEW | RR | 2 | 1.450 | 0.717 to 2.932 | — | 0.0% | 1.000 | 0.0000 | Yes |
| TDXD_HER2LOW_BC | OR | 2 | 0.561 | 0.002 to 163.583 | 0.000 to 8285.956 | 93.0% | 1.51e-04 | 0.3713 | — |
| TECOVIRIMAT_MPOX_AUTO_FULL | OR | 2 | 1.013 | 0.103 to 9.977 | — | 17.8% | 0.270 | 0.0000 | — |
| TENAPANOR_HYPERPHOS_AUTO_FULL | OR | 3 | 1.174 | 0.000 to 23234.149 | 0.000 to 441806384.324 | 67.3% | 0.047 | 15.7748 | Yes |
| TENAPANOR_HYPERPHOS_AUTO_FULL_REVIEW | MD | 2 | 0.075 | -84.951 to 85.100 | — | 92.6% | 2.38e-04 | 89.4782 | Yes |
| TENAPANOR_IBS_AUTO_FULL | OR | 2 | 1.568 | 0.293 to 8.396 | — | 0.0% | 0.863 | 0.0000 | Yes |
| TEPLIZUMAB_T1D_AUTO_FULL | OR | 2 | 1.017 | 0.000 to 1348034313371107.500 | — | 72.1% | 0.058 | 14.9261 | Yes |
| TEPROTUMUMAB_TED_AUTO_FULL | OR | 3 | 0.247 | 0.000 to 14902355033258262605841589988229120.000 | 0.000 to 878326502412976516959354109244230910512636225085994668805599694684160.000 | 93.9% | 7.77e-08 | 1038.9353 | Yes |
| TERIFLUNOMIDE_MS_AUTO_FULL | OR | 3 | 1.017 | 0.002 to 424.025 | 0.000 to 112137.904 | 87.8% | 2.81e-04 | 5.3161 | Yes |
| TEZEPELUMAB_ASTHMA_REVIEW_FULL | OR | 3 | 1.256 | 0.461 to 3.421 | 0.461 to 3.421 | 0.0% | 0.612 | 0.0000 | Yes |
| THIAMINE_SEPSIS_AUTO_FULL | OR | 2 | 0.856 | 0.069 to 10.674 | — | 0.0% | 0.503 | 0.0000 | Yes |
| TIGECYCLINE_INFECTION_AUTO_FULL | OR | 3 | 0.694 | 0.000 to 3979352.236 | 0.000 to 21910736584706.027 | 78.4% | 0.010 | 39.1077 | Yes |
| TIRZEPATIDE_ARDS_AUTO_FULL | OR | 3 | 0.005 | 0.000 to 0.312 | 0.000 to 0.312 | 0.0% | 0.431 | 0.0000 | Yes |
| TIRZEPATIDE_ARDS_AUTO_FULL_REVIEW | MD | 3 | 49.259 | -1147.399 to 1245.917 | -2344.021 to 2442.539 | 99.8% | 1.14e-182 | 232044.8167 | Yes |
| TIRZEPATIDE_OBESITY | OR | 3 | — | — | — | 97.8% | 2.03e-19 | 22.3159 | — |
| TIRZEPATIDE_OBESITY_REVIEW | MD | 3 | -16.705 | -28.593 to -4.817 | -40.252 to 6.842 | 97.8% | 2.03e-19 | 22.3159 | — |
| TIRZEPATIDE_T2D | OR | 3 | — | — | — | 96.3% | 7.50e-14 | 0.1810 | — |
| TIRZEPATIDE_T2D_REVIEW | MD | 3 | -1.520 | -2.595 to -0.446 | -3.643 to 0.602 | 96.3% | 7.50e-14 | 0.1810 | — |
| TNK_VS_TPA_STROKE | OR | 6 | 1.121 | 0.924 to 1.359 | 0.924 to 1.359 | 0.0% | 0.085 | 0.0000 | — |
| TNK_VS_TPA_STROKE_REVIEW | RR | 6 | 1.056 | 0.973 to 1.146 | 0.973 to 1.146 | 37.4% | 0.157 | 0.0000 | — |
| TOFACITINIB_AS_AUTO_FULL | OR | 2 | 0.326 | 0.000 to 11733120004360918268933002744175433598965997342134118651503212929462585786368.000 | — | 95.6% | 1.96e-06 | 384.7478 | Yes |
| TOFACITINIB_PSA_AUTO_FULL | OR | 2 | 1.791 | 0.000 to 203535690551120038461440.000 | — | 84.5% | 0.011 | 34.8340 | Yes |
| TOFACITINIB_UC | OR | 3 | 4.178 | 1.390 to 12.560 | 0.761 to 22.937 | 40.7% | 0.199 | 0.0912 | — |
| TOFACITINIB_UC_REVIEW | RR | 3 | 3.280 | 1.556 to 6.917 | 1.556 to 6.917 | 5.1% | 0.349 | 0.0000 | — |
| TOFERSEN_ALS_AUTO_FULL | OR | 2 | 0.241 | 0.000 to 365820.759 | — | 0.0% | 0.755 | 0.0000 | Yes |
| TOLEBRUTINIB_MS_AUTO_FULL | OR | 3 | 0.804 | 0.414 to 1.561 | 0.414 to 1.561 | 0.0% | 0.989 | 0.0000 | Yes |
| TOLVAPTAN_ADPKD_AUTO_FULL | OR | 2 | 1.110 | 0.096 to 12.824 | — | 0.0% | 0.724 | 0.0000 | Yes |
| TOLVAPTAN_ADPKD_AUTO_FULL_REVIEW | MD | 2 | -1.893 | -23.028 to 19.242 | — | 0.0% | 0.976 | 0.0000 | Yes |
| TOTAL_NEOADJ_RECTAL_NMA | OR | 10 | 1.187 | 0.710 to 1.985 | 0.233 to 6.053 | 92.5% | 9.35e-18 | 0.4671 | — |
| TOTAL_NEOADJ_RECTAL_NMA_REVIEW | HR | 5 | 0.796 | 0.685 to 0.925 | 0.685 to 0.925 | 0.0% | 0.830 | 0.0000 | Yes |
| TRALOKINUMAB_AD_2_AUTO_FULL | OR | 3 | 1.611 | 0.000 to 32304.174 | 0.000 to 623491209.124 | 61.5% | 0.074 | 15.8204 | Yes |
| TRALOKINUMAB_AD_2_AUTO_FULL_REVIEW | RD | 3 | 10.135 | 2.082 to 18.189 | 2.082 to 18.189 | 0.0% | 0.502 | 0.0000 | Yes |
| TRALOKINUMAB_AD_AUTO_FULL | OR | 3 | 1.611 | 0.000 to 32304.174 | 0.000 to 623491209.124 | 61.5% | 0.074 | 15.8204 | Yes |
| TRALOKINUMAB_AD_AUTO_FULL_REVIEW | RD | 3 | 10.135 | 2.082 to 18.189 | 2.082 to 18.189 | 0.0% | 0.502 | 0.0000 | Yes |
| TRICUSPID_TEER_TMVR_NMA | OR | 9 | 3.521 | 2.793 to 4.438 | 2.180 to 5.686 | 35.3% | 0.150 | 0.0331 | — |
| TRICUSPID_TEER_TMVR_NMA_REVIEW | RR | 2 | 2.127 | 0.646 to 7.000 | — | 0.0% | 0.822 | 0.0000 | Yes |
| TRIPLE_THERAPY_COPD | OR | 9 | 0.576 | 0.338 to 0.983 | 0.113 to 2.948 | 97.2% | 9.94e-22 | 0.4475 | — |
| TRIPLE_THERAPY_COPD_REVIEW | RR | 8 | 0.802 | 0.740 to 0.869 | 0.675 to 0.952 | 16.7% | 0.298 | 0.0041 | Yes |
| TROP2_ADC_BROAD | OR | 8 | 0.471 | 0.251 to 0.884 | 0.089 to 2.487 | 91.7% | 2.40e-05 | 0.4241 | — |
| TROP2_ADC_BROAD_REVIEW | HR | 3 | 0.603 | 0.000 to 5785.005 | 0.000 to 55134342.081 | 88.8% | 1.37e-04 | 13.6102 | Yes |
| TXA_NONCARDIAC_SURGERY | OR | 4 | 0.824 | 0.689 to 0.985 | 0.615 to 1.105 | 44.0% | 0.151 | 0.0053 | — |
| UBROGEPANT_MIGRAINE_AUTO_FULL | OR | 2 | 0.979 | 0.188 to 5.096 | — | 0.0% | 0.557 | 0.0000 | Yes |
| UC_BIOLOGICS_NMA | OR | 9 | 2.782 | 1.931 to 4.008 | 1.066 to 7.260 | 64.5% | 8.90e-04 | 0.1479 | — |
| UPADACITINIB_AD_AUTO_FULL | OR | 3 | 0.339 | 0.162 to 0.706 | 0.162 to 0.706 | 0.0% | 0.375 | 0.0000 | Yes |
| UPADACITINIB_CD | OR | 3 | 2.716 | 1.434 to 5.144 | 1.120 to 6.588 | 33.0% | 0.213 | 0.0204 | — |
| UPADACITINIB_CD_REVIEW | OR | 3 | 2.675 | 1.417 to 5.052 | 1.417 to 5.052 | 35.3% | 0.213 | 0.0000 | — |
| UPADACITINIB_CROHNS_DISEASE_AUTO_FULL | OR | 2 | 0.417 | 0.000 to 311703389679769415528637259886884814848.000 | — | 93.9% | 4.86e-05 | 99.1826 | Yes |
| UPADACITINIB_PSA_AUTO_FULL | OR | 2 | 0.212 | 0.024 to 1.852 | — | 0.0% | 0.407 | 0.0000 | Yes |
| UPADACITINIB_RA_AUTO_FULL | OR | 5 | 0.404 | 0.000 to 60646992.157 | 0.000 to 42856290068024958976.000 | 96.2% | 4.10e-22 | 229.8458 | Yes |
| UPADACITINIB_UC_AUTO_FULL | OR | 2 | 1.135 | 0.000 to 4880032474784600310193294325731799281055984356433688856100864.000 | — | 95.4% | 3.35e-06 | 241.3419 | Yes |
| USTEKINUMAB_CD_AUTO_FULL | OR | 2 | 0.602 | 0.086 to 4.200 | — | 0.0% | 0.980 | 0.0000 | Yes |
| USTEKINUMAB_CROHN_AUTO_FULL | OR | 2 | 0.602 | 0.086 to 4.200 | — | 0.0% | 0.980 | 0.0000 | Yes |
| USTEKINUMAB_PSORIASIS_AUTO_FULL | OR | 3 | 1.065 | 0.000 to 4686400531636885504.000 | 0.000 to 20427969485142259092609980955665367040.000 | 93.4% | 2.71e-07 | 298.5451 | Yes |
| USTEKINUMAB_PSO_AUTO_FULL | OR | 3 | 1.065 | 0.000 to 4686400531636885504.000 | 0.000 to 20427969485142259092609980955665367040.000 | 93.4% | 2.71e-07 | 298.5451 | Yes |
| VADADUSTAT_ANEMIA_AUTO_FULL_REVIEW | MD | 3 | -0.156 | -4.119 to 3.806 | -8.069 to 7.756 | 81.9% | 0.004 | 2.5336 | Yes |
| VADADUSTAT_RENAL_ANEMIA_AUTO_FULL_REVIEW | MD | 3 | -0.156 | -4.119 to 3.806 | -8.069 to 7.756 | 81.9% | 0.004 | 2.5336 | Yes |
| VAMOROLONE_DMD2_AUTO_FULL | OR | 4 | 1.438 | 0.223 to 9.280 | 0.223 to 9.280 | 0.0% | 0.867 | 0.0000 | Yes |
| VANCOMYCIN_CDI_AUTO_FULL | OR | 4 | 1.035 | 0.053 to 20.161 | 0.002 to 674.030 | 51.0% | 0.106 | 3.2738 | Yes |
| VANDETANIB_LUNG_AUTO_FULL | OR | 4 | 1.850 | 1.102 to 3.106 | 1.102 to 3.106 | 39.1% | 0.177 | 0.0000 | — |
| VANDETANIB_LUNG_AUTO_FULL_REVIEW | MD | 3 | 4.138 | -0.444 to 8.720 | -0.444 to 8.720 | 0.0% | 0.542 | 0.0000 | Yes |
| VANDETANIB_THYROID_AUTO_FULL | OR | 2 | 3.502 | 0.133 to 91.933 | — | 0.0% | 0.502 | 0.0000 | Yes |
| VARENICLINE_AUD_AUTO_FULL_REVIEW | MD | 2 | -0.218 | -8.127 to 7.691 | — | 76.1% | 0.041 | 0.0000 | — |
| VARENICLINE_SMOKING_AUTO_FULL | OR | 3 | 0.268 | 0.000 to 228195409571963.094 | 0.000 to 189568748814908379564857098240.000 | 84.0% | 0.002 | 191.3313 | Yes |
| VARENICLINE_TOBACCO_AUTO_FULL | OR | 2 | 0.561 | 0.052 to 6.116 | — | 0.0% | 0.588 | 0.0000 | Yes |
| VARENICLINE_TOBACCO_AUTO_FULL_REVIEW | MD | 2 | -0.501 | -10.511 to 9.508 | — | 91.8% | 4.84e-04 | 0.0000 | — |
| VEDOLIZUMAB_IBD_AUTO_FULL | OR | 2 | 0.591 | 0.000 to 1964.668 | — | 93.5% | 8.98e-05 | 0.0000 | — |
| VENETOCLAX_AML | OR | 2 | 0.484 | 0.052 to 4.462 | 0.052 to 4.462 | 0.0% | 0.337 | 0.0000 | Yes |
| VENETOCLAX_AML_REVIEW | HR | 2 | 0.674 | 0.186 to 2.438 | — | 0.0% | 0.782 | 0.0000 | Yes |
| VENETOCLAX_CLL | OR | 3 | 0.320 | 0.053 to 1.944 | 0.010 to 10.286 | 90.7% | 4.30e-05 | 0.4748 | — |
| VENETOCLAX_CLL_REVIEW | HR | 3 | 0.292 | 0.000 to 39373.972 | 0.000 to 5220517105.407 | 82.8% | 0.003 | 22.5646 | Yes |
| VENLAFAXINE_DEPRESSION_AUTO_FULL | OR | 4 | 1.048 | 0.283 to 3.878 | 0.283 to 3.878 | 79.2% | 0.002 | 0.0000 | — |
| VENLAFAXINE_DEPRESSION_AUTO_FULL_REVIEW | MD | 3 | 1.806 | -56.852 to 60.463 | -115.468 to 119.079 | 91.4% | 9.21e-06 | 557.0441 | Yes |
| VIASKIN_PEANUT_AUTO_FULL | OR | 2 | 0.136 | 0.000 to 78708640965753255714723699123454519149040467918677274029917338208668124358188279395448624771211967832091705116417736385292836298254023894813649232998066234725561174956146589433856.000 | — | 97.3% | 9.96e-10 | 2121.8172 | Yes |
| VIBEGRON_OAB_AUTO_FULL | OR | 2 | 0.627 | 0.000 to 1693.980 | — | 95.7% | 1.41e-06 | 0.0000 | — |
| VIBEGRON_OAB_AUTO_FULL_REVIEW | MD | 2 | -0.619 | -2.144 to 0.905 | — | 18.1% | 0.269 | 0.0000 | — |
| VIBOSTOLIMAB_LUNG_AUTO_FULL_REVIEW | HR | 2 | 1.208 | 0.385 to 3.795 | — | 0.0% | 0.583 | 0.0000 | Yes |
| VILAZODONE_DEPRESSION_AUTO_FULL | OR | 2 | 1.645 | 0.039 to 69.015 | — | 59.7% | 0.115 | 0.0000 | — |
| VILAZODONE_DEPRESSION_AUTO_FULL_REVIEW | MD | 4 | -1.702 | -44.973 to 41.568 | -98.241 to 94.836 | 54.1% | 0.088 | 735.3150 | Yes |
| VITAMIN_C_THIAMINE_SEPSIS | OR | 10 | 0.930 | 0.753 to 1.148 | 0.642 to 1.347 | 19.1% | 0.342 | 0.0182 | — |
| VITAMIN_C_THIAMINE_SEPSIS_REVIEW | RR | 5 | 0.953 | 0.109 to 8.324 | 0.005 to 186.819 | 59.9% | 0.041 | 3.0047 | Yes |
| VITILIGO | OR | 3 | 4.620 | 1.859 to 11.483 | 1.859 to 11.483 | 0.0% | 0.477 | 0.0000 | Yes |
| VITILIGO_REVIEW | RR | 3 | 3.388 | 1.349 to 8.504 | 1.349 to 8.504 | 0.0% | 0.644 | 0.0000 | Yes |
| VOCLOSPORIN_LN_AUTO_FULL | OR | 3 | 1.461 | 0.000 to 713932.848 | 0.000 to 339187155913.991 | 73.9% | 0.022 | 27.7274 | Yes |
| VOCLOSPORIN_LN_AUTO_FULL_REVIEW | OR | 2 | 2.432 | 0.189 to 31.278 | — | 0.0% | 0.536 | 0.0000 | Yes |
| VOCLOSPORIN_LUPUS_AUTO_FULL | OR | 3 | 1.461 | 0.000 to 713932.848 | 0.000 to 339187155913.991 | 73.9% | 0.022 | 27.7274 | Yes |
| VOCLOSPORIN_LUPUS_AUTO_FULL_REVIEW | OR | 2 | 2.432 | 0.189 to 31.278 | — | 0.0% | 0.536 | 0.0000 | Yes |
| VORTIOXETINE_DEPRESSION_AUTO_FULL | OR | 3 | 0.720 | 0.000 to 7229780.125 | 0.000 to 71394155685720.938 | 85.2% | 0.001 | 42.0634 | Yes |
| VORTIOXETINE_DEPRESSION_AUTO_FULL_REVIEW | MD | 3 | -2.438 | -64.995 to 60.119 | -127.429 to 122.554 | 80.4% | 0.006 | 632.5090 | Yes |
| VOXELOTOR_SCD_AUTO_2_FULL | OR | 2 | 0.472 | 0.010 to 22.229 | — | 0.0% | 0.663 | 0.0000 | Yes |
| VOXELOTOR_SCD_AUTO_FULL | OR | 2 | 0.472 | 0.010 to 22.229 | — | 0.0% | 0.663 | 0.0000 | Yes |
| VT_ABLATION_NEW_NMA_REVIEW | HR | 2 | 0.667 | 0.115 to 3.849 | — | 0.0% | 0.425 | 0.0000 | Yes |
| WARFARIN_AF_AUTO_FULL | OR | 2 | 1.429 | 0.214 to 9.545 | — | 0.0% | 0.809 | 0.0000 | Yes |
| WATCHMAN_LAAO_NMA | OR | 10 | 0.779 | 0.682 to 0.891 | 0.682 to 0.891 | 0.0% | 0.721 | 0.0000 | Yes |
| WATCHMAN_LAAO_NMA_REVIEW | HR | 2 | 0.846 | 0.148 to 4.833 | — | 0.0% | 0.376 | 0.0000 | Yes |
| WEEKLY_INSULIN_BROAD | OR | 10 | 1.135 | 1.071 to 1.203 | 1.071 to 1.203 | 0.0% | 0.979 | 0.0000 | Yes |
| WEEKLY_INSULIN_BROAD_REVIEW | RR | 6 | 1.059 | 0.984 to 1.140 | 0.984 to 1.140 | 0.0% | 0.815 | 0.0000 | Yes |
| ZILUCOPLAN_GMG_AUTO_FULL | OR | 2 | 0.462 | 0.001 to 152.815 | — | 0.0% | 0.491 | 0.0000 | Yes |
| ZILUCOPLAN_GMG_AUTO_FULL_REVIEW | MD | 2 | -2.135 | -8.719 to 4.450 | — | 0.0% | 0.868 | 0.0000 | Yes |
| ZILUCOPLAN_MG_AUTO_FULL | OR | 2 | 0.462 | 0.001 to 152.815 | — | 0.0% | 0.491 | 0.0000 | Yes |
| ZILUCOPLAN_MG_AUTO_FULL_REVIEW | MD | 2 | -2.135 | -8.719 to 4.450 | — | 0.0% | 0.868 | 0.0000 | Yes |
| ZIRCONIUM_HYPERKALEMIA_AUTO_FULL | OR | 2 | 0.834 | 0.052 to 13.474 | — | 0.0% | 0.363 | 0.0000 | Yes |
| ZOLBETUXIMAB_GASTRIC | OR | 2 | 0.996 | 0.994 to 0.999 | 0.994 to 0.999 | 0.0% | 1.000 | 0.0000 | Yes |
| ZOLBETUXIMAB_GASTRIC_AUTO_FULL | OR | 2 | 1.242 | 0.001 to 2655.577 | — | 91.2% | 7.69e-04 | 0.0000 | — |
| ZOLBETUXIMAB_GASTRIC_AUTO_FULL_REVIEW | HR | 2 | 0.712 | 0.261 to 1.940 | — | 0.0% | 0.689 | 0.0000 | Yes |
| ZOLBETUXIMAB_GASTRIC_REVIEW | HR | 2 | 0.721 | 0.250 to 2.081 | — | 0.0% | 0.618 | 0.0000 | Yes |
| ZOLMITRIPTAN_MIG_AUTO_FULL | OR | 2 | 0.555 | 0.060 to 5.115 | — | 2.2% | 0.312 | 0.0000 | — |
| ZURANOLONE_PPD | OR | 2 | — | — | — | 0.0% | 0.416 | 0.0000 | Yes |
| ZURANOLONE_PPD_REVIEW | MD | 2 | -3.135 | -12.553 to 6.282 | — | 0.0% | 0.416 | 0.0000 | — |